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“Proteins embody the active life of cells,  
while nucleic acids represent only plans. 
 
There is more to paella than the recipe,  
more to Bach than ink on paper,  
and more to a society than its code of laws.” 
 Anderson & Anderson 1998  
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Zusammenfassung 
Diese Dissertation entstand im Rahmen einer Cotutelle zwischen der Université de Pau 
et des Pays de l’Adour (UPPA) in Pau, Frankreich und der Christian-Albrechts Universität 
zu Kiel (CAU), Deutschland. Während dieser internationalen Zusammenarbeit wurden 
bioanalytische Methoden für die quantitative wie qualitative Analyse markierter Peptide 
und Proteine erarbeitet. Die Arbeiten basierten auf der Kopplung von Chromatographie 
und Massenspektrometrie.  
Peptide und Proteinverdaue wurden nach einem optimierten Protokoll mit DOTA-
basierten Verbindungen lanthanid-markiert. Die Separation auf Peptidebene wurde 
mittels IP-RP-nanoHPLC durchgeführt. Komplementäre Datensätze wurden mittels 
MALDI-MS zur Peptidindentifizierung und mittels ICP-MS zur Quantifizierung erstellt. In 
diesem Rahmen wurde ein online Aufreinigungsschritt zur effektiven Entfernung von 
Reagenzüberschüssen entwickelt und in die nanoHPLC Trennungsmethode 
implementiert. Dies führte zu niedrigeren Metallhintergrundwertem in nanoHPLC-ICP-
MS Messungen und einer besseren Interpretierbarkeit der Daten, gleichzeitig konnten 
die Peptidausbeuten auf höchstem Niveau erhalten bleiben. Alternative offline 
Reinigung mittels Festphasenextraktion (SPE) verursachte beträchtliche Verluste in den 
Peptidausbeuten und konnte für quantitative Analysen als ungeeignet erachtet werden. 
Die Zumischung verschiedener Substanzen, wie HFBA und EDTA zu den Eluenten der 
nanoHPLC wurde untersucht und für die Analyse normaler Peptidproben als wenig 
nutzbringend befunden. HFBA kann dennoch eventuell für Spezialanwendungen auf 
besonders hydrophile Peptide in Betracht gezogen werden.  
Ein Satz markierter Peptide wurde zusammengestellt, welcher durch Verwendung 
bekannter Mengen für eine schnelle und einfache Quantifizierung einer wenig 
komplexen Probe eingesetzt werden konnte. Zudem konnten diese Peptide dazu 
verwendet werden, eine zuverlässige Überlagerung von Chromatogrammen zu erwirken 
und damit die Probenvergleichbarkeit speziell zwischen ICP-MS und MALDI-MS sicher zu 
stellen. 
Versuche zur Anwendung von fsLA-ICP-MS auf MALDI-Stahlplatten wurden durchgeführt 
und zeigten vielversprechende Ergebnisse. Hierzu sollten bereits mit MALDI-MS 
identifizierte Proben, erneut mittels fsLA-ICP-MS gemessen werden. Erste 
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Quantifizierungsversuche auf modifizierten MALDI-Platten waren erfolgreich. 
Angepasste MALDI-MS Parameter ermöglichten eine eindeutige Peptididentifikation. 
Schlüsselwörter 
Molekulare Massenspektrometrie und Elementmassenspektrometrie, MALDI-MS, ICP-
MS, fsLA-ICP-MS 
Lanthanid Markierung, NHS-DOTA, maleimido-monoamide-DOTA,  
Peptide, Proteinverdaue 
nanoHPLC, online Vorreinigung, Festphasenextraktion, HFBA, EDTA 
Abgleichen von Daten, Identifizierung, Quantifizierung 
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Résumé 
Cette thèse est le résultat d’une cotutelle entre l'Université de Pau et des Pays de 
l'Adour (UPPA) à Pau, en France et l'Université Christian Albrecht (CAU) à Kiel, en 
Allemagne. Dans le cadre de cette collaboration internationale, des méthodes bio-
analytiques sont développées pour analyser quantitativement et qualitativement des 
peptides et protéines marquées par le couplage de la chromatographie avec la 
spectrométrie de masse. 
Les peptides et les digestats des protéines sont marquées selon un protocole optimisé 
par des lanthanides en utilisant des composés à base de DOTA. La séparation des 
peptides est réalisée par IP-RP-nanoHPLC. Des données complémentaires sont acquises 
par MALDI-MS pour l'identification et par ICP-MS pour la quantification. Dans ce 
contexte, une étape de pré-nettoyage en ligne est développée et mise en œuvre dans le 
protocole de séparation par nanoHPLC. Cette étape permet l'élimination efficace des 
réactifs appliqués en excès et ainsi la diminution du bruit de fond lié à la présence de 
métaux lors des analyses par ICP-MS. Les données obtenues sont alors plus facile à 
interpréter, la sensibilité des signaux des peptides n’étant par ailleurs pas modifié. 
L'extraction en phase solide (SPE) appliquée comme alternative entraîne des pertes 
importantes de peptides et peut être considérée comme inadaptée pour l'analyse 
quantitative. Des additifs pour éluants de nanoHPLC, tels que l'EDTA et le HFBA sont 
testés et jugés non bénéfiques pour l'analyse des échantillons peptidiques normaux. 
HFBA peut être reconsidéré pour une application spéciale sur des peptides très 
hydrophiles.  
Des peptides marqués sont développés. Leur utilisation en quantité connue pourrait 
permettre la quantification rapide et simple d'un échantillon de digestat à faible 
complexité. De plus, cet ensemble de peptides permet la superposition fiable des 
chromatogrammes, et ainsi de comparer des données complémentaires obtenues par 
l’analyse d’échantillon par ICP-MS et MALDI-MS.  
Expériences d'application avec le couplage laser femtoseconde avec ICP-MS sont 
effectuées sur des plaques métalliques de MALDI-MS et montrent des résultats très 
prometteurs. Pour cela, les échantillons préalablement identifiés par MALDI-MS sont 
analysés par fsLA-ICP-MS. Les premières tentatives de quantification sur la plaque en 
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acier modifiée sont satisfaisantes et donnent des résultats répondant aux attentes. 
L’optimisation des paramètres de MALDI-MS facilite l’identification des peptides.  
Mots Clés 
Spectrométrie de masse moléculaire et élémentaire, MALDI-MS, ICP-MS, fsLA-ICP-MS 
Marquage avec des lanthanides, NHS-DOTA, maleimido-monoamide-DOTA,  
peptides, digestats de protéines 
nanoHPLC, purification en ligne, extraction en phase solide, HFBA, EDTA 
Superposition des chromatogrammes, identification, quantification 
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Abstract 
This PhD thesis was a Cotutelle between the Université de Pau et des Pays de l’Adour 
(UPPA) in Pau, France and the Christian-Albrechts University (CAU) in Kiel, Germany. In 
the course of this international collaboration, bio-analytical methods for the 
quantitative and qualitative analysis of labelled peptides and proteins were developed, 
which were based on the hyphenation of chromatography with mass spectrometry.  
Peptides and protein digests were lanthanide labelled using DOTA-based compounds 
according to an optimised protocol. Separation on the peptide level was performed 
using IP-RP-nanoHPLC. Complementary data sets were acquired using MALDI-MS for 
identification and ICP-MS for quantification. In this context, an online precleaning step 
was developed and implemented in the nanoHPLC separation routine, which allowed for 
effective removal of excess reagents. This lead to lowered metal backgrounds during 
ICP-MS measurements and thus better data interpretability, while guarding peptide 
recovery at a maximum level.  
An alternative offline purification using solid phase extraction (SPE) resulted in 
important peptide losses and can be considered unsuitable for quantitative analysis. 
Additives to the nanoHPLC eluents, such as HFBA and EDTA were tested and not 
deemed beneficial for the analysis of normal peptide samples. HFBA can be 
reconsidered for special application on very hydrophilic peptide species.  
A set of labelled peptides was developed, which due to application of known quantities 
could be employed for quick and simple quantification of a low complexity digest 
sample. In addition this peptide set allowed for the reliable superposition of 
chromatograms, enabling sample comparability especially for complementary ICP-MS 
and MALDI-MS data.  
Experiments for application of fsLA-ICP-MS on MALDI-MS target plates were conducted 
and showed very promising results. For this purpose, samples that were already 
identified using MALDI-MS were supposed to be remeasured using fsLA-ICP-MS. First 
quantification attempts on the modified steel target plate were successful and in the 
range of expectance. Adjusted parameters for MALDI-MS allowed for proper peptide 
identifications.  
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I Introduction 
Proteins are the building blocks of life: Structural proteins give cells stability, enzymes 
conduct chemical reactions, transport proteins are regulating supply and removal of 
substances to and from cells and their compartments. Life is a complex interplay and 
proteins play a vital role in it. 
In order to understand these interactions, now the involved proteins need to be 
characterised. This is where the field of proteomics comes into play, which concerns 
itself with the analysis of proteins in a large scale, elucidating questions about functions 
and structure and thus helping to map out biological pathways. The most powerful tool 
in proteomics is molecular mass spectrometry (MS), which can be utilised to determine 
the molecular weight of proteins and their sequence. Proteomics goes hand-in-hand 
with genomics and bioinformatics in form of sequence databases and tools for data 
interpretation.  
But not only is it important to know which proteins are present and where, their 
quantities are of equal importance. Therefore a growing interest is held in quantitative 
proteomics, as can be seen by taking a look at the rising number of publications in the 
field. Unfortunately molecular MS is limited in regard to quantitative applications. 
Recent developments therefore try to implement elemental MS into protein analysis.  
Elemental MS, e.g. inductively coupled plasma MS (ICP-MS) is a highly sensitive 
analytical method providing matrix independent analysis of elements. It has an 
unrivalled dynamic range of commonly 9 orders of magnitude, which means that certain 
metals can still be detected at attomole levels. ICP-MS is already commonly applied for 
protein analysis based on elements such as S, Se or P which are occurring naturally in the 
proteins of interest. Such approaches quickly reach their limitations, since these 
elements show low ionisation efficiencies and require quite high protein concentrations. 
An alternative are labelling approaches, which introduce a detectable element into the 
molecule of interest. Labels employing chelators, such as DOTA and DTPA are especially 
interesting, since the introduced element can be chosen quite freely, allowing for 
multiplex analysis. DOTA is commercially available in form of bifunctional reagents with 
different reactive groups enabling targeted derivatisations. 
I   INTRODUCTION 
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Two of these very versatile DOTA-based reagents were employed during this PhD thesis. 
NHS-DOTA targets amino groups in both N-termini and lysine residues, whereas 
maleimido-monoamide DOTA can be used to tag sulfhydryl groups in cysteines. They 
were applied in combination with five mostly monoisotopic lanthanides, forming 
extremely stable complexes and enabling multiplex analysis. In addition, lanthanides are 
among the elements with the best ionisation efficiencies in ICP-MS, enabling sensitive 
and accurate detection of peptides labelled with these tags. 
The destructive nature of the ICP process causes a complete loss of the structural info, 
causing a need for complementary identification by e.g. molecular MS. 
1.1 Aim of the Thesis  
The general aim of the thesis was the development of bio-analytical methods that 
contribute to the analysis of peptides, proteins and proteomes both in a qualitative and 
quantitative manner. A combination of separation techniques was supposed to be 
employed alongside mass spectrometry. The main basis for the experiments were the 
labelling approaches using DOTA-reagents and their detection with molecular MS, 
represented by MALDI-MS on the one hand and the application of elemental MS in form 
of ICP-MS on the other. For separation purposes classical approaches, such as gel 
separations and nanoHPLC were employed. 
Being a cotutelle between two universities, the experiments were conducted at both 
sites, namely at the ‘Laboratoire de Chimie Analytique, Bio-inorganique et 
Environnement’ (LCABIE) of the ‘Institut des Sciences Analytiques et de Physico-Chimie 
pour l’Environnement et les Matériaux’ (IPREM) at the UPPA in Pau and at the facility for 
Systematic Proteomics and Bioanalytics of the Institute for Experimental Medicine (IEM) 
as a part of the CAU in Kiel. 
The experiments in both laboratories were not separated per se; they rather were 
conducted in conjunction, since the equipment of both laboratories was of 
complementary nature. This posed an additional challenge to the thesis, through the 
geographical distance. The laboratory in Pau provided access to a nanoHPLC system and 
several ICP-MS instruments. A fraction collector was provided for the facilities in Pau by 
the laboratory in Kiel as an item on loan. Thereby samples could be analysed via 
I   INTRODUCTION 
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nanoHPLC ICP-MS for quantification and in a second analysis they could be spotted on 
MALDI-target plates using the fraction collector. Like this, the measured samples could 
be transported to Kiel for the complementary MALDI-MS analysis.  
The implementation of this ‘in-between laboratories routine’ was part of the aims of the 
thesis. It should thereby be shown, that it is possible to conduct experiments of this 
kind, without the need of having all necessary instruments in the same locality. 
Regarding the experimental part, firstly the DOTA-labellings were supposed to be 
optimised and evaluated for the use with nanoHPLC ICP-MS based quantification. 
Therefore special attention was given to the excess reagents employed during 
derivatisation. Several options should be enquired for the reliable removal of the excess 
metal prior to ICP-MS analysis, in order to facilitate data interpretability. This included 
online purification approaches implemented in the nanoHPLC routine, as well as offline 
purification attempts. Another challenge lay in the baseline separation of peaks in ICP-
MS chromatograms, which is a vital prerequisite for quantification approaches. 
Furthermore the general comparability of ICP-MS based data sets to data sets from 
complementary techniques, such as MALDI-MS should be ensured. This was especially 
important in regard to the experiments conducted on different equipment at both 
laboratories. The peptide identifications from MALDI-MS generally needed to be 
attributed to the respective peaks in the ICP-MS chromatograms. For this purpose data 
superposition in form of chromatograms should be conducted, including the 
development of a reliable tool to resolve possible difficulties with such overlays. 
Concepts for lanthanide-DOTA based quantification of peptides and protein digests 
should be developed and tested for their applicability. Aim was the development of an 
assay which would in the best of cases be applicable on any kind of protein and peptide 
sample, thus suitable for proteome analysis. Therefore the capabilities of labelled 
standard peptides should be evaluated and analysed according to their comparability 
with the unrelated labelled peptide samples.  
Lastly, novel combinations of different complementary analysis techniques should be 
investigated, such as the use of consecutive MALDI- and laser ablation (LA) ICP-MS.  
II  SCIENTIFIC BACKGROUND 
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II Scientific Background 
2.1 From Genes to Proteins – a Short Historic Overview 
In the 1990s, the world’s attention was drawn to the human genome project. During the 
rapid development in the genomics sector, the interest in the proteins linked to those 
sequences grew again and in 1996 the term proteome finally appeared[5] and gave a 
modern name to this complementary piece of the biology puzzle. Especially the 
introduction of soft ionization methods for mass spectrometry enabled a great leap in 
protein studies. It was thereby possible to determine the molecular weights of proteins 
and peptides in a fast and accurate manner.[6, 7] 
It was then clear pretty quickly that mRNA measurements cannot substitute direct 
protein analysis. Not only was it merely impossible to reliably predict protein abundance 
on a cellular level, just by looking at mRNA copy numbers. Also the correlation between 
the mRNA and protein abundance was shown to be somewhere in the middle between 
perfect and no correlation at all, suggesting that post-transcriptional regulation plays a 
great role in gene expression in higher organisms.[8]  
Currently scientists are trying to develop a map of the human proteome, to further 
investigate signalling pathways, protein families and interactions. To date, proteomics is 
a large and indispensable research field, contributing to the web of knowledge trying to 
enlighten biological pathways. Many other ‘omics’ followed since: Metabolomics, 
lipidomics, transcriptomics, metallomics or metallothiolomics, just to name some.[9-12] 
2.2 Proteins – Structure and General Properties 
Proteins are made of AA chains which can have fairly large dimensions (e.g. titin[13] 
isoforms with up to 3.000kDa). The AAs incorporated are linked by peptide bonds and 
consist mainly of a set of 20 proteinogenic α-AAs. This set is universal and can be found 
in all organisms likewise, from bacteria to mammals. Depending on the type of 
organism, sometimes other proteinogenic AA can be incorporated, such as 
selenocysteine or pyrrolysine which are indirectly coded on the DNA, as special cases of 
stop codons.[14, 15] The combination of all those amino acids leads to hundreds of 
thousands of protein sequences, each protein afterwards unique in its structure and 
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function. The sequence of the AA in the polypeptide chain is called primary structure. 
Interactions between adjacent side chains cause the strands to fold characteristically, 
the most prominent secondary structures being α-helices, β-pleated sheets and β-turns. 
The tertiary structure comprises the complete three-dimensional configuration of the 
protein, also including side chain interactions between AA residues that are farther away 
from each other and intra-molecular disulfide bonds. Subareas of the protein often fold 
in independent structures, which are then called domains. When several folded 
polypeptide chains assemble to form a bigger complex, we speak of the quaternary 
structure, with the separate polypeptide chains being the subunits.  
 
Figure 1. Structure of proteins
[16]
 
To add even more to the protein diversity, post translational modifications (PTMs) can 
occur which give certain properties to the proteins. To name only some examples: 
hydroxyproline helps building out the triple helix of the structural protein collagen; 
phosphorylations (e.g. on Ser, Thr or Tyr) can induce conformation changes and thereby 
activate and deactivate certain enzymes; carboxylation of glutamic acid in blood factors 
can start the coagulation cascade and glycosylation on e.g. Asp, Ser or Thr, can add to 
protein stability and plays roles in cell-cell adhesion, interaction and recognition, thus 
playing a major role in immune system recognition reactions.[16]  
2.2.1 Functions 
The real importance of proteins becomes quite clear when looking at the vast amount of 
tasks taken over by them. In fact most functions in living organisms are taken on by 
proteins. 
 
 
 
 
primary secondary tertiary quaternary 
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It already starts with the static stability of cells and tissues, where proteins such as 
collagen, keratin or actin and tubulin are giving structural support. Proteins also play key 
roles in biochemical cascades or in signal transmission in form of neurotransmitters. 
They regulate the reproduction of cells and the replication of DNA, as well as the 
production of the proteins themselves in the ribosomes. Trophic factors are influencing 
the development and growth of tissues. The immune response is taken on by 
immunoglobulins.  
Proteins are also in charge of storage and transport of substances (e.g. transport of 
oxygen by haemoglobin). Enzymes conduct chemical reactions that would not be 
possible in the normal surrounding of the cell. Also they catalyse the reactions in a way 
that they are much faster than it would ever be possible in a laboratory.[16] 
2.3 Sample Preparation for Protein Analysis 
Before being able to analyse the proteins, they have to be made accessible. When 
working with biological samples, like cells or tissue, it starts with homogenisation and 
cell disruption. In order to not destroy or inactivate the proteins of interest, several 
precautions should be taken, such as the use of suitable buffers, protection from 
proteolysis by addition of protease inhibitors and sample preparation at low 
temperatures (≤4°C). Depending on the protein of interest and its location in the cell or 
the cell compartments, even fractionation by ultracentrifugation can be utilised. 
A very essential problem is to keep the proteins in solution: an inadequate pH can cause 
certain proteins to precipitate because of their IP. Also protein structure (secondary and 
tertiary) can hinder solubilisation. Denaturing agents, such as urea, can be employed to 
convert the native proteins to more soluble denatured monomers. Detergents (SDS, 
CHAPS) further improve solubilisation, reducing agents (DTT, TCEP, β-mercaptoethanol) 
can be utilised to break disulfide bridges. Reducing agents also prevent unwanted 
oxidations. 
In order to keep the free thiol groups from reacting with each other, alkylation is applied 
(e.g. with iodoacetamide or methyl methanethiosulfonate). 
Cell disruption itself can be carried out in different ways: osmotic shock lysis (in 
hypotonic solutions), mechanic (sonication, pressing, grinding with glass beads) or 
chemical (alkali or enzymatic treatment). After the disruption, the sample contains cell 
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debris that needs to be removed by centrifugation or microfiltration. The supernatant is 
supposed to be transparent and contains a multitude of compounds: proteins, added 
chemicals for the lysis, lipids, salts, nucleic acids, amino acids, peptides and metabolites. 
For removal of lipids, extraction with an organic solvent (e.g. chloroform) can be 
performed. Nucleic acids can be broken down to nucleotides by RNAse and DNAse. 
While, back in the days, it was interesting to just isolate and purify single proteins, for 
modern protein analysis it is necessary to avoid changes in the protein composition of 
the sample. Unfortunately, classical protein purification methods like e.g. precipitation, 
tend to favour certain protein species and lose others, making quantitative whole 
proteome analysis impossible.[17, 18] 
2.3.1 Separation and Purification 
In order to remove proteins from their matrix after cell lysis and in order to separate 
them from each other, different separation and purification techniques can be 
employed. They can e.g. be separated according to physical properties, such as size, 
isoelectric point, hydrophobicity or charge state. 
Precipitation. For removal of interfering species in the matrix of a protein mixture, 
protein precipitation can be used. One option is the use of organic solvents, such as 
ethanol, methanol or acetone. Proteins can also be salted out, using anti-chaotropic 
salts from the Hofmeister-series.[19, 20] The precipitate can then be removed from the 
supernatant and be washed and reconstituted in a suitable buffer. Precipitation is 
commonly used prior to gel electrophoresis and isoelectric focussing.[21] Dialysis enables 
protein purification through diffusion processes by application of a semi-permeable 
membrane. The driving force for the process is a concentration difference between the 
sample inside the membrane and the dialysate solution outside of it. The membrane 
pores only let the low molecular weight compounds pass through, leaving behind the 
purified proteins. This method does not lower the sample volume, but provides high 
recoveries and enables purification of proteins in their native form.[22] Ultrafiltration 
(UF) can also be used on native proteins. It employs membranes with pore sizes that 
retain particles with more than 10-200 Å, which makes it ideal for macromolecules 
between 1 and 500 kDa. For small scale applications, centrifugal filters can be applied, 
leading to a purification and concentration of the sample in the filter by removal of low 
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molecular weight impurities and solvents. The choice of adequate pore sizes (molecular 
weight cut-off) also allows for fractionation of proteins according to their size.[22] Solid 
Phase Extraction (SPE) can be utilised to extract compounds from a solution by binding 
them reversibly to a stationary phase. Different materials can be employed (further 
discussed in section 2.3.3): ion exchange, reverse and normal phase materials. The 
sample is loaded onto an extraction cartridge under specific conditions that allow for the 
binding of the analyte. In the following the cartridge can be washed to remove 
impurities and the analyte then be eluted from the cartridge. By variation of elution 
solution composition, fractionation is possible.  
2.3.2 Electrophoresis 
Gel Electrophoresis (GE) is based on the migration of macromolecule ions through a gel 
by application of an electric field. In protein analysis SDS-PAGE (sodium dodecyl sulphate 
poly acrylamide gel electrophoresis) is one of the methods of choice for protein 
separation. SDS inhibits protein-protein interaction, keeping the proteins in solution, by 
shielding direct protein-protein interactions. All proteins are negatively charged in the 
same way, so that the charge state does not play a role in the separation. In the electric 
field the proteins are therefore separated according to their size (Stoke’s radius), while 
they migrate though the pores of the gel with different velocities. The polymerisation 
grade of the gel can be manipulated by the percentage of acrylamide in the gel mixture. 
After the separation, proteins have to be made visible with staining (coomassie, 
silver).[23] Isoelectric Focussing (IEF) separates proteins according to their isoelectric 
point (pI). The pI of a protein is the pH where the protein reaches a global charge state 
of zero. For IEF a pH gradient is immobilised in form of a gel. Proteins are applied and 
migrate in the electrical field until they reach the pH where their net charge is zero and 
thus stop migrating. IEF is commonly used together with SDS-PAGE in 2D-GE (two-
dimensional gel electrophoresis). The IEF strip as a first dimension is applied on a SDS-
PAGE gel and the pI separated protein groups are separated in a second dimension 
according to their molecular weight. Separations of up to 5 000 proteins in one gel are 
possible.[24] Capillary Electrophoresis (CE) is based on the separation of ions in an 
electrically conductive liquid within an applied electrical field. In the most basic setup, a 
fused silica capillary (I.D. 25-100 µm) is linking two buffer reservoirs which contain one 
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electrode each. All ions, both positive and negative, as well as neutral species are pulled 
in the same direction because of the electro-osmotic flow in the capillary. This leads to a 
separation according to charge state, shape and size of the analyte. Variations of CE are 
capillary zone electrophoresis (CZE), capillary electro chromatography (CEC), capillary gel 
electrophoresis (CGE), micellar electro kinetic chromatography (MEKC), capillary 
isotachophoresis (CITP) and capillary array electrophoresis (CAE).[25] 
2.3.3 Chromatography 
Basically, chromatography is the separation of a mixture dissolved in a mobile phase 
through interaction with a stationary phase. The categories in chromatography are 
numerous and it already starts with the mobile phase: it can be a liquid – as in liquid 
chromatography (LC), a gas – as in gas chromatography (GC) or a supercritical fluid (SFC). 
Another possibility of differentiation is into column and planar chromatography (e.g. 
TLC, thin layer chromatography). Depending on the capacity of the chromatography 
system, it can further be distinguished between analytical and preparative application or 
into miniaturised formats like micro or nanoLC. 
In column based chromatography the pressure that is applied by the pump during 
analysis is another parameter for categorisation: LC runs at low pressure, high 
performance liquid chromatography (HPLC) applies pressures between approx. 50 and 
350 bar, ultra high performance liquid chromatography (uHPLC) has a pressure limit of 
approx. 3600 bar.  
The choice of the stationary phase material is the parameter which determines through 
which physical or chemical property the analytes are going to be separated:  
Size-Exclusion Chromatography (SEC) also referred to as gel filtration, separates 
proteins according to their size. In contrary to SDS-PAGE big molecules move faster and 
elute first, since small molecules interact more intensively with the porous structure of 
the stationary phase. SEC can be used to remove low molecular species from the 
mixture and since mobile phases with the physiological pH of 7.4 can be applied, it is 
valid for separation of native proteins. Limitations are its applicability on water-soluble 
proteins, since hydrophobic proteins can precipitate on-column.[26] Ion Exchange 
Chromatography (IEX) is based on the separation of ions and polar molecules according 
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to their charge. The stationary phase carries either positively (anion exchange, AEX) or 
negatively charged groups (cation exchange, CEX). AEX and CEX both exist as strong or 
weak ion exchange. The interaction between the ion exchange material and the analyte 
is mainly depending on the pI of the protein and the pH and ionic strength of the 
employed buffer. IEX-purification is usually more efficient than with SEC and the sample 
is concentrated in a smaller volume after elution.[23] Affinity Chromatography is based 
on highly specific interactions and allows a selective purification of proteins or protein 
groups of interest. It can be used to deplete highly abundant proteins or isolate a 
protein of interest, which is especially interesting for less abundant protein species. 
Depending on the application different functional groups are immobilised on the 
stationary phase to reversibly bind the target structures: Antibodies (ABs) can be utilised 
for specific application, biotin-tags can be used with immobilised streptavidin, lectins 
can be employed to bind glycoproteins, Ni or Co can be used to bind hexahistidine 
tagged proteins.[23, 27] Reverse Phase (RP) is one of the most commonly used column 
materials in peptide and protein analysis. It relies on hydrophobic interactions between 
the analyte and alkyl hydrocarbon chains which are often bound on a silicagel surface as 
support. Column material which contains unmodified SiOH or other polar moieties is 
called ‘normal phase’(NP). The most popular RP material is C18, which is applicable for 
analytes with MWs up to 5 kDa (peptides and small proteins). For proteins larger than 5 
kDa, C4 columns are recommended (see Figure 2).[28] 
 
Figure 2: Pore size and RP materials recommended for various MWs and hydrophobicities. Reproduced from 
Carr.
[28]
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Ion Pairing (IP) reagents such as TFA can be added to the mobile phase in order to 
enhance the interaction between hydrophilic species and the hydrophobic surface of the 
RP material. Hydroxylapatite (HA) is a calcium phosphate based material which interacts 
with both carboxyl and amino groups in native proteins. Low molecular weight 
compounds or denatured proteins do not bind. It can be regarded as a mixed-mode ion 
exchange chromatography and its outcome is usually hard to predict in advance. 
Analytes can be eluted with a rising phosphate buffer gradient.[23] HIC and HILIC. 
Hydrophobic Interaction Chromatography (HIC) is based on interactions between 
hydrophobic parts of the analyte and the hydrophobic surface of the stationary phase, 
while hydrophilic interaction liquid chromatography (HILIC) is pretty much the same 
with hydrophilic moieties. It is another mode which can be used with e.g. RP and NP 
materials and only differs in the composition of the mobile phase. While in RP 
chromatography, the most commonly used eluents are mixtures of organic solvents and 
water, in HIC mode, the elution is done with a decreasing salt gradient (e.g. NH4SO4).
[23, 
29] Two-dimensional LC (2D-LC) is referring to the consecutive combination of two 
orthogonal LC separation techniques. It can be conducted by direct elution from the first 
column onto the second (online) or by e.g. fraction collection from the first column and 
reinjection of the fractions onto the next column (offline). Orthogonal techniques which 
were reported are: high pH RP and low pH IP-RP,[30] IEX and RP, RP and CEC, SEC and RP, 
AC and RP.[31] 
2.4 Mass Spectrometry  
 
 
 
Mass spectrometry in the broadest sense, can also be seen as a separation technique. It 
concerns itself with the determination of the mass to charge (m/z) ratio of atoms or 
molecules. As a first step, analytes need to be converted into ionized species and 
brought into a gaseous state. The sample is therefore vaporised and ionised in an ion 
source. The ions are then transferred into a mass analyser, which separates them 
according to their m/z ratios, prior to their arrival at the detector. The resulting spectra, 
Ion Source Mass Analyser Detector 
Figure 3: General scheme of a mass spectrometer 
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in general, show abundance in form of signal intensity over m/z. The most accurate mass 
spectrometers can determine ion masses with errors smaller than 1ppm.[32] Mass 
spectrometry, including tandem MS is one of the most important and powerful 
analytical tools in life science, chemistry and industrial applications. 
2.4.1 Ionisation Techniques 
As mentioned above, the analyte has to be brought into a gaseous state before it can be 
analysed. Depending on the analyte there is a multitude of ionisation techniques, 
distinguished between soft and hard ionisation methods. The soft ionisation methods 
for biomolecules comprise among others: Matrix Assisted Desorption/Ionisation 
(MALDI), Electrospray Ionisation (ESI), Surface Enhanced Laser Desorption/Ionisation 
(SELDI) and Fast Atom Bombardment (FAB). They enable ionisation of macromolecules, 
without destroying them prior to their analysis. Those soft ionization techniques are 
utilised in molecular MS. A hard ionisation method is inductively coupled plasma (ICP), 
where the analytes are broken down to their atoms, due to the high thermal energy. It is 
used for elemental MS. 
2.4.1.1 Inductively Coupled Plasma 
ICP-MS is a highly sensitive analytical method and is widely used in trace element and 
environmental analysis. The ionisation takes place in an argon plasma flame at 5.000-
10.000 K, leading to a complete loss in structural information of the sample. The scheme 
for the ion generation in the plasma is shown in Figure 4. The sample is usually 
introduced as a liquid aerosol using a nebuliser, which is adapted to the experimental 
needs. Due to the different heat zones of the plasma, the aerosol is dried, vaporised, 
atomised and then ionised. The plasma itself is generated by induction of a high 
frequency current into ionised argon. 
The extent to which an element is ionised depends on its first ionisation energy. The 
available energy of the argon plasma is approximately 15.8 eV, whereas the majority of 
the elements have first ionisation potentials between 4 and 12 eV.[33] 
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Figure 4: Generation of positively charged ions in the plasma, adapted from Thomas 
[33]
 
As shown in Figure 5, the required ionisation energies rise from bottom to top and left 
to right in the periodic table. Metals in general, except for platinum, gold and mercury, 
show good to excellent ionisation efficiencies. It has been shown that even attomole 
amounts of certain metals can still be detected using ICP-MS.[34] Apart from its 
remarkable sensitivity, ICP-MS also shows a very high dynamic range, which cannot be 
rivalled by any other method. Usually nine orders of magnitude are possible,[35, 36] but 
also twelve orders of magnitude were reported for metal-salt solutions.[34] Since 
ionisation is virtually matrix and molecule independent, external calibration can be used 
for quantification.[37] 
Table 1: Polyatomic interferences for selected lanthanides 
[38, 39]
 
Element m/z values Interference Required resolution R 
for peak separation[39] 
Erbium 166 
167 
168 
          150Sm16O 
          151Eu16O+ 
          152Sm16O 
 
 
9470 
Holmium 165           149Sm16O  
Lutetium 175           159Tb16O 8520 
Terbium 159           142Nd16O+  
Thulium 169           154Eu16O 9342 
 
Depending on the analyte species, interferences can occur: elemental isobaric 
interferences can be caused by isotopes of an element which have the same mass to 
charge as the analyte, e.g. 114Cd and 114Sn. Also doubly charged ions can interfere, which 
is the case for 150Sm++ and 75As+. The most commonly occurring interferences are 
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polyatomic, where molecular species with the same m/z as the analyte hamper with the 
analysis. Especially reaction products of argon, atmospheric gases, salts and acids pose 
problems. For example, ArO+ can interfere with 56Fe+, 52Cr+.[38] 
 
Figure 5: Periodic table of elements with calculated values of the degree of ionisation of M
+ 
(T = 7500K ne = 
1x10
15
cm
-3
)
[40]
 and limits of detection in LA-ICP-MS
[41]
 
A collision/reaction cell can remove those interferences by kinetic energy discrimination 
through collision with an inert gas or by shifting their m/z by reaction with a gas in a way 
that it won’t interfere anymore. Commonly used gases are ammonia, methane, oxygen 
or hydrogen. As an example, the instrument used in this thesis from Agilent’s 7500 
series uses an octopole reaction system (ORS) which runs with helium or hydrogen. In 
collision mode, pure Helium is used to remove unwanted molecules: it collides more 
frequently with the larger ionised molecules than it does with ionised atoms, causing the 
molecules to lose more of their kinetic energy. The needed collision energy is 
characteristic for each ion species, allowing the application of a kinetic energy filter 
using the octopole. Being inert, Helium does not form new interferences. The reaction 
mode is mostly used for analytes which show plasma based interferences (e.g. Se). 
Hydrogen reacts quickly with the Ar-based interfering species, but reacts only slowly or 
not at all with the analyte.[42]   
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2.4.1.2 Laser Ablation 
For analysis of solid samples with ICP-MS, a hyphenation with laser ablation (LA) became 
the method of choice, ever since it was introduced in 1985.[43] Ablation is the removal of 
material by heating, by e.g. a laser or through atmospheric friction. In LA, small amounts 
of solid sample (or rarely liquids) are removed by short but intense laser pulses. 
Depending on the laser fluence, the sample is either evaporated by heat (low fluence) or 
directly converted into a micro plasma (high fluence). The ablation takes place in an air-
tight ablation cell. The particle/vapour mixture created through LA is then transported 
by a vector gas from the cell to the plasma of the ICP-MS. Ideally, the LA should result in 
a quantitatively transportable aerosol, which is representative for the sample in its 
composition.  
 
Figure 6, left: Simple scheme of a fsLA-ICP-MS system. Right: ICP-MS signal obtained by femtosecond (785 nm, 
130 fs) and nanosecond (266 nm, 8 ns) LA-ICP-MS of steel. Adapted from Shaheen et al.
[44]
 
The analytical performance is influenced by a large variety of parameters, which makes 
it hard to implement laser ablation as a routine analysis tool. Laser related parameters 
comprise: wavelength (IR, UV, deep UV), pulse width, fluence, pulse repetition rate, 
beam profile and focus. Apart from ICP and MS related parameters, the geometry and 
volume of the ablation cell, as well as the type or composition of the vector gas, also 
play a role in the performance. Lastly, physical properties of the sample itself can also 
have an influence.[44] 
Classification of the laser system is usually based on the laser pulse width, which ranges 
from nanoseconds (ns), down to femtoseconds (fs). Ablation quality of fsLA-systems is 
shown to be better than longer wavelength ns-LA, which is due to the interaction of the 
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ultra short laser pulses with the matter: the energy transfer of a fs pulse is too short to 
leave the material enough time to melt, resulting in more uniform ablation behaviour of 
materials with different physic-chemical properties. The generated particles (size in 
nanometre range) are more efficient to transport and ionise, than the ones resulting 
from a ns pulse.[44-47] 
The most evident advantage of this technique is the possibility to analyse solids without 
having to put them in solution via mineralisation with strong acids. This is avoiding 
further contamination and loss of sample. Another advantage is the possibility of 
spatially resolved analysis, either on a plane or in depth.  
LA-ICP-MS is used on various materials and has applications in chemical analysis (alloys, 
crude oils),[48, 49] geochemistry (soils, sediments),[50] industry (semiconductors, 
coatings)[51, 52] and biology (tissue imaging, blotted membranes and IEF-strips/2D-
gels).[53-55] 
2.4.1.3 Matrix Assisted Laser Desorption/Ionisation 
The MALDI process was discovered by Karas and Hillenkamp in 1985 as a way of ionising 
small organic compounds[6] and it was published for the application on proteins in 
October 1988.[56] Shortly before their report, Koichi Tanaka succeeded in applying ‘Soft 
Laser Desorption’ for the ionisation of macromolecules without losing their structure in 
the process.[57] Tanaka was therefore awarded the Nobel Prize in chemistry in 2002. 
Today MALDI is the technique that remained present in laboratories, since Tanaka’s 
approach has poorer ionisation efficiencies. 
 
Figure 7: Commonly used MALDI matrices 
CHCA: α-Cyano-4-hydroxycinnamic acid  
(for proteins and peptides < 10 kDa) 
 
 
THAP:  2,4,6-Trihydroxy acetophenone   
(for RNA, glycoproteins, glycolipids) 
 
Sinapinic acid, SA:  
Trans-3,5-dimethoxy-4-hydroxy cinnamic acid 
(for proteins, polymers >10 kDa)  
 
DHB: 2,5-Dihydroxybenzoic acid  
(for carbohydrates, glycopeptides,  
proteins, peptides < 10 kDa) 
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 MALDI stands for Matrix Assisted Laser Desorption/Ionisation, meaning that the 
desorption and ionisation process of analytes with the laser is aided by a matrix. 
Properties of this matrix must comprise a good ability at absorbing photons from the 
laser and converting the thereby absorbed energy into heat, as well as the potential for 
charge transfer reactions. Therefore, most UV-MALDI matrices are organic acids with 
aromatic structures, such as CHCA, DHB, SA or THAP (Figure 7). The analyte is usually 
embedded in a huge molar excess of matrix molecules due to co-crystallisation, e.g. as a 
dried droplet on a ground steel target. Under vacuum conditions, the matrix/analyte 
spot is then shot with a pulsed UV laser, commonly N2 (337nm, up to 60 Hz) or Nd:YAG 
(frequency tripled: 355nm, up to 1 kHz). Lasers of other wavelengths are seldom found 
in commercial MALDI systems.  
The π-electrons in the aromatic structures 
of the matrix are excited by the laser 
photons, which leads to an energy and 
heat transfer into the volume of the 
crystal and a phase explosion due to the 
rise in temperature and pressure. The high 
excess in matrix molecules prevents most 
of the thermal decomposition of the 
analytes. [58]  
Figure 8: Scheme of ionisation via MALDI. The laser beam is ablating the matrix/analyte spot; neutral species as 
well as ions of both matrix and analytes are released into the gas phase and accelerated in direction of the mass 
analyser using an acceleration electrode/extraction grid.  
There was a controversy going on about the mechanism of the ionisation process, 
between the ‘gas phase protonation model’ and the ‘lucky survivor model’ (unified 
mechanism in Figure 9). The first model postulates that neutral analytes collide with 
protonated ma+H+ or deprotonated [ma-H]- matrix molecules in the gas phase, thus 
leading to the transfer of a proton, either from or to the analyte molecule A, thus leaving 
positive AH+ and negatively charged [A-H]- analyte species respectively.[59-61] In the lucky 
survivor scenario it is stated that the analyte molecules already have their charge state 
prior to incorporation in the matrix crystal. After ablation and during matrix cluster 
dissociation, a portion of the analytes are either still paired with a counter ion X (no net 
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charge) or they get re-neutralised, due to photoelectrons or electrons from the metallic 
target. The ‘lucky survivors’ which still carry a charge can then be detected.[62, 63] Both 
models were proven to be valid using deuterated matrix esters.[64] The complete 
mechanism is still being debated. 
MALDI creates mostly singly charged ions, which makes the spectra quite easy to 
interpret, contrary to e.g. ESI-MS with its series of multiply charged ions.  
Figure 9: Unified MALDI analyte protonation mechanism. Combination and connection between the lucky survivor 
and the gas phase protonation model by Jaskolla and Karas.
[64]
 
2.4.1.4 Electrospray ionisation 
Electrospray ionisation (ESI) is, like MALDI, a soft ionisation method commonly used for 
macromolecules. Unlike MALDI which has to be hyphenated to HPLC in an offline 
manner, ESI can be coupled directly to an HPLC System. 
The analyte solution is introduced into a metallic capillary/needle on whose tip a high 
voltage is applied. An electrical field is formed between the capillary and its counter 
electrode which leads to the formation of a Taylor cone at the tip of the capillary. A jet 
of liquid leaves the cone end which dissociates to a fine spray of charged droplets. 
Evaporation of the solvent reduces the droplet size until the repulsion of the charges 
causes a coulomb explosion of the aerosol droplets. Before entering the high vacuum of 
the mass spectrometer the analyte is completely desolvated and can carry multiple 
charges. 
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The multiple charges enable the analysis of very large molecules (up to 150kDa). The low 
m/z ratios make ESI-sources compatible with all types of mass analysers. Unfortunately 
the signal for an analyte is distributed over several charge states, thus elevating its limit 
of detection and causing elaborate interpretation of the spectra.  
 
 
 
 
 
 
 
Figure 10: Scheme of ionisation via ESI and essential features of the experimental arrangement. Analyte ion 
formation: (a) solvent evaporation, (b) droplet fission at Rayleigh limit, (c) formation of desolvated ions by further 
droplet fission and /or ion evaporation. Adapted from Gaskell. 
[65]
 
2.4.2 Mass Analysers 
After ionisation of the analyte molecules, their molecular weight (m/z ratio) needs to be 
determined. Using ICP as a mean for ionisation, it is usually paired with quadrupole mass 
analysers, whereas MALDI is mostly coupled with a time-of-flight (TOF) or TOF-reflectron 
mass analysis system. 
Other mass analysers comprise sector field mass analysers, with electrostatic and/or 
magnetic sectors (e.g. used in multi-collector MS), 3D- and linear ion traps, orbitrap and 
Fourier transform ion cyclotron resonance. Resolution power and other figures 
regarding the mass analysers are shown in Table 2.[32] 
Table 2: Typical figures of merit for different mass analysers. Adapted from Hart-Smith and Blanksby
[32]
  
Mass analyzer Double focusing  
sector field 
Quadrupole Linear ion 
trap 
TOF FT-ICR Orbitrap 
Mass resolving 
power 
100 000 100 –  
1 000 
1 000 –  
10 000 
1 000 – 
40 000 
10 000 –
 1 000 000 
10 000 –
 150 000 
Mass accuracy <1 ppm 100ppm 50 – 100 ppm 5-50 ppm 1-5 ppm 2 – 5 ppm 
Mass range 10 000 4 000 4 000 > 100 000 > 10 000 6 000 
Linear dynamic 
range 
1x10
9 
1x10
7 
1x10
3 
– 1x10
4
 1x10
6 
1x10
3 
– 1x10
4
 1x10
3 
– 1x10
4
 
Abundance 
sensitivity 
1x10
6 
– 1x10
9 
1x10
4
 – 
1x10
6 
1x10
3 
– 1x10
4
 1x10
6
 1x10
3 
– 1x10
4
 1x10
4
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2.4.2.1 Quadrupole 
A quadrupole (Figure 11) consists of four metallic rods through which the ions have to 
make their way. The application of radio frequency and direct current voltages 
determine the trajectories of the ions. Depending on the way those voltages are 
combined, only ions with a given m/z can achieve a stable trajectory in the mass filter 
and pass through to the detector, all others will hit the electrodes and be neutralised.   
 
 
 
 
 
 
Figure 11: Quadrupole mass analyser. Reproduced from Hart-Smith and Blanksby. 
[32]
  
 
2.4.2.2 Time of Flight 
With the development of MALDI in the 1980s, the time of flight (TOF) analyser gained 
more importance, since it is ideal to be interfaced with this ionisation technique. In 
order to function reliably, TOF requires discrete packages of ions with the same start 
time. They are provided by the pulsed ionisation via the laser in MALDI. 
Figure 12 shows an orthogonal TOF analyser. Even though in the instrument used during 
the thesis, the flight tube is arranged on-axis with the laser, the principle stays the same. 
The sample is ionised in the source, ions are accelerated through a fixed potential and 
enter a field-free drift zone of defined length. The velocity of the ions is dependent on 
their m/z ratio: all ions with the same charge obtain the same kinetic energy, resulting in 
a higher velocity of small molecules and a lower velocity of heavier analytes. In 
consequence, small molecules need less time to pass through the drift region and hit the 
detector than the bigger ones with the same charge state. The analytes are thereby 
separated according to their m/z.  
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Small differences in kinetic energies between analytes of the same m/z, which can be a 
result of the ionisation process, are usually ruled out by the use of an ion mirror. The 
enlarged flight distance also improves resolution and mass accuracy, without the need 
of a larger instrument. The problem of different kinetic energies can also be taken on by 
a delayed extraction. For this technique, the MALDI process is conducted without an 
electric field and the ions then accelerated using a high voltage pulse after a defined 
delay of time. [32, 58] 
 
 
 
 
 
 
 
 
Figure 12: Orthogonal TOF mass analyser with an ion mirror. Reproduced from Hart-Smith and Blanksby. 
[32]
 
2.4.3 Tandem Mass Spectrometry 
Tandem MS (also: MS/MS or MS2) is a technique for structure determination. Big 
molecules are broken apart to smaller characteristic fragments, which are then mass 
analysed and thus enable the identification of the parent molecule. The acquired 
fragment spectra provide highly credible, qualitative information. In the case of proteins 
or peptides, their sequence can be determined with this technique, making it the first 
choice for fast peptide/protein identification. For the purpose of fragmentation, a 
collision cell is built into the mass spectrometer, usually situated between two mass 
analysers. One of the simplest arrangements of a tandem mass spectrometer is a triple 
quadrupole (QqQ), with the first quadrupole (Q1) conducting parent ion selection, the 
second one (q2) acting as a collision cell for fragmentation and transport and the third 
one (Q3) scanning the product ions. Alternatively an ion trap can be used, where the 
parent ion can be trapped and fragmented through collision with a gas. The product ions 
will then be released to the detector in order of their m/z. Depending on the setup, even 
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MSn experiments can be performed in such a way, which is especially interesting for 
intact proteins. Fragment ions from MS2 can be selected and fragmented again, resulting 
in MS3, MS4, ... , MSn.  
There are many scan modes that make use of tandem MS. Their utility depends entirely 
on the problem that needs to be resolved. Product ion scan. In this scan mode, a 
precursor ion is selected and subjected to fragmentation. All resulting product ions are 
then being recorded. Precursor ion scan. This method is not possible with time based 
MS, like TOF or ion traps. In a triple quadrupole for example, the product ion is selected 
in Q3, while Q1 is scanning the mass spectrum for possible parent ions. Only those 
precursors that result in the product ion are recorded. Neutral loss scan. Since many 
classes of molecules tend to lose a neutral moiety during fragmentation, this neutral loss 
can be monitored using this scan mode. The two analysers scan both precursor and 
product ions for a constant mass offset. This scan mode is interesting to determine the 
presence of certain modifications, like for example phosphorylations, with a mass offset 
of 98 Da for the loss of phosphoric acid. Selected reaction monitoring (SRM) In order to 
achieve increased sensitivity for a certain compound, the mass analyzers (e.g. Q1 and 
Q2) can be programmed with predetermined masses for precursor and product ions to 
let only the ions of interest pass. If more than one precursor is monitored, it is called 
Multiple reaction monitoring (MRM).[66] 
2.4.3.1 Post Source Fragmentation Techniques 
The type of product ions in MS2 largely depends on the used fragmentation technique 
and the underlying mechanism. Most commonly used is the collision induced 
dissociation (CID), also referred to as collision aided or activated dissociation (CAD): The 
parent ions are fragmented by collision with an inert gas, a neutral molecule or a 
surface. The kinetic energy is then converted into internal energy and after its 
accumulation, the parent ion breaks apart. This usually happens at the peptide bond 
between CO and NH, resulting in b- and y-ion series (Figure 13). For the generation of c- 
and z-ion series (Figure 13), the ion trap exclusive technique ETD (electron transfer 
dissociation) can be used. It is based on ion-ion interactions, where specially generated 
anions react with the multiply charged parent cation, promoting fragmentation by 
electron transfer. Also based on electron transfer is ECD, electron capture dissociation. It 
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has the advantage of leaving most PTMs intact. In this method, the parent ion reacts 
with low energy electrons, building radicals, resulting in reduction of its charge state and 
generation of c- and z-ions. It is optional in FTMS and Orbitrap mass spectrometers. The 
fragmentation techniques are often combined for complementary information.[66] 
 
Figure 13: Fragmentation pattern in tandem-MS, with a-/x-, b-/y- and c-/z-ion series. Reproduced from Khalsa-
Moyers and McDonald.
[67]
 
There are also several types of fragmentation which are only indirectly induced by the 
user and can be used for interpretation. In source fragmentation occurs directly in the 
ion source, because of the high amount of energy of the ionisation process. It is not 
tandem MS per se, but it can be used for fragment analysis in a similar way. Especially in 
combination with an additional post source fragmentation, a pseudo MS3 can be 
performed. Post source decay is a phenomenon commonly used in MALDI-TOF/TOF 
analysis. Some of the parent ions fall apart in the flight tube of the analyser. This can be 
utilised for a special type of analysis because the parent ions and their matching 
fragments both have the same velocities, but different kinetic energies. In linear mode 
they hit the detector at the same time because of their velocities, but in reflector mode 
they are separated according to their kinetic energies, resulting in product-ion 
spectra.[66] 
2.5 Proteomics 
The term proteome was introduced as the protein counterpart to the genome[68] – a 
quite misleading definition, since the genome is a rather static construct, while the 
proteome is very dynamic in its nature. During the lifetime of an organism, the genome 
does not alter (except for mutations), whereas the proteome is always changing. 
Therefore the definition was changed shortly after by Jungblut:  
‘The proteome of an individual is defined by the sum and the time dynamics of all protein 
species occurring during the life-time of this individual’ [69] 
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With these definitions, it is not very surprising to find, that it is merely impossible to 
draw direct conclusions regarding protein expressions from translational data: One gene 
can be easily translated into several proteins with different functions.[70, 71] Many 
metabolic and regulatory processes are involved on the way to protein formation: 
splicing, post-translational modification, proteolytic processing, etc. Genomic techniques 
alone, like the determination of mRNA concentrations, cannot provide information on 
the final appearance of a protein species, including its PTMs or its function and 
destination in the organism.[72]  
Already the qualitative analysis of the proteome is a challenge, since no method ever 
comprises all proteins likewise. There is always a loss when analysing acidic or basic, 
very large or very small proteins. Also concentrations of proteins in natural samples can 
easily differ by up to 12 orders of magnitude (see e.g. the millimolar range for albumin 
versus an attomolar range for cytokines in plasma)[73], leading to the necessity of higher 
sample amounts for the detection of low abundant proteins. Unfortunately, unlike PCR 
for nucleic acids, there is no generic amplification method for proteins.[23] 
The most powerful tool in proteomics is mass spectrometry and it enabled a giant leap 
in protein analysis since its introduction. 
2.5.1 Classical Proteomic Approaches 
The two main strategies in MS based proteomics are the top-down and the bottom-up 
approach.  
Top-Down. In this approach, intact proteins are separated by e.g. multidimensional 
chromatography and then subjected to MSn fragmentation, typically by CID, ECD, ETD or 
IRMPD. Interpretation of the resulting spectra is fairly complicated though and 
identification of the parent ion needs special algorithms for data processing prior to 
database search. This is why top-down is rarely applied and still not well established. 
Bottom-up. For the bottom-up approach the proteins are digested, and the peptide 
mixture can then be separated and analysed. Complex protein mixtures can first be 
separated by e.g. 1D- or 2D-gel electrophoresis. After tandem MS the spectra are 
compared with published protein databases to find the most likely match for the parent 
protein. Bottom-up approaches starting with the direct digestion of a crude protein 
mixture are referred to as ‘shotgun’ protein sequencing. The resulting complex peptide 
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mixture can then be separated using 1D or 2D HPLC and analysed using tandem MS. 
Database searches then help the reconstruction of protein mixture composition. [66] 
2.5.1.1 Protein Identification 
Thanks to genomic research, the sequences of many organisms are fully or at least partly 
known. Those sequences are available in databases, such as UniProtKB/Swiss-Prot and 
TrEMBL, on open access servers, free for everyone to use.[74] With the help of special 
software, the data obtained from MS and MS2 experiments can be compared with the 
sequence data from those databases. This way the analysed proteins can be identified 
and the reliability of the result assessed, e.g. by taking a look at the score given out by 
software such as Mascot.[75] Identification can almost be fully automated for shotgun 
and bottom-up approaches, using e.g. proteomic grade trypsin for selective cleavage. 
The database search parameters can be set according to the experimental setup. 
2.5.2 Quantitative Proteomics 
It already is a challenge to identify the complete set of proteins in a given sample, 
because of their different properties, sizes, abundances, etc. But only having the 
information about a protein species’ presence in a sample does not help much 
elucidating its role in the cell or organism. Knowledge about its amounts is equally 
important for the understanding of the fundamental processes in biological pathways.[76] 
Quantitative protein analysis though, is a far more difficult task than ‘only’ identification; 
it is likely the most challenging part of proteomic research. As seen in Figure 14, only a 
fraction of peptides present in a sample can be quantified. 
Traditional quantitative approaches are based on differential analysis of 2D-gels and 
blots, stained with dyes, fluorophores or radioactivity: two or more gels are dyed 
differentially and the corresponding spots/bands are then compared with each other, 
allowing relative quantification through their intensities. Even though the methods show 
good sensitivity, linearity and dynamic range, they are only applicable on abundant and 
soluble protein species. Also they do not provide data on the identities and they are 
unfortunately quite user subjective. [1, 2] 
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Figure 14: In general only a small fraction of peptide ions resulting from a sample can really be identified and 
quantified. Reproduced from Wasinger et al.
[1]
 
Relative quantification can also be achieved with label free MS, where several 
experiments are directly compared with regard to the MS ion intensity of peptides or 
spectral counts, giving data on relative quantities in form of fold-changes.[2, 77] 
The field of absolute quantification is increasingly popular, which is mirrored by the 
rising amount of approaches and publications. Figure 15 on the next page shows the 
rising number of publications on quantitative proteomics. Currently 45% of the 
publications on quantitative proteomics also contain the keyword ‘labeling’, whereas 
approximately 20% are on absolute quantification – with a rising tendency. 
Absolute quantification can give exact amounts of proteins in e.g. ng/mL or copies/cell.  
Quantitative information is interesting for various fields in life science. Especially clinical 
applications such as biomarker discovery are a popular topic.[78, 79] In medical science, 
the interest often lies in the discovery of differences between two states e.g. healthy 
and diseased. Comparing those states, the only difference to be seen might be in the 
presence and change in abundance of proteins or their posttranslationally modified 
forms.[80] Being able to monitor the protein expression in an organism, like eukaryotic 
cells or bacteria, also facilitates a more reliable manipulation of the mechanisms of 
synthesis in those organisms, potentially resulting in a sustainable bio-production of a 
compound of interest in cell culture. Many potentially interesting pharmaceuticals are 
protein or peptide based compounds with posttranslational modifications that cannot 
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be synthesised reliably by chemical means. Especially the glycosylation is a challenge, 
which is important for compatibility of those compounds when applied on patients.[81] 
To date already plenty of products in healthcare, such as vaccines, hormones, antibodies 
or coagulation factors are synthesised by cell culture and thus made commercially 
available.[82]  
 
Figure 15: Number of publications per year, listed in Scopus
[83]
 for the keyword ‘Quantitative Proteomics’, +/- the 
keywords ‘Labeling’ or ‘Absolute Quantification’ 
Table 3 gives a brief overview on the main approaches used in quantitative proteomics. 
It can be seen, that most approaches are only applicable for relative quantification. 
Another way of absolute peptide/protein quantification are approaches using metal 
labels together with a combination of molecular and elemental MS. Therefore a 
comparison of the characteristics of ICP-MS and molecular MS is shown in Table 4, which 
emphasises the complementary nature of both techniques. Metal labelings are 
discussed in a separate paragraph, because of their special importance for this thesis. 
 
[84, 85] [86, 87] [88] [89, 90] [91, 92] [93, 94] [95, 96] [97, 98] [99, 100] [101-103] [104, 105] 114, 115 
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2.5.3 Labelling 
Using ICP-MS for quantification, the molecule of interest needs to contain a detectable 
element, such as heteroelements (S, P or Se) or metals (Zn, Fe). Unfortunately, only 
about one third of the whole proteome contains metals (mostly in form of protein 
cofactors)[106] and the ionisation efficiencies for heteroelements are usually very low, 
which makes them unsuitable for the quantification of less abundant proteins. An 
alternative approach is the introduction of a label into the biomolecule.  
In the past decade, researchers have come up with quite a few strategies on how to 
modify biomolecules – especially proteins, in such a way that they are accessible for 
quantification.[107] 
2.5.3.1 Target Groups for Chemical Modification Reactions 
 
Figure 16: Chemical modification reactions in peptides and proteins. All reactions occurring on the N-terminal α-
amino group also occur on the ε-amino group of lysine; adapted from Pieper, Julka and Regnier.
[39, 108]
 
(1) 2-Methoxy-4,5-dihydroxy-1H-Imidazol
[109]
   (2) O-methylisourea
[110]
   (3) malondialdehyde
[111]
 
(4) p-hydroxymercuribenzoic acid
[112]
    (5) alkyl-maleimide
[113]
   (6) acrylamide
[114]
   (7) iodoacetamide
[95]
   
(8) 
18
O labelling 
[115]
   (9) methanol
[116]
   (10) 2,4-Dinitrobenzylsulfenylchlorid
[117]
   (11) Sanger’s reagent
[118]
 
(12) carbonic acid anhydride
[119]
   (13) phenylisothiocyanate
[120]
   (14) DTPA-anhydride
[121]
   (15) NHS-ester 
[122]
 
Figure 16 lists a number of chemical reactions for derivatisation of reactive groups in 
peptides and proteins. Most commonly used chemistries for commercially available 
derivatisation agents are based on maleimido-derivatives (5) or NHS-esters (15). 
Maleimido-compounds target sulphhydryl-groups, whereas NHS-esters can be used to 
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modify free amino-groups. Iodoacetamides (7) are usually used to block sulphhydryl-
groups in order to keep them from interfering with the following reactions, but they can 
also be used for modification reactions on cysteine residues. O-methylisourea (2) 
enhances ionisation efficiencies of lysine-containing peptides through conversion of 
lysine to homoarginine by guanidination. This can also be utilised to block ε-amino-
groups in lysine side chains selectively, so that α-amino-groups are still available for 
derivatisation. This is due to their different pKa-values. 
Reactions 1-3 were reported to be beneficial for the quality of MS and MS2 data in terms 
of fragmentation behaviour and ion intensity of the labelled peptides. Reactions 1, 6 and 
8 to 13 can be used for isotopic labelling with either deuterium or 13C-variants of the 
reagents, enabling relative quantification through differential labelling of two different 
samples. 
2.5.3.2 Isotope Labels 
In SILAC (stable isotope labelling by amino acids in cell culture), two cell populations are 
grown in cell culture, incorporating light or heavy AAs in their protein synthesis. The 
heavy AAs are labelled using 2H, 13C or 15N. After a few cell divisions with only the heavy 
AA present, the labelling is close to 100%. Using the fact, that there is virtually no 
chemical difference between the heavy and light AAs, the samples can be compared 
directly for differences in expression.[93] The AQUA (absolute quantification) approach 
uses stable isotope labelled standard peptides which can be added in known amounts to 
the sample prior to MS. Absolute quantification is done using the peak ratios of both the 
native and the labelled peptides. It can be seen as a variation of isotope dilution analysis 
(IDA).[123] ICAT (Isotope-coded affinity tag) utilises chemical labelling of target side chains 
in peptides with isotopically marked probes (3H, 13C). Using light and heavy probes, two 
samples can be compared to each other. Additionally the probes contain a biotin group 
which can then be used for avidin affinity chromatography. [95, 96]  ICPL (isotope-coded 
protein label) is a similar approach, targeting intact proteins.[100] Labelling with 18O: 
Alternatively a digestion in H2
18O can be used to introduce an isotopic label by enzymatic 
proteolysis (Figure 16-8). The oxygen is incorporated in the C-terminus of the peptide 
during the cleavage with the proteolytic enzyme. The thereby obtained ‘heavy’ sample 
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can be directly compared with a ‘light’ sample, obtained from a digest in normal 
water.[97, 98] The approaches in this section are all used with molecular MS. 
2.5.3.3 Isobaric Labelling 
Another technique applied in molecular MS is based on the introduction of isobaric tags 
into the analytes. This approach is especially interesting because of its multiplexing 
capabilities. Several samples can be labelled differentially and then be analysed 
altogether. The tags have nominally the same mass, ensuring the same chromatographic 
or MS behaviour for the differentially labelled peptides of the same type. In the course 
of fragmentation the tags release reporter ions of different masses, which can then be 
quantified according to their signal intensities, which are directly proportional to the 
peptide amounts.  
 
Figure 17 A shows the example of the isobaric tagging reagent iTRAQ (isobaric tag for 
relative and absolute quantification), which contains a reactive group and an isobaric 
tag, comprising reporter and balance group. Four examples for the balanced isobaric tag 
are shown in B. Quantification is made possible by MS2: the labelled peptides of interest 
are selected through their unresolved precursor mass and subjected to fragmentation. 
Resulting peptide fragments give information on the identity of the peptide, whereas 
the signal intensity of the reporter ions provides information on the peptide’s quantities 
in the different samples (Figure 17 C).[101] 
 
 
 
 
 
Figure 17: iTRAQ reagent (A), Isobaric variations (B), Reaction, MS and MS
2
 Scheme (C), adapted from Ross et al.
[101]
 
 
Another type of isobaric labels are tandem mass tags (TMT), which function in the same 
way as iTRAQ. The TMT reagents consist of four regions: reporter region, cleavable 
linker, a mass normalisation region and a protein reactive group. Reporter and mass 
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normalisation region are balanced by isotopes and upon MS2 of the precursor of 
interest, the reporter ions give quantifiable signal intensities.[104] 
TMT is currently available up to 10-plex,[124] iTRAQ up to 8-plex.[125]  
2.5.3.4 Metal Labels 
Making use of ICP-MS for quantification, metal labels offer a good sensitivity due to their 
high ionisation efficiency (see Figure 5). Mercury has a lower ionisation efficiency than 
most other metals (~50%), but it is known to react readily with sulphur. This is why it 
reacts easily with the sulphhydryl groups in proteins, which also happens to be one of 
the reasons for the element’s toxicity.[126] The compound used for labelling is 
p-hydroxymercuribenzoate (Figure 16-4).[112, 127, 128] Far less hazardous is the labelling 
approach using ferrocene compounds, where the ICP-MS detectable iron atom is 
sandwiched in a stable complex between two cyclopentadienyl rings. Together with a 
linker and a reactive group, such as iodoacetamide[129], maleimide[130] or NHS[131], free 
amino- or sulfhydryl-groups in proteins and peptides can be targeted. A back draw for 
ferrocene labelling is the relatively high iron background in biological samples. Another 
alternative is the attachment of a chelating moiety to the analyte and its combination 
with a metal of choice: The anhydride of DTPA (diethylenetriamine pentaacetic acid, 
Figure 16-14), can be used for specific derivatization of amino groups. After reaction 
with the protein or peptide, DTPA can form a stable complex with triple positively 
charged metal ions, such as lanthanides (complex stabilities in Table 5).[132, 133] DTPA 
anhydride does not require the introduction of a linker and a reactive group, since it 
already reacts readily with amino groups.  
2.5.3.5 DOTA 
Another chelator used for labelling is DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid) which also forms complexes with triple positively charged metals. 
DOTA-lanthanide complexes are even more stable than the ones formed by DTPA (Table 
5) and reagents for peptide and protein labelling can be synthesised/purchased with 
different linkers and reactive groups, making application possibilities more variable and 
specific than with DTPA anhydride.  
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Table 5: Stabilities of lanthanide complexes formed by DOTA, DTPA and EDTA, 
K being the thermodynamic stability constant
[134]
 adapted from Byegard et al. 
Cation DOTA 
log K 
DTPA 
log K 
EDTA 
log K 
Nd
3+ 
23.3
 
21.7 16.6 
Eu
3+
 23.5 22.5 17.4 
Gd
3+
 24.7 22.6 17.4 
Tb
3+
 24.2 22.8 17.9 
Yb
3+
 25.0 22.7 19.5 
Lu
3+
 25.4 22.6 19.8 
For labelling of amino groups, DOTA-N-hydroxysuccinimide ester (NHS-DOTA)[135] and 2-
(4-isothiocyanatobenzyl)-DOTA (SCN-DOTA)[136] reagents are available, whereas for 
sulfhydryl-groups, maleimido-monoamide (Mal-DOTA) and iodoacetamide derivatives 
can be applied. Together with the 14 lanthanides from the periodic table, this provides a 
large number of potential labels for multiplex analysis in ICP-MS. Additionally it was 
shown by Gregorius et al. that the DOTA-label enhances peptide detection in MALDI-MS, 
in particular for Cys-containing peptides.[137] A commercially available labelling kit, using 
metal-coded affinity tags (MeCAT) is adding an affinity tag to the DOTA chemistry 
mentioned above.[138-141] The affinity tag is attached to the linker between DOTA and the 
reactive group and it brings ICAT back to mind, where the tagged peptides can also be 
isolated with biotin-avidin affinity chromatography.  
 
 
Figure 18 left: Structures of Mal-DOTA (R1) and NHS-DOTA (R2), including complexed Ln
3+
 ion. Right: 3-dimensional 
structure of Gd[(DOTA)H2O]
-
. Adapted from Gregorius et al. and Pieper.
[39, 137]
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2.5.3.6 Lanthanides 
Lanthanides are also referred to as rare earths. Even though this name implements that 
they are indeed rare elements, they are still relatively abundant in the Earth’s crust. 
Taking a look at the least abundant element of the series, thulium, it can be seen that is 
still nearly 200-times more common than the precious metal gold. As for the most 
abundant lanthanides such as lanthanum, cerium and neodymium they can be found in 
a similar abundance to the common industrial metals nickel, copper or lead (Figure 19). 
Mining and isolation of lanthanides is a very environmentally destructive process, with 
the demand by the industry for those elements rising continuously. Unlike ordinary 
metals, lanthanides have very little tendency to concentrate themselves into ore which 
makes it more complicated to access them.  
Lanthanides are commercially used in many everyday products, such as magnets which 
can be found in electronic devices like computers and loud speakers. Even the lasers 
used in the ABSCIEX MALDI-MS and the LA-ICP-MS system utilised during this thesis are 
based on lanthanide doted crystals, such as Nd:YAG.  
 
Figure 19: Abundance of the chemical elements in Earth’s upper continental crust as a function of atomic number. 
Lanthanides, La–Lu, and Y are labelled in blue. Adapted from the US geological survey 2002 
[142]
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Lanthanides are very uncommon to be found in biological samples, which makes them 
an ideal choice for labelling approaches using chelators. There is virtually no background 
to be monitored in protein samples, so that the acquired lanthanide signals can be 
exclusively attributed to the labelling procedure. Another big advantage is the complete 
ionisation of the lanthanides in the ICP process and the absence of important polyatomic 
interferences, because of their high molecular mass. 
2.5.4 Hyphenated Systems used with ICP-MS and Molecular MS Detection  
 Figure 20 shows a simplified overview of hyphenated techniques used together with 
ICP-MS and molecular MS. In this thesis, one major particularity is the uncommon online 
hyphenation of RP-IP-nanoHPLC to ICP-MS and its combination with MALDI-MS in an 
offline approach by coupling the same nanoHPLC to a fraction collector. Hyphenations of 
HPLC with ICP-MS are very common, but need special precautions, since the high 
amounts of organic solvent employed in RP-LC can hamper with the stability of the 
plasma. Very often a compromise needs to be found between separation efficiency and 
plasma stability, leading to limitations of the HPLC flow rate, the use of flow-splits or 
restriction to isocratic gradients.[143] Alternatively the plasma gas can be modified by 
mixing e.g. 20 % oxygen into argon. This way the organic solvents can be introduced into 
the plasma directly. Platinum cones are required with this approach.[144] 
 
Figure 20: Hyphenated systems used with ICP-MS and molecular MS 
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These limitations are only one of the reasons why nanoHPLC represents such an 
attractive option for hyphenation with ICP-MS: one of them is the possibility to apply 
extremely low sample amounts in nanoHPLC (pmol range), which is a perfect match with 
the high sensitivity detection of ICP-MS. Also, the flow rates of the nanoHPLC are 
directly compatible with ICP-MS. For this purpose a custom made total consumption 
nebuliser was employed during the PhD thesis.[145-148] The outlet capillary of the 
nanoHPLC (Figure 21-a1) was directly joint with the nebuliser needle (a2) without dead-
volume. Like this, the eluting separation can be introduced completely and be nebulised 
in the nebulisation chamber using argon. The chamber is connected directly to the torch 
where the sample is ionised in the plasma. The low amounts of solvent do not have an 
influence on the plasma stability. 
 
Figure 21: nano-nebuliser for hyphenation of nanoHPLC and ICP-MS. (a) nebuliser scheme with magnifications of (1) 
the outlet capillary from the nanoHPLC and (2) the dead-volume free connection to the (3) nebuliser capillary and 
(4) the orifice made of industrial sapphire. (b) Short nebuliser type T1 with (1) orifice, (2) nebuliser capillary, (3) 
argon inlet and (4) liquid inlet with screw for adjustment of the capillary position. (c) Spray chamber type S2 
(12.5 cm
3
) with (1) connection to nebuliser, (2) transition, (3) tube, (4) connection with ICP-MS torch and (5) make-
up gas inlet. 
Adapted from Giusti et al., Rappel and Schaumlöffel. 
[146, 148]
 
The downside of HPLC/ICP-MS couplings is the necessity of baseline separation of the 
analytes, due to the destructive nature of ICP-MS and the loss in structural information. 
Only by baseline separation, the accurate quantification in ICP-MS can be attributed to 
the identified analyte species (in e.g. MALDI-MS) without doubt. 
In order to acquire the complementary identification data, molecular MS in form of 
ESI-MS and MALDI-MS can be employed. While for ESI-MS, online coupling to the 
nanoHPLC is possible, for MALDI-MS, only offline couplings are applicable. This can be 
both seen as advantage and disadvantage. Advantageous is the fact that the fraction 
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collection in form of dried droplets prior to MALDI-MS, allows sample preservation. This 
enables a thorough analysis without time limitation. Also re-measurements of the same 
spot/sample can be conducted. Another advantage is the fact that the instruments do 
not need to be in the same laboratory. MALDI-targets are easier to be transported than 
a whole LC-system. In comparison to e.g. online coupling of HPLC with ESI-MS, one 
disadvantage lies in the higher time requirements of MALDI-MS based approaches, due 
to the disconnectedness of the separation and measurement.  
2.6 Scientific Context of the Thesis 
Table 6 gives a brief overview on current developments in the field of labelling 
approaches for quantification in combination with detection via ICP-MS. Some of the 
publications were already mentioned in the sections above. The table starts with 
publications from 2010, as a follow up to the review by Tholey and Schaumlöffel from 
the same year.[3] 
There are also several other reviews related to the topic which can be recommended for 
reading, by Pröfrock [149], Wasinger et al. [1] and Sanz-Medel et al.[150] 
Even with the rising number of publications in quantitative proteomics, recent 
developments still mainly concern themselves with relative quantification, mapping out 
the differences between two or more samples. This also counts for quantitative 
approaches in protein and peptide analysis, which employ labelling and ICP-MS. Only a 
fraction of the publications concerns themselves with absolute quantification 
approaches, comparing the sample to an independent standard and thus providing 
information on absolute quantities. For absolute quantification, mainly isotope dilution 
analysis (IDA) is employed. The simplest setup for IDA is the application of an isotopically 
enriched standard of known concentration which is analysed together with the sample. 
Using the signal ratios of both isotopes the sample concentration can be determined.[151] 
Taking a look at Table 6, it can be seen that most samples consist of purified proteins or 
synthetic peptides. More complex samples, e.g. tissue samples, cells and groups of 
proteins were analysed mostly with imaging techniques, employing LA-ICP-MS. For 
chromatography based analysis, the higher complexity samples consist of purified 
proteins, most of which are commercially available. This shows that the methods are still 
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on a ‘proof-of-principle’ stage, mainly working with standard material. None of the 
techniques has been reported to be valid for application of absolute quantification on 
complex protein samples or for proteome analysis. This is most likely also due to the 
separation difficulties which were discussed in the section before. 
In this prospect, the global aim of the thesis is the development of new methods that 
facilitate the analysis of labelled protein and peptide samples on the basis of 
hyphenations of chromatography with mass spectrometry. For labelling, the versatile 
DOTA-based compounds were chosen, in combination with mostly mono-isotopic 
lanthanides. The different labels should be characterised regarding their applicability 
and behaviour during the separations and detection in both molecular and elemental 
MS. Different means of separation and purification techniques for the labelled analytes 
should be inquired. 
General obstacles, such as the baseline separation of the analytes, data interpretability 
or comparability and limitations of sample complexity should be addressed.  
A method for absolute sample quantification should be developed, that in the best case 
is not only applicable on peptide and low complexity protein digests, but also on 
biological samples and for proteome analysis. 
 
 
 
 
 
 
[152] [129] [153] [154] [131] [155] [141] [156] [157] [158] [159] [121] [160] [139] [122] [138] 
[161] [162] [136] [163] [164] [165] [166] [167] [168] [169] [170] 
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III Methods 
3.1 Material 
Detailed information regarding chemicals, consumables and employed equipment can 
be found in Appendix II, Table 20 to Table 23, starting on page 151. 
3.2 Workflow 
 
Figure 22: Generic workflow for analysis of biological samples with MALDI-MS and ICP-MS. Instrument photos from 
manufacturer websites. 
Figure 22 shows the generic workflow for experiments conducted during this thesis. 
Starting point are biological samples, including experimental steps, such as protein 
extraction, separation via SDS-PAGE and in-gel digestion. When working with single 
model proteins, no separation is needed and in-solution digestion is performed instead 
of step 4 and 5. Standard peptides are directly derivatised, starting with step 6.  
In general, digest samples were combined with differentially labelled model peptides 
prior to analysis. The labelled peptide samples were separated via nanoHPLC (step 9). 
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The nanoHPLC was coupled either directly to an Agilent 7500ce ICP-MS, to obtain 
information on lanthanide amounts (online analysis) or it was coupled to a Probot 
fraction collector (step 10). Fractions of the nanoHPLC run were collected as spots on 
MALDI-target plates. The fractions were mixed directly with the matrix CHCA, dried and 
the plates shipped to the university in Kiel (CAU). In Kiel they were measured on an 
ABSCIEX TOF/TOF 5800 MALDI-MS, to obtain information about the identities of the 
peptides (step 11). 
3.3 Methods 
3.3.1 Protein and Peptide Handling 
In general, peptides and proteins were either stored in lyophilized form or as aliquots in 
buffered solution (HEPES, 50mM, pH7) at -20°C. Refreezing was avoided and working 
solutions were kept at 0-4°C up to maximum one fortnight. 
It was also found, that the plastic ware used for experiments can hamper with 
quantitative analysis approaches. Different types of peptides and proteins show 
different behaviour regarding their unspecific interaction with the surface of the tubes. 
It was also seen that they might bind irreversibly and be lost during sample preparation. 
The binding behaviour does not follow strict rules and is not predictable. This is why 
plastic ware should be evaluated prior to the use with the respective protein and 
peptide species.[171] 
One series of peptide solutions which was stored as aliquots in 200 μL PCR tubes posed 
problems and was not detectable anymore. Therefore for aliquotation and 
derivatisation experiments, only high quality Eppendorf low-bind tubes were used for 
peptide and protein samples. This prevented changes between experiments and ruled 
out errors which might be caused by the use of different tubes. 
Exceptions to this were the use of the special tubes provided with the spin filter 
cartridges for protein extraction. 
3.4 In-Solution Digestion 
Solutions: 50 mM ABC; 200 mM DTT in 100 mM ABC; 1 M IAA in 100 mM ABC; 25 ng/μL 
protease. 
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For digestion of model proteins, no SDS-PAGE was necessary. Proteins were directly 
weighed, solved in buffer and digested in solution.  
Digestion of 5 µg of the model proteins respectively: proteins were taken up in 50 mM 
ABC and volumes were adjusted to 100 µL. Reduction was conducted with 5µL of 
200 mM DTT at 95°C for 10 min, followed by alkylation using 4 µL of 1 M IAA for 30 min 
at room temperature in the dark. To deactivate the remaining IAA, the sample was 
posed in daylight for 10 min. Digest was conducted for 18h at 37°C, using either 4 µL of 
trypsin or chymotrypsin (25 ng/µL).[172] 
3.5 Derivatisation of Peptides and Protein Digests 
3.5.1 Derivatisation using NHS-DOTA 
Precautions: 
The DOTA-NHS-ester is a highly reactive compound. At best, it is to be kept at -80 °C for 
long time storage and at least at -20 °C if it is used in a regular manner. Since it reacts 
readily with water, it is also recommended to keep it under a protective atmosphere 
(e.g. argon or nitrogen) to keep it from degradation. The stability of NHS-esters in 
general depends on the water content and the pH of the solution: at pH 7 the half-life is 
about 4 to 5 hours, 1h at pH 8 and only 10 min at pH 8.6. [173] This shows how vital the 
correct pH is for the derivatisation reaction. There is a need for a compromise between 
the best derivatisation conditions for the ε-NH2 groups in the lysyl residues (pKa ∼ 10.5) 
and N-termini (pKa ∼ 9.5) and the least destructive conditions for the NHS-ester. 
Optimisations: 
The NHS-DOTA solution is to be prepared freshly immediately prior to its use. In the 
former protocol by Gregorius et al. the NHS-DOTA was solved in water-free DMSO.[137] 
For direct measurement via MALDI-MS, the total reaction volume must not contain 
more than 4 % v/v DMSO. This did not pose a problem for immediate nanoLC analysis. 
For lyophilisation and drying by speedvac though, it was found to be more beneficial to 
solve NHS-DOTA in ACN. This also resulted in the necessity of lowering the total ACN 
amount during derivatisation. It was supposedly necessary to conduct the derivatisation 
step in as less water as possible (approx. 15-25 % water). Without DMSO as a solubilising 
III  METHODS 
-57- 
 
agent though, salts were precipitating at ACN amounts higher than 80 %, especially after 
pH adjustment. It was found that it was already sufficient to lower the ACN amount to 
70-75 % in order to obtain a homogeneous solution. The derivatisation efficiency 
between the two protocols did not differ. 
Protocol A: 
This protocol is the basic protocol used in the beginning and is based on Gregorius et 
al.[137] Earlier studies, including the ones presented in sections 4.1 to 4.3 employ 
labellings after protocol A. 
Stock solutions: 1 mM TCEP; 1 mM MMTS; 10 mM NHS-DOTA in water-free DMSO; 
100 mM HEPES pH 8; ACN; 6 N NaOH; 100 mM TEAA pH 5; 10 mM lanthanide(III) salt in 
100 mM TEAA pH 5;  
1. Peptide reduction with TCEP using a 2-fold molar excess of TCEP per cysteine 
residue, for 1 h at 60 °C with mild shaking. 
2. Alkylation of free thiol-groups using a 6-fold molar excess of MMTS regarding 
free SH-groups, for 10 min in the dark. 
3. Derivatisation of amino groups with NHS-DOTA using a 100-fold molar excess of 
NHS-DOTA in regard to free N-termini and ε-amino-groups in Lys residues. 
Reaction medium: 75 % ACN, 25 % HEPES (100mM, pH 7.5). Reaction for 1 h at 
room temperature and mild shaking.  
pH control and pH adjustment required: pH 7 for peptides without Lys; pH 7.5-
8.5 for peptides with Lys 
4. Stabilisation and chelation using a 10-fold molar excess of lanthanide-salt 
solution regarding NHS-DOTA. Reaction for 2 h at 37 °C, mild shaking and pH 5 to 
5.5 
Protocol B: 
This protocol is the optimised version, which was modified from Protocol A. It was used 
for the later experiments which are presented starting in section 4.4. 
Stock solutions: 500 µM TCEP; 1 mM MMTS; 75 mM NHS-DOTA in ACN; 100 mM HEPES 
pH 8; ACN; 6 N NaOH; 100 mM TEAA pH 5; 1M lanthanide(III) salt in 100 mM TEAA pH 5;  
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Molarities can be adjusted depending on sample amounts/free reactive groups. Sample 
volume for each step must not be lower than 30 µL, to avoid complete 
evaporation/condensation of the solvents in the cap of the tube. 
1. Peptide reduction with TCEP using a 2-fold molar excess of TCEP (in HEPES) per 
cysteine residue, for 1h at 60 °C with mild shaking. 
2. Alkylation of free thiol-groups using a 6-fold molar excess of MMTS (in HEPES) 
regarding free SH-groups, for 10 min in the dark. 
3. Derivatisation of amino groups with NHS-DOTA using a 100-fold molar excess of 
NHS-DOTA regarding free N-termini and ε-amino-groups in Lys residues. Reaction 
medium: < 75 % ACN including the DOTA-solution, filled up to 100 % with HEPES 
(100mM, pH 8), including the buffer amounts from the previous steps. Reaction 
for 1h at 20 °C and mild shaking.  
pH control and pH adjustment required: pH 7 for peptides without Lys; pH 7.5-
8.5 for peptides with Lys. 
4. Chelation using a 10-fold molar excess of lanthanide-salt solution regarding NHS-
DOTA. Reaction for 1 h at room temperature, mild shaking and pH 5 to 5.5.  
It was found that the chelation was already near 100 % after vortexing only. 
3.5.2 Derivatisation using Maleimido-DOTA 
Precautions: 
Also the maleinimido-group in Mal-DOTA is prone to hydrolysis and reacts to a half-
amide of the modified maleic acid. Therefore a reaction time of more than two hours 
must be avoided. The Mal-group can also react with primary and secondary amines if 
they are present in high concentrations. Buffers containing amines, such as TEAB and 
TEAA must not be used prior or during the derivatisation reaction. 
Mal-DOTA, as purchased from Macrocyclics (Dallas, TX), contains non-negligible 
amounts of acid in form of TFA and hexafluorophosphoric acid as a result of the 
manufacturing process. pH adjustment with higher amounts of base might be required. 
Protocol C: 
This protocol was derived from the Gregorius et al.[137] Peptides must not be treated 
with alkylating agents (IAA or MMTS) prior to derivatisation, which is a standard step in 
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protein digestion. During digestion, only the reduction step should be performed. The 
sulfhydryl groups are the Mal-DOTA reagent’s target groups and must not be blocked by 
other modifications.  
Stock solutions: 100 µM TCEP; 1 mM Mal-DOTA in HEPES; 50 mM HEPES pH 7; 6 N 
NaOH; 100 mM TEAA pH 5; 1M lanthanide(III) salt in 100 mM TEAA pH 5;  
Molarities can be adjusted depending on sample amounts/free reactive groups. Sample 
volume for each step must not be lower than 30 µL, to avoid complete 
evaporation/condensation of the solvents in the cap of the tube, especially during 
heating. 
1. Peptide reduction with TCEP using a 2-fold molar excess of TCEP (in HEPES) per 
cysteine residue, for 1 h at 60 °C with mild shaking. 
2. Derivatisation of sulphhydryl groups with Mal-DOTA using a 20-fold molar 
excess of Mal-DOTA regarding free thiol groups. pH adjustment using NaOH (pH 
must be < 7.5). Reaction in 50mM HEPES, for 2 hours at 37 °C, mild shaking.  
3. Chelation using a 10-fold molar excess of lanthanide-salt solution regarding NHS-
DOTA. Reaction for 1 h at room temperature, mild shaking and pH 5 to 5.5.  
Sample is to be used immediately for analysis. Respectively it can be stored as described 
in Section 3.3.1 lyophilised at -20 °C or for short time at 4 °C. 
 
3.6 nanoHPLC Parameters 
Two nanoHPLC systems were employed during the thesis: Instrument 1 was situated in 
Pau, which was used with a fraction collector or directly coupled to an ICP-MS, while 
instrument 2 was situated in Kiel, used with a fraction collector for MALDI-MS 
experiments.  
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Table 7: Employed nanoHPLC systems and parameters 
nanoHPLC systems  
Instrument 1 LC Packings (Dionex) FAMOS, SWITCHOS, ULTIMATE 
Chromatographic column Acclaim® Pepmap100 C18 
75 µm I.D., 15 cm in length;  
particle size 3 µm, pore size 100 Å 
Pre-column Acclaim® Pepmap C18, 0.3 mm I.D. x 10 mm 
Flow rate Loading:  30 µL/min 
Nano:       300 nL/min 
Sample loop 5µL (0.5 – 2.5µL Injection volume) 
Instrument 2 Dionex UltiMate 3000 nanoHPLC 
Chromatographic columns Acclaim® Pepmap100, C18, 3 µm, 100 Å, 75 µm I.D.  
Lengths:  15 cm or 25 cm 
Pre-column Acclaim® Pepmap C18, 0.3 mm I.D. x 10 mm 
Flow rate Loading:  30 µL/min 
Nano:       300 nL/min 
Sample loop 20 µL (2.5 – 10 µL injection volume) 
3.6.1 Eluents 
Eluent A:  Ultrapure water, 0.05 % TFA 
Eluent B:  80 % ACN in ultrapure water, 0.04 % TFA 
Loading pump:  3 % ACN in ultrapure water, 0.1 % TFA 
Eluents for the LC Packings nanoHPLC system were degassed using a constant helium 
flow. The system was purged on a daily basis. 
3.6.2 Employed nanoLC Gradients and Programs 
Samples were loaded onto a C18 pre-column after injection. A wash step of 6 min was 
employed before elution to the analytical column was performed. Optimisation of this 
wash step is discussed in section 4.1.   
After switching of the valve to the analytical column, different gradients were employed, 
depending on the complexity of the sample (Figure 23). Low complexity samples of 
labelled model peptides were analysed with a gradient of 5 to 70 % Eluent B in 20 min 
(red gradient). Low complexity digests of small model proteins were analysed using a 
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gradient of 5 to 70 % Eluent B in 4 min (green gradient). Digests of SDS-PAGE bands were 
analysed with a less steep gradient of 5 to 70 % Eluent B in 60 min (blue gradient). 
Maximum percentage of Eluent B was 95 %, which equals 76 % ACN.  
 
Figure 23: Gradients employed for different sample complexities 
3.7 Probot Fraction Collection 
For measurement using MALDI-MS, the nanoHPLC system was coupled to a LC Packings 
Probot fraction collector. Therefore the exit capillary from the Ultimate UV detector was 
connected directly to the inlet capillary of the Probot using a Teflon connector. Eluting 
peptides were mixed automatically with matrix solution in a T-junction and spotted in 
intervals of 15 s on an Opti-TOF 384-well plate. nanoHPLC flow rate was constant at 
0.300 µL/min, Probot syringe speed was 0.899 µL/min. 
Basic matrix solution:  
3 mg/mL CHCA in 70 % ACN (v/v), 0.1 % TFA (v/v), 5 nM Glu1-fibrinopeptide B (internal 
standard MALDI-MS). 
Erbium matrix solution: 
40 μg/L Erbium (internal standard fsLA-ICP-MS), 3 mg/mL CHCA in 70 % ACN (v/v), 0.1 % 
TFA (v/v), 5 nM Glu1-fibrinopeptide B. 
3.8 MALDI-MS and MS/MS Parameters 
MALDI-MS mass spectra were acquired in positive ion reflectron mode by averaging the 
spectra of 1000 to 2000 laser shots with a laser pulse rate of 400 Hz. 10 subspectra with 
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200 shots per subspectrum were accumulated. Internal calibration of the MS spectra in 
LC-MALDI-MS experiments was performed on Glu1-fibrinopeptide B and the matrix 
cluster signal at m/z of 877.034.  
For MALDI-MS/MS, precursor ions were separated using a 300 resolution window in 
timed ion selection. 2500 laser shots were averaged with a pulse rate of 1000 Hz. For 
peptide fragmentation, CID with deceleration of the ions to 1 kV was used. The collision 
gas for CID experiments was ambient air (10-6 Torr medium pressure). The 
fragmentation spectra were manually inspected and analysed with the ’Ion 
fragmentation calculator’ tool embedded in the Data explorer software 4.10. For LC-
MALDI-MS/MS analysis, a job-wide interpretation method was employed, selecting the 
15 most intense precursors per spot with a minimum signal-to-noise (S/N) of 30. 
3.8.1   Protein Identification by Database Search 
The MALDI MS/MS data of the respective digests was analysed using Mascot 2.4 in 
combination with the SwissProt database, which was downloaded in the version from 
the 15.02.2011. The entries for the search were limited in an appropriate manner: 
 to vertebrates, for the digested proteins lysozyme, cytochrome C, α-lactalbumin, 
β-lactoglobulin 
The employed proteolytic enzyme was specified to be trypsin or chymotrypsin, 
respectively, with a maximum of two missed cleavages. Precursor tolerance was set to 
25 ppm and the MS/MS fragment tolerance to 0.4 Da. Variable modifications were 
chosen depending on the experimental setup: 
Table 8: Variable modifications for mascot search. 
Variable modifications Residue, target group Remarks 
Oxidation Methionine - 
Alkylation (methylthio) Cysteine, -SH NHS-DOTA labelling only 
Mal-DOTA Cysteine, -SH If complexation incomplete 
Ln-Mal-DOTA Cysteine, -SH Ln :   175Lu ; 169Tm ; 159Tb ; 165Ho ; 141Pr 
NHS-DOTA N-terminus or lysine, -NH2 If complexation incomplete 
Ln-NHS-DOTA N-terminus or lysine, -NH2 Ln :   
175Lu ; 169Tm ; 159Tb ; 165Ho ; 141Pr 
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3.9 ICP-MS Parameters 
The nanoHPLC was coupled to the ICP-MS using a fused silica tubing (20 µm I.D., 280 µm 
O.D.), connecting the UV detector’s outlet capillary with the nano nebuliser (nDS-200e: 
nebuliser type T1, spray chamber S2, see Figure 21).[146, 147] ICP-MS operating conditions 
are listed in Table 9. 
Table 9: ICP-MS system operating conditions when coupled to nanoHPLC 
ICP-MS System  
Instrument Agilent 7500ce 
Plasma Power 1500 W 
Reaction mode Off 
Cones Nickel skimmer cone (G3270-65024) 
Nickel sampling cone (G1820-65238) 
Nebuliser nDS-200e, type T1[146] 
Spray chamber nDS-200e, type S2[146] 
Nebuliser/carrier gas flow 1.17 – 1.24 L/min 
Makeup gas flow 0 L/min 
Tuning isotopes 166Er, 167Er, 168Er 
Monitored isotopes 166Er, 141Pr, 159Tb, 165Ho, 169Tm, 175Lu 
An erbium standard solution was added to the nanoHPLC eluents A and B to a final 
concentration of 40 µg/L. It was used for monitoring of the signal stability during 
nanoHPLC gradients and daily tuning of the instrumental settings. Signal behaviour 
during gradients is shown in Figure 24. The sudden drop in the erbium signal after 520 s 
is caused due to the valve switching from the trap column to the analytical column and 
corresponds to the arrival of erbium free loading pump eluent at the ICP-MS detector. 
Delay between programmed gradient and arrival of the eluents at the UV detector was 
2 min, delay between UV detection and ICP-MS detection was 40 sec. 
It can be seen that a less steep gradient leads to a slightly more stable erbium signal. 
Quick changes in the eluents compositions lead to reproducible disturbances, especially 
in the later part of the chromatography. All peptides are already eluted prior to 4000 s 
(80 min gradient), respectively 2500 s (60 min gradient), so that the grave disturbance of 
the signal did not interfere with the peptide signals. The erbium signal was used for 
normalisation of the peptide signals, during quantification. 
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Figure 24: Erbium signals monitored by ICP-MS in the course of chromatography gradients with 4800 sec (left) and 
3600 sec (right) length. 
3.10 fsLA-ICP-MS Parameters 
3.10.1 Instrumental Setup and fsLA-ICP-MS Parameters 
Table 10: fsLA-ICP-MS system and parameters 
Laser Parameters Novalase ALFAMAT 
crystal Yb:KGW  [Yb doped KGd(WO4)2] 
Wavelength 1030 nm 
Pulse width 360 fs 
Vitesse platine 5 μm/s 
Scanner speed 20 mm/s 
Repetition rate 1000 Hz 
Energy 3 μJ/pulse 
Fluence 1.3 J/cm3 
Crater diameter 1350 µm (77 concentric circles) 
He gas flow 300 mL/min 
ICP-MS parameters PERKIN Elan DRC II 
Configuration Wet 
Nebuliser type PFA μflow (100 μL/min) 
Nebuliser gas flow rate 0.7 L/min 
Dwell time 5 ms 
Sweeps 5 
Monitored isotopes 166Er ; 175Lu ; 169Tm ; 159Tb ; 165Ho ; 141Pr ; 60Ni 
Power 1050 W 
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Experiments were conducted using the following instruments: a Dionex U3000 
nanoHPLC coupled to a Probot fraction collector and an ABSCIEX TOF/TOF 5800. The 
matrix was modified by addition of an erbium standard solution, to a final concentration 
of 40 μg/L Er (see section 3.7). 166Er was monitored as an internal standard during fsLA-
ICP-MS. fsLA-ICP-MS was performed on a Novalase ALFAMET high repetition rate IR 
fsLA-system[174] coupled to a Perkin Elmer Elan DRC II ICP-MS system.  
Ablation was conducted by arranging the laser shots in concentric circles (cc). Surfaces 
between 900 µm and 1350 µm were covered using up to 77 cc. Microscopic images of 
the different diameters with the cc can be seen in section 4.5.9. 1350 µm was the 
approximate diameter needed to cover the surface of the faction spots made with the 
spotter; therefore it was employed for sample measurement after the optimisation step. 
3.11 MALDI-Target Plate Design for fsLA-ICP-MS 
The LA-chambers diameter was 45 mm, restricting the maximum diagonal of the 
rectangular target pieces to 44 mm. The targets were cut using a guillotine. A rotary 
cutter or a saw as means for cutting were ruled out, since they result in a significant 
distortion of the target surface and might cause unwanted frazzling of the cutting sites. 
The guillotine shows an equal force distribution during the cutting process, resulting in a 
better control of possible surface distortions. For TOF analysis, it is imperative to have a 
perfectly even target surface, to not induce variations in ion flight times. Small 
differences can be corrected by MALDI-MS calibration. 
Two designs were tested for the cutting pattern of the Opti-TOF 384-well plates (Figure 
25). Design 1 was found to be less convenient for LA of real samples. The gas flow 
transporting the ablated particles to the ICP-MS might have different efficiencies, 
depending on the position of the spot on the long metal pieces. In order to rule out such 
an effect, a second cut design was developed, with the fractions being spotted in a more 
centred manner. This is why design 1 was used mainly for preliminary testing and the 
spotting of standards, whereas design 2 was used for the actual nano-HPLC runs 
measured with MALDI-MS.  
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Figure 25: Scheme of the two designs for cutting of the MALDI-targets. Left hand design (1) was used for 
preliminary tests and spotting of standards, right hand design (2) was used for the model sample. 
The plate pieces were fixated on the plate holder prior to sample spotting. The spotter 
had to be reprogrammed in regard to the z-axis to avoid breaking the spotter’s needle 
due to the 1 cm height difference. Spotting alignment was done with the help of an 
uncut target: Spot A1 was aligned on the uncut target, the spotter table was then moved 
down in z-direction. The cut target on the holder was put on the table and aligned with 
the x and y coordinates of A1 found for the uncut target. The plate holder was then 
fixated on the spotter table. The spotting scheme is shown in Figure 26. An alternative 
approach of spotting the cut target prior to its assembly on the target holder results in 
severe alignment difficulties. It also increases the risk of touching and thereby rubbing 
off the sample spots. Consequently it was ruled out in favour of the approach using the 
plate holder. 
Design 2 was supposed to be used for measurement of the model sample with both 
MALDI-MS and fsLA-ICP-MS. For MALDI-MS measurements, the three magnets in the 
target plate holder had to be removed. They usually serve the purpose of holding the 
MALDI-target in place during transport and measurement inside the MALD-MS 
instrument. Unfortunately they were interfering with the fixation of the cut-up plate. 
The cut pieces were immobilised on the target holder using twin-sided adhesive tape 
and the magnets on the bottom of the plate holder were causing some pieces to get 
partly detached from the holder. This can be particularly dangerous during the 
introduction of the cut plate into the instrument: magnetic arms lift the plate up very 
abruptly and could cause pieces to detach from the plate holder entirely. If they were to 
fall off from the holder into the instrument during the loading process, there would be 
the need to shut down the whole system and get the instrument opened up by the 
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technical support. Without the magnets, no detaching was observed and the cut up 
pieces could be analysed without harm to the instrument. 
There was also the necessity to block all openings in the plate holder during 
experiments, when not employing all target pieces. The open holes in the plate holder 
(e.g. from removed magnets or the bar code area) caused a failure in settling of the 
source chamber pressure. Application of standard sticky tape was already sufficient to 
deal with this problem. 
3.12 Spotting Pattern and MALDI-MS and MS2 Calibration Parameters 
 For MALDI-MS calibration, it was found that it was merely impossible to use the 
standard calibration spots (marked as ‘Cal spots standard’ in Figure 26) of the original 
plate design, since the height differences between the different cut pieces were too big 
for the TOF analysis. For calibrations using the standard Cal spots, mass tolerance was 
off by at least 3 m/z, which is intolerable for accurate peptide identification. Plate 
alignment for automated measurement also posed a problem for spot groups that were 
spread too far across the target plate. In order to deal with these two problems, new 
alignment and calibration spots were set for each plate piece, so that calibration and 
alignment could be conducted independently on each piece. The new calibration spots 
were spotted in the approximate area by hand, prior to MALDI-MS measurements. For 
alignment the four outmost spots of each plate piece were chosen. This meant 
recalibration and realignment in MALDI-MS was to be done three times for a normal LC 
run, since the fractions were spotted on three plate pieces (four times for LC run 3 
respectively). 
A set of four to six Cal spots (‘Cal spots new’ in Figure 26) was provided for each 
segment of the cut target. Calibration was done on at least four different Cal spots per 
target piece. Repeated calibration on the same spot can also be used and is accepted by 
the software. MS-Calibration was conducted on the Cal spots with a min. signal to noise 
ratio (S/N) of 12, max. mass tolerance of ± 0.5 m/z, min. 5 to 6 calibrant peaks to match 
and a max. outlier of 5 ppm. MS2 calibration was conducted with the following 
parameters: min. S/N of 12, max. mass tolerance ±0.5 – 1, min. peaks to match 4 to 5, 
max. outlier 30 ppm. 
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Internal calibration of each sample spot was done using the masses of GluFib and the 
CHCA matrix clusters, as already described in section 3.8.   
 
Figure 26: Spotting scheme for LC runs on cut target design 2. 
3.13 Microscopy 
The target plates from the LA-ICP-MS experiments were examined using a Leica dfc 280 
microscope.  
The employed objectives were: X5 0.12 bd, X10 0.25 bd; X20 0.40 bd; X50 0.75 bd 
Photos were taken using the software “Leica im50 IAccess”, which provided the 
respective scale for each magnification. 
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IV Results 
4.1 Pre-Cleaning Experiments 
Due to the derivatisation procedure which employs high amounts of salt (200- to 
1000-fold molar excess of lanthanide ions regarding target groups in the molecule), 
sample pre-cleaning is a substantial need. Not only does the excess in salt impact 
ionisation efficiencies in ESI- and MALDI-MS, it also hampers co-crystallisation of the 
matrix with the analyte. Furthermore and most importantly it leads to a significant 
background during ICP-MS analysis, potentially impairing quantitative approaches. The 
excess metal causes a tremendous peak in the beginning of the chromatography, which 
tails throughout the whole chromatogram. This leads to an elevated, indefinite 
background, which can impair detection of less abundant peptide species. It was also 
reported that the unbound metal-complexes can cause an additional peak later in the 
chromatogram, which coelutes with the analytes. [129, 132, 133, 175]  
Examples from publications on different labelling approaches which do not include pre-
cleaning steps are shown in Figure 27.  
 
Figure 27: Selected figures from publications on labelling approaches, without pre-cleaning step prior to LC-ICP-MS 
analysis. (a) Ferrocene based approach by Bräutigam et al.
[129]
  (b) DTPA based approach by Patel et al.
[132]
  (c) Mal-
DOTA-based labelling by Yan et al.
[175]
  (d) DTPA-based labelling by Rappel and Schaumlöffel.
[133]
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In each of the examples, the high peak of excess metal / reagent can be seen (marked 
with the blue boxes). Especially in Figure 27 a and b, the coelution of analytes with the 
excess reagent can be observed. The height of the excess peaks in the figures cannot be 
determined, since the scale is commonly cut off in favour of the analyte peaks. 
A multitude of purification methods is described in Section 2.3.1. Methods, such as 
ultrafiltration (UF) or solid phase extraction (SPE) are employed in addition to the 
sample analysis itself in an offline manner. This additional sample treatment contributes 
to the risk of sample alteration, by e.g. introduction of impurities. Also, the absolute 
amounts of the analytes can be lowered, leading to changes in the overall sample 
composition by discrimination of certain analyte species according to their properties.  
As an offline purification approach, SPE is commonly implemented in most proteomics 
laboratories (e.g. in the form ‘ZipTips’). In the following section an approach employing 
ZipTips as a representative of offline purification will be discussed. SPE was employed 
together with nanoHPLC for analysis with ICP-MS, in order to elucidate the merits of SPE 
for a lowered metal background. 
Part of the results in this section are published in Holste et al. 2013[4] 
4.1.1 Offline Purification with Solid Phase Extraction 
ZipTip® pipette tips are available with different stationary phases and different 
capacities. For a SPE recovery test, C18 ZipTips were chosen and applied using the Merck 
Millipore standard protocol with 0.1 % HFBA (heptafluorobutyric acid) instead of TFA. 
The protocol states that other ion pairing reagents can be used as an alternative to TFA. 
[176] 
nanoHPLC-ICP-MS measurement of the peptide mixture with and without ZipTip C18 
treatment showed that more than 95 % of the sample was lost during treatment (Figure 
28 a). The treated sample was eluted from the ZipTip and taken up in the same volume 
as the initial sample. Both samples were analysed in a multiplex approach. The loading 
buffer contained 0.1 % HFBA, Eluents A and B contained TFA. 
Significant losses were not only found when employing HFBA. Same observations were 
made in SPE experiments employing ZipTips with 0.1 % TFA. The panels (b) to (f) show 
samples that were treated accordingly, followed by nanoHPLC-ICP-MS analysis of both 
the ZipTip eluate as well as the ‘remnant’ solution. The remnant comprises all liquids 
IV RESULTS 
-71- 
 
other than the eluate which had contact with the ZipTip during treatment – namely 
wash solutions after peptide binding and the solution that was carrying the peptides 
prior to binding. By only applying 2.5 µg of labelled peptide, it was taken care, that the 
maximum capacity of 5 µg was far from being reached. To further ensure binding, ACN 
from the derivatisation reaction was removed completely from the samples and they 
were solved in 0.1 % TFA. Binding and elution was performed with 20 cycles minimum. 
The remnant solutions and the elutates were lyophilized and both taken up in the same 
amount of loading buffer, immediately before injection. None of the interfering 
substances listed in the userguide were present during SPE. 
 
Figure 28: Monitored peptide recoveries after SPE with ZipTip C18, multiplex analysis of labelled peptide mixtures 
via nanoHPLC-ICP-MS. (a) Mal-DOTA labelled peptides A, B, C, with and without ZipTip treatment. (b) through (f): 
NHS-DOTA labelled peptides treated with ZipTip: eluate (orange) versus remnants/supernatants from the ZipTip 
treatment (violet). (b) Cytochrome C digest, (c) S27 (d) S17 (e) GluFib (f) LeuEnkephalin. Partly published in Holste et 
al. 2013 
[4]
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Figure 28 b shows a NHS-DOTA labelled Cytochrome C digest that was treated with SPE 
as decribed. It can be seen that only a fraction of the digest’s peptides were bound by 
the C18 material of the ZipTip. The binding of the earlier eluting (more hydrophilic) 
peptides is obviously discriminated. This trend can also be seen for the labelled model 
peptides (sequences in Table 24). When run altogether in a multiplex, their elution 
sequence is S17 – S27 – GluFib – LeuEnk, following the GRAVY index from most 
hydrophilic to most hydrophobic. The GRAVY values can be seen in Table 24 on 
page 154, the value for S27 is not comprising phosphoserine, therefore being too high.  
Peptide recovery is worst for LeuEnk (Figure 28 f), the most hydrophobic peptide, which 
is most likely due to its relatively low molecular weight (5 AA). The other peptides have 
an average length of 14 AA, equalling almost three times less single peptides to be 
bound by SPE for the same sample amount. For S17 (d) the losses in the remnant and 
the recovery in the eluent are almost equal, whereas for S27 (c) and GluFib (e) the 
recoveries are slightly above the losses. This is consistent with the observations in the 
Cyt C digest. (Quantification data for the digest can be found in Appendix III, section 9.3) 
Table 11: Recoveries for the respective peptide samples in Figure 28 (c) to (f) 
Sample Label Total counts % recovery 
S17 Eluate Pr141 59 931 765 61.4 
S17 Remnant Ho165 37 677 021 38.6 
S27 Eluate Tm169 18 129 159 20.9 
S27 Remnant Tb159 68 755 268 79.1 
LeuEnk Eluate Tb159 28 318 326 23.7 
LeuEnk Remnant Pr141 91 342 627 76.3 
GluFib Eluate Ho165 40 104 458 56.2 
GluFib Remnant Lu175 31 241 809 43.8 
This leads to the conclusion that SPE, at least in form of C18 ZipTips is not an option for 
sample cleanup, if quantitative analysis is to be conducted afterwards. Metal 
backgrounds are significantly lowered, but come along with tremendous peptide losses. 
Especially hydrophilic peptides do not seem to bind properly to the C18 resin, even 
when using HFBA as an ion pairing reagent. 
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4.1.2 Online Pre-Cleaning using a Trap Column 
Apart from the observed peptide losses in the case of C18 ZipTips, offline purification 
steps are often time consuming and can have a bad influence on an experiment’s 
reproducibility – if the purification is not by any chance automated. The alternative is an 
online purification, which can for example be implemented in the chromatographic 
routine. 
The nanoHPLC systems employed in this thesis already comprised a precolumn which is 
mainly used for sample pre-concentration and protection of the fragile chromatographic 
column. The analytical column, a C18-resin filled capillary (I.D. 75 µm), is preceded by a 
short C18-precolumn with a higher diameter (I.D. 0.3 mm), which will not be clogged 
easily by impurities and can be cleaned by a back flush, if it should be necessary. The 
injected samples will be trapped on the precolumn and then be eluted with the same 
flow direction onto the analytical column. The time period before switching onto the 
analytical column can be programmed freely. This allowed for a series of experiments 
determining the optimal parameters for an online purification approach, employing the 
precolumn for the removal of low MW compounds, such as metal ions and metal-
complexes. 
 
Figure 29: (a) Raw signals of metal backgrounds for a 
165
Ho Mal-DOTA labelled peptide mixture, treated with 
different precolumn wash lengths. Lowest background found for 20 min. (b) Principle of valve switching between 
precolumn/‘trap’ washing (blue) and elution from the trap column to the analytical column (green).  
Original data from Holste et al. 2013 
[4]
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Figure 29 a shows the background signals in ICP-MS for a series of experiments with 
wash steps of different lengths, (b) shows the connectivity of the 10-port valve and the 
principle of the valve switch (violet) between the precolumn wash (blue) and the elution 
to the analytical column (green). These phases of the analysis are also marked in (a) at 
the top of the diagram: During the washing of the precolumn, the signal for the internal 
standard erbium (grey) – found in both eluents A and B, stays steady, since the 
precolumn is bypassed. After the switch of the valve from position 10_1 to position 1_2, 
the 166Er free loading buffer gets washed off the precolumn, causing the sudden drop in 
the erbium signal for the length of the trap column’s eluent volume. The 166Er signal rises 
and goes back to a steady level upon arrival of the gradient at the detector. At the same 
time the signals for the metal background of the samples rise accordingly, depending on 
the length of the wash step.  
With reference to Figure 27 (page 69), no large excess reagent/metal peak in the 
beginning of the elution can be observed. Only the background of the 3 min flush shows 
a slight elevation in the beginning. The others show a steady background right from the 
start. It can also be observed, that the metal background is significantly lowered for the 
wash steps longer than 3 min. Percentages for the background (Figure 30, left) were 
calculated with the 3 min wash equalling 100 % background. With 6 min pre-cleaning, 
the background level is already reduced by 63 %. After 10 min it is diminished by 86 % 
and with a wash length of 20 min it can be further decreased to up to 93 %. At the same 
time significant peptide losses for more hydrophilic peptides were found, starting with a 
10 min wash time (Figure 30, right). After 20 min, peptide C stayed mostly unaffected 
with a loss of approximately 6 %, whereas more than 75 % of peptide A and more than 
25 % of peptide B were lost. 
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Figure 30: Decrease in background signal in percent with elongation of the wash step (left) and peptide recoveries 
in percent for the three Mal-DOTA labelled model peptides A, B and C for the different wash lengths (right), both 
diagrams with 3 min being 100 %. Average of 4 independent experiments. Original data from Holste et al. 2013, 
supporting information.
[4]
 
Figure 31 shows five nanoHPLC-ICP-MS chromatograms for 165Ho labelled peptides, 
treated with different wash lengths. The first four chromatograms correspond to the 
backgrounds shown in Figure 29 a. The three Mal-DOTA labelled peptides A, B and C can 
be clearly distinguished in those four chromatograms, with peptide A being marked by 
an ‘A’. Taking a direct look at the peak area of peptide A after the 20 min pre-cleaning 
step, the decrease in peptide recovery is evident.  
Another observation to be made is that metal backgrounds are generally very low, 
compared to the actual peptide signals. Already the 3 min wash step shows a 
background signal of only 1.24 % of peptide C’s peak height. This is further lowered to 
0.44 % for 6 min, 0.13 % for 10 min and lastly 0.08 % for the 20 min wash. The reference 
to peptide C was chosen, because it did not show a significant loss in recovery.  
In contrast to the Mal-DOTA labelled peptide mixture, the NHS-DOTA labelled variant 
shows a significantly higher background. This is due to the 5-times higher excess in NHS-
DOTA reagent utilised during derivatisation and the overall higher number of free 
amino-groups in peptide mixtures and digests, consecutively leading to the application 
of higher amounts of lanthanide salts. The elevated number of reactive groups is also 
responsible for the different peak profile of the NHS-DOTA labelled peptide mixture, due 
to possible double derivatisations. Even with the higher background for the NHS-DOTA 
mixture, no large excess peak in the beginning of the chromatography as seen in Figure 
27 (page 69), can be found. 
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Figure 31: nanoHPLC-ICP-MS chromatograms for the
 165
Ho labelled peptides A, B, C: Four chromatograms showing 
Mal-DOTA labelled peptides treated with different wash lengths and additionally, the same mixture labelled with 
NHS-DOTA and after 6 min washing. Peptide A is marked ‘A’, the arrow shows the moment of the valve switch. The 
double-sided arrow corresponds to the part of the chromatogram considered as the background signal (as shown in 
Figure 29 a). Original data from Holste et al. 2013 
[4]
 
4.1.3 Conclusions 
It was shown that the background can be significantly reduced by this simple online pre-
cleaning step, which is easy to implement in common HPLC systems. Already 6 min 
washing decreases the background signal by more than 60 % (compared to the 3 min 
flush), while guarding quantitative recovery of the peptides. This was deemed to be the 
optimised parameter, since a 10 min flush already shows significant peptide losses for 
the more hydrophilic peptide species.  
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4.2 Eluent Additives 
In the course of nanoHPLC optimisation, several additives were tested in the eluent of 
the loading pump. The standard ion pairing reagent TFA was compared with the more 
hydrophobic HFBA for analysis of hydrophilic peptide species (structures, see Figure 32). 
EDTA was employed in order to test whether it would aid the lanthanide metal removal 
during the washing step. 
Part of the results in this section are published in Holste et al. 2013[4] 
4.2.1 Ion Pairing Reagents 
Ion pairing (IP) reagents are used in RP-HPLC setups to enhance the separation of 
ionisable and highly polar substances, which show low or no interaction with the RP-
material of the stationary phase. Most RP-HPLC setups use a pH below 3. This usually 
leads to very good separation results and is due to several different effects, depending 
on the acid employed. In general, interactions between acidic compounds and the silica 
support of the packing material are suppressed through the complete protonation of 
both by the acid. Fluorinated acids, such as TFA are often used with RP-HPLC, mainly for 
acidification during peptide and protein analysis.  
Fluorinated acids show several advantages, such as pH stabilisation during analysis and 
volatility, so they can be removed from the sample if necessary. Most importantly they 
supposedly ameliorate peak shapes and allow control of selectivity and retention. 
Several studies lead to the conclusion that this is due to interactions between basic 
residues in the peptides and the carboxylic group in TFA. However another study 
concluded that ionic and hydrophobic interactions with the RP-material are involved.[177]  
F
F
F
COOH
F F
F F
COOHF
F
F
HFBA TFA  
Figure 32: Ion pairing reagents for RP-HPLC. Heptafluorobutyric acid (HFBA) and tetrafluoroacetic acid (TFA) 
Very hydrophilic peptides are known to have a very poor retention on RP-columns.[178] 
Since this is also the case when TFA is used as an IP reagent, great losses for hydrophilic 
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peptides were expected during the online precleaning. This is why a very hydrophilic 
model peptide Hy (ESLSSSEE) was chosen and the application of a more apolar 
fluorinated acid, HFBA (Figure 32) for the trapping on the precolumn was tested. HFBA 
was employed with a percentage of 0.1 % (v/v) in 3 % ACN/water to replace the 
standard loading buffer. Eluents A and B stayed the same and contained TFA.  
 
Figure 33: nanoHPLC-ICP-MS analysis of DOTA-labelled peptide mixtures, using 0.1 % HFBA in the loading buffer. 
Loss of the peptide signal for peptide Hy after reinjection. Original data from Holste et al. 2013, 
[4]
 
Chromatograms for these experiments were acquired using nanoHPLC-ICP-MS. Figure 33 
shows the chromatograms for a 165Ho NHS-DOTA labelled peptide mixture (blue) 
including Hy, which was analysed alongside the 169Tm labelled single peptide Hy 
(orange). In (a) the sample was injected immediately, while (b) represents the same 
sample reinjected after two hours. Hy can be easily identified within the peptide sample 
because of the labelled single peptide which was measured in parallel. In both runs, the 
peak pattern for the normal model peptides stays virtually the same. Surprisingly a loss 
in recovery for the labelled peptide Hy was observed upon reinjection of the same 
sample. Already after five hours the labelled peptide could not be detected anymore 
(not shown). The other synthetic peptides seem completely unaffected by this effect. 
In order to understand these findings, a closer look was taken at the applied parameters: 
The freshly labelled samples for these experiments were stored as aliquots at -20 °C in 
100 mM TEAA at pH 5. Immediately before injection the labelled peptide samples were 
acidified by addition of TFA to a final concentration of 0.1 % (v/v) TFA for optimal 
binding on the trap column. After the first injection, the sample was kept at ambient 
temperature in the autosampler and was reinjected after two and five hours. The result 
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was confirmed in a second experiment series with a freshly prepared sample that 
showed the exactly same effect.  
One possible explanation for the effect might be a hydrolysis of the bond between the 
peptide and its label over time. The addition of 0.1 % TFA creates a highly acidic 
environment (pH 2-3) which might induce acidic hydrolysis of labile bonds. In this case, 
the structure of the peptide must have a special influence on the stability, given the fact 
that the other peptides were not affected. For verification, it was tried to track the loss 
of the label with MALDI-MS, but neither of both Hy peptides, labelled or unlabelled, 
could be detected.  
 
Figure 34: Difference in retention behaviour after nanoHPLC-ICP-MS analysis of Mal-DOTA-labelled peptide mixture 
(peptides A, B, C) with different loading buffers: 0.1% TFA (green), 0.1% HFBA (blue). Original data from Holste et al. 
2013, 
[4]
 
In addition to the findings for the recovery of the hydrophilic peptide, it was found that 
the use of HFBA has a significant influence on the retention behaviour of the model 
peptide mixture (Figure 34). With the same gradient, peptides that were easily 
separated using TFA could not be separated anymore when employing the same amount 
of HFBA in the loading buffer. The carryover of HFBA from the trap column to the 
analytical column was deemed to be the cause of this change in retention. It was also 
shown, that the metal background with HFBA was significantly higher than with TFA, 
including a broad peak in the beginning of the elution, as seen in both Figure 33 and 
Figure 34. Metal background when employing HFBA instead of TFA is elevated by 145%, 
whereas peptide recovery stays the same as with TFA (Figure 35, last column pair). 
The altered retention behaviour alongside with the elevated background lead to the 
decision not to follow the approach employing HFBA any further. All in all, it was found 
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that very hydrophilic peptides can be retained and detected using HFBA. For future 
applications, HFBA, applied in lower concentrations than 0.1 %, can be taken into 
consideration for the targeted analysis of hydrophilic peptide species. For routine 
analysis though, it seems to be more disadvantageous than beneficial. 
 
Figure 35: Background and peptide peak areas in % for different loading buffers, with TFA set as 100 %. TFA 
(0.1 % TFA, 3 % ACN), EDTA in vial (EDTA added to sample vial, normal loading buffer), EDTA/TFA (1 mM EDTA, 
0.1 % TFA, 3 % ACN), EDTA pH7 (1 mM EDTA, 3 % ACN), HFBA (0.1 % HFBA, 3 % ACN). n=2 
4.2.2 EDTA 
In this study, the loading buffer was modified by addition of the chelator EDTA. As 
shown in Table 5, EDTA forms far less stable complexes with the lanthanide ions than 
DOTA (log K difference ~ 6 orders of magnitude). EDTA was applied to aid the removal of 
unbound metal ions during the wash step, consecutively enabling a shorter wash step. 
EDTA was chosen over e.g. DTPA, since the applied chelator must not compete with the 
already present DOTA complexes. For further avoiding competition, EDTA amounts 
added to the loading buffer were calculated in a way, that the amount of EDTA applied 
during the wash step equalled the amount of unbound metal from the injected sample. 
Calculations were based on the injected excess metal amount, the flow rate of the 
loading pump and the length of the EDTA wash step.  
General experimental setup: The labelled peptide sample was loaded onto the 
precolumn with standard loading buffer for 1 min. Then the precolumn was flushed for 
2 min with the modified EDTA buffer, followed by another 3 min wash step with 
standard loading buffer. The last step was applied to avoid a carryover of EDTA onto the 
analytical column.  
In a first experiment 1 mM EDTA was added directly to the standard loading buffer (3 % 
ACN, 0.1 % TFA, pH 2-3). After application and analysis, the background was not lowered 
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in the slightest. On the contrary, the background seemed to be elevated in comparison 
with the standard 6 min wash step (see Figure 35, ‘EDTA/TFA’). A possible explanation 
can be the low pH of the loading buffer, which might impair the proper complexation by 
EDTA. Optimal complexation with EDTA is achieved in mildly basic medium. The second 
attempt was therefore conducted with a TFA-free EDTA loading buffer (3 % ACN, 1 mM 
EDTA, pH 7), which was applied in exactly the same way as above. After analysis, the 
samples still showed an elevated background (Figure 35, ‘EDTA pH7’). Same result was 
found with an alternative procedure, where EDTA was added directly to the sample vial 
prior to analysis. The equivalent amount of EDTA to the unbound lanthanide ions in the 
sample vial was added and the sample analysed using the 6 min standard wash step. The 
background was also elevated (Figure 35, ‘EDTA in vial’). At the same time it was found 
that the peptide peak heights in all of the experiments were elevated.  
In conclusion, EDTA did not benefit the metal removal, neither during the wash step nor 
as an additive in the sample vial. It rather seems to impair the removal of the unbound 
lanthanide ions. In addition, peptide recoveries when employing EDTA are also elevated 
in an unpredictable manner:  
When employing EDTA with TFA, the background is elevated by 20 %, while peptide 
recovery is elevated by 10 %. When applying EDTA at pH 7, the background is elevated 
by 30 %, while peptide recovery is elevated by 20 %. When adding EDTA directly to the 
vial, background is elevated by 60 %, with a 25 % higher peptide recovery. 
The EDTA approach was not deemed beneficial for the analysis, so it was not followed 
any further. 
4.3 Superposition of MALDI-MS and ICP-MS Data via UV-Detection 
For identification of the labelled peptides in ICP-MS chromatograms, ICP- and MALDI-MS 
data have to be aligned. Some difficulties were encountered regarding this task, since 
varying retention times of up to 2 to 3 min were observed between chromatograms 
recorded with the nanoHPLC coupled to the nano-nebuliser in the ICP-MS setup and the 
ones recorded when the nanoHPLC was coupled to the Probot fraction collector for later 
use with MALDI-MS. Those differences cannot be caused by only the lengths of the 
fused silica tubings employed in both setups. It rather seems to be a result of the 
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different backpressures caused by the gas flow in the nebulizer and the matrix dosage by 
the syringe in the Probot. While the Ar gas in the ICP-MS setup is flowing alongside the 
capillary in the nebulizer in order to carry the droplets into the torch in form of a fine 
mist, the Probot is giving a constant active backpressure through the syringe which 
doses the matrix. For the latter, the outlet capillary of the nanoHPLC is connected to a 
T-junction, which joins the matrix-dosing syringe and the nanoHPLC outlet capillary with 
the spotting needle. This is necessary for the mixture of the sample with the matrix 
before fraction collection on the target. nanoHPLC flow is set to 300 nL/min, while the 
flow of the matrix is set to 900 nL/min. The backpressure caused by the three times 
higher flow rate seems to have quite an impact on the retention times.  
To overcome these difficulties, the analysis of low complexity samples, such as standard 
peptide mixtures and digests from single proteins (lysozyme, cytochrome C, α-
lactalbumin and β-lactoglobulin) were taken as a starting point. In those cases, the peak 
patterns can usually be recognised easily in both UV-chromatograms acquired from the 
separate nanoHPLC runs. After alignment of the UV-trails, the ICP-MS and MALDI-MS 
data can be aligned accordingly. An example for the alignment of a simple peptide 
mixture is shown in Figure 36. 
 
Figure 36: Example for the superposition of MALDI-MS and ICP-MS data of a simple three peptide mixture. 
Alignment was achieved using the respective UV-chromatograms (left). Identified peaks from MALDI-MS are 
assigned to the detected signals in ICP-MS (right). Original data from Holste et al. 2013, 
[4]
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Figure 37: Overlays of nanoHPLC (UV 214 nm), ICP-MS and MALDI-MS data for a 
169
Tm NHS-DOTA and 
141
Pr Mal-
DOTA labelled tryptic digest of chicken lysozyme. 
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The peptide mixture consisted of the three 165Ho Mal-DOTA labelled synthetic peptides 
A, B and C (sequences in Table 24). Since Mal-DOTA can form stereoisomers (see 
reaction scheme in section 9.5.1), this leads to characteristic split-peaks in the 
chromatograms, which in the case of peptide C can be seen with all three detection 
methods. The formation of stereoisomers was reported before by several groups.[39, 160, 
179] After alignment of the UV-chromatograms the retention time shift between the two 
methods was applied to both MALDI- and ICP-MS data, resulting in the unambiguously 
assignment of the identified peptide peaks – in form of extracted ion chromatograms 
(XICs), to the respective signals acquired in ICP-MS.  
The same alignment principle was employed for a labelled lysozyme digest and is shown 
in Figure 37. The digest was labelled with both DOTA-reagents separately, employing 
different lanthanides for each reagent. Thereafter, the samples were pooled for 
multiplex analysis in ICP-MS. They were spotted separately for analysis in MALDI-MS. 
The labelled peptides were identified and XICs were generated. Even though the online 
precleaning was employed, the 169Tm background in the ICP-MS chromatogram is 
elevated. This is due to the application of NHS-DOTA, which needs to be employed with 
a very high excess of the reagent, leading to an accordingly high excess in lanthanide 
ions. Nonetheless the elevated background did not interfere with data interpretation. 
There is only a small excess peak in the beginning, and the background stays on a steady 
level. 
Being more complex than a simple peptide mixture, it was far less evident to recognise 
the peak patterns in both UV chromatograms. In this case, the alignment was still a 
success and the XICs could be assigned. Already for the peptide mixture in Figure 36, the 
signal intensities of the labelled peptides differ between MALDI- and ICP-MS and UV-
detection. When taking a closer look at the signal intensities of several peptides in the 
lysozyme digest in MALDI- and ICP-MS, it can also be seen that intensities are not always 
comparable: for example the second, third and last peptide peak in the ICP-MS 
chromatogram of 169Tm have different intensities. In MALDI-MS the second peptide of 
the thulium series is among the most intense peaks, while in ICP-MS it only shows a 
medium intensity. The third peptide was not detectable using MALDI-MS and the last 
peptide seems to be less intense in MALDI- than it is in ICP-MS detection. This shows yet 
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again, that MALDI-MS is very limited as a stand-alone technique for absolute 
quantification, if not used with specially developed approaches.  
A simple correction factor for the alignment cannot be determined, since the retention 
times of the chromatograms were not only shifted, the chromatograms were also 
stretched horizontally. 
Since the digest shown above was not completely labelled, a coelution of labelled and 
unlabelled peptides could be observed in the latter MALDI-MS fractions (Figure 38). 
Data regarding the identified peptides in MALDI-MS can be found in Appendix 9.1. 
 
Figure 38: Overlapping elution of labelled and unlabelled peptides of a tryptic lysozyme digest, detected with 
MALDI-MS
2 
For more complex samples, a differentially labelled model peptide mixture was 
developed. These peptides with known quantities should be applicable for absolute 
quantification and as retention time markers in more complex samples. With the 
marker-peptides distributed throughout the chromatography, the alignment should be 
simplified, since they are specifically detectable with both techniques, independent from 
the labelled sample itself: in ICP-MS, the label containing a differently chosen metal will 
be detected, while in MALDI-MS, the m/z ratio and the following MS2 can be applied for 
identification, by e.g. the use of an inclusion list. (Approach shown in section 4.6) 
4.3.1 Sequence Coverage for Labelled Digests 
Three model proteins were chosen and digested with trypsin: lysozyme (LYSC_CHICK), 
α-lactalbumin (LALBA_BOVIN) and β-lactoglobulin (LACB_BOVIN). Additionally, a 
cytochrome C (CYC_BOVIN) digest from Dionex was employed. After labelling of the 
MALDI-fraction 
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tryptic digests with both Mal- and NHS-DOTA (protocol C and A), the samples were 
analysed both with ICP-MS and MALDI-MS. In the following step the sequence coverage 
was studied. The nanoHPLC-ICP-MS chromatograms and sequence details can be found 
in Appendix 9.2.  
Data in Table 12 is based on MALDI-MS measurements and consecutive Mascot search. 
For labelling with NHS-DOTA all peptides contain target groups for the reagent, whereas 
Mal-DOTA only targets peptides containing cysteine residues. This is why peptides for 
the NHS-DOTA series are categorised in ‘labelled’ and ‘not detected’, while for Mal-
DOTA also sequences and peptides are listed that are no target for the reagent.  
Table 12: Sequence coverage in percent for differentially labelled model protein digests and detected peptides 
using Mascot search  
 
It was found that for each protein, between 32 % and 51 % of the sequence could 
neither be detected in form of labelled nor unlabelled peptides. The overlap of the 
undetected sequences in both the Mal- and NHS-DOTA experiments hinted that it is not 
a problem of the derivatisation itself: taking a closer look at the undetected sequences 
and their hydrophobicities, it was found that all of the resulting peptides are most likely 
very poorly soluble in water (positive GRAVY values). Therefore it cannot be ruled out 
that they are lost prior to or during their analysis. No precipitate was visible during 
sample treatment, which is not a surprise regarding the very limited concentration range 
Protein NHS-DOTA 
Sequence coverage 
 
N° of detected 
peptides (mascot) 
Mal-DOTA 
Sequence coverage 
 
N° of detected 
peptides (mascot) 
Lysozyme 67.35 % labelled 
32.65 % not detected 
 19 labelled 
 6 unlabelled 
28.89 % labelled 
28.57 % not detected 
42.18 % no target 
5 labelled target 
3 unlabelled target 
16 peptides in total 
α-Lactalbumin 49.30 % labelled 
50.70 % not detected 
 13 labelled 
 5 unlabelled 
33.80 % labelled 
29.58 % not detected 
36.62 % no target 
4 labelled target 
1 unlabelled target 
6 peptides in total  
β-Lactoglobulin 68.54 % labelled 
31.46 % not detected 
 11 labelled 
 3 unlabelled 
13.48 % labelled 
25.28 % not detected 
61.24 % no target 
3 labelled target 
0 unlabelled target 
13 peptides in total 
Cytochrome C 50.48 % labelled 
49.52 % not detected 
 16 labelled 
 2 unlabelled 
N/A N/A 
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of the experiments (pmol to nmol per μL). For nanoHPLC analysis, peptide mixtures were 
diluted to a 5 pmol/µL solution in 3% ACN, 0.1 % TFA. The low amount of ACN might not 
be sufficient for solubilisation of highly hydrophobic peptides. On the other hand, it is 
also possible that the interaction between these hydrophobic species and the C18 
material of the columns is too strong. Very hydrophobic peptides might not be eluted 
with the employed gradients (max. 76 % ACN). Another possibility is that these peptides 
are not ionisable in the MALDI process. Thus they are not visible in the MALDI-MS 
chromatograms and spectra, while they might still be detected with ICP-MS. This could 
also explain the peaks observed in ICP-MS, which show no match when compared with 
peptides identified by MALDI-MS. The example in Figure 39 confirms this assumption: 
signal intensities (SI) for peak 1 and 2 are in the same range in ICP-MS, with peak 1 being 
more intense. In contrast to this the SI for peak 1 in MALDI-MS is far lower than the SI of 
peak 2. This hints towards a lower ionisation efficiency of peptide 1. It can be assumed 
that peak 3 has an even lower ionisation efficiency than 1, so that it was not detectable 
with MALDI-MS and MS2 anymore, but on the contrary still shows a prominent peak in 
ICP-MS. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39: Extracted ion chromatograms (MALDI-MS, below) attributed to the corresponding peaks in the ICP-MS 
chromatogram. SI for peak 1 is very low in MALDI-MS, peak 2 has a very good SI, whereas peak 3 did not show a 
match in MALDI-MS. 
To conclude, for quantification approaches with this nanoHPLC setup, a set of target 
peptides has to be chosen carefully. It should be made sure that they are detectable 
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with MALDI-MS. Incomplete derivatisation at this time point still posed a problem. 
Mascot search identified several peptides that were only partly labelled. In addition, 
double derivatisations occurred which further contribute to sample complexity. When a 
doubly and singly labelled peptide coelute, quantification is merely impossible, since the 
ratio between the two peptides is unknown. In contrast to this, application of Mal-DOTA 
leads to far less complex ICP-MS chromatograms and can be considered as an 
alternative for NHS-DOTA in order to obtain more conclusive data. 
In theory, only a few completely labelled peptides should be sufficient for a reliable 
quantification, due to the theoretically equal proportion of the peptides in the digest. 
Therefore the aim is to identify these peptides in order to conduct an absolute 
quantification. 
4.4 Labelled Model Peptides for Quantification in nanoHPLC ICP-MS 
Aim was the development of the mentioned set of labelled standard peptides 
(sequences in Table 24) which could be used as a standard for quantification purposes. 
The chosen peptides should cover the major part of the chromatogram and they should 
be well characterised in terms of their quantities. They could also be used for simplifying 
the alignment of data acquired with ICP-MS and MALDI-MS, which will be discussed in 
section 4.6. 
4.4.1 Labelling of Model Peptides and their Quantification 
The set of model peptides was labelled separately using NHS-DOTA according to 
protocol B. The NHS-DOTA labelled single peptide solutions were split into three equal 
parts and complexation was performed with different lanthanide salt solutions. The 
lanthanides for each peptide were chosen in a way which would allow the generation of 
three peptide mixtures, each containing five differentially labelled model peptides. 
In order to be able to use these peptides as standards, quantification needed to be 
performed. For quantification via ICP-MS total metal analysis, the excess metal 
employed during derivatisation had to be removed in order to determine the 
concentration of the peptide bound metal only. 
Peptide samples after derivatisation and complexation were dried using a speedvac –   
mainly for ACN removal. The samples were then resolubilised in 0.1 % TFA and treated 
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with C18 ZipTips according to protocol, for excess reagent removal. After elution the 
samples were lyophilised as aliquots and kept at -20 °C for later use. 
For quantification using ICP-MS total analysis, the instrument was tuned using a rare 
earth tuning solution with a concentration of 500 ng/L for each metal in 2 % HNO3. 
Monitored elements: 141Pr, 159Tb, 165Ho, 169Tm, 175Lu. Sensitivity for the respective 
elements: approximately 25 000 cps with a RSD between 2.5 and 3.4 %. 
A dilution series of the respective metals in 2 % HNO3 was prepared, ranging from 
0.5 ng/L to 1000 ng/L. This concentration range was chosen, since the amounts of the 
labelled peptides were limited. A minimum of 2 mL sample solution was needed for the 
total metal analysis. The lyophilised peptide samples were each solved in a matching 
amount of 100 mM TEAA (pH 5) to reach a concentration of 100 μg lanthanide per litre: 
around 500 μL were used, depending on the employed lanthanide. These solutions were 
further diluted using 2 % HNO3, to be in the range of the dilution series. The first 
dilutions analysed (approximately 10 ng/kg) were too low in concentration for reliable 
quantification. A second, five times more concentrated series was prepared and 
analysed.  
Quantities of the labelled peptides in the respective aliquots were determined to be 
0.78 nmol GluFib (Lu, Ho or Tb), 0.25 nmol LeuEnk (Lu, Tb or Pr), 0.45 nmol S17 (Ho, Tm 
or Pr), 0.44 nmol S19 (Lu, Ho or Tm) and 0.16 nmol S27 (Tb, Tm or Pr).  
The lowered recoveries for the peptides LeuEnk and S27 are in coherence with the 
findings in Figure 28 (page 71), where the analysed remnant solutions after ZipTip 
treatment of the samples contained more lanthanide than the eluate. 
4.4.2 Semi-Quantitative Analysis of a Labelled Cytochrome C Digest 
For the development of a semi-quantitative approach for the analysis of a digest sample, 
several assumptions were made. Firstly, in order to simplify the calculations, the 
monoisotopic lanthanide metals and lutetium were expected to behave the same way 
during ICP-MS analysis, since their first ionisation energies are similar (see Table 13). 
This would mean that same amounts of the lanthanides in mol results in a similar 
number of counts. Lutetium alone was expected to show a slightly lower number of 
counts, due to its second isotope. This assumption should allow for a first approximation 
IV RESULTS 
 
-90- 
 
of the quantity of one lanthanide through calibration with another. With a relative 
standard deviation (RSD) for the ionisation efficiencies of 0.058, it is expected that the 
resulting systematic error is lower as the statistical error of the approach.  
Table 13: Isotopes and first ionisation energies for the employed lanthanides.
[180]
 
Lanthanide Isotopes 1st ionisation energy 
Praseodymium  100.0% 
141
Pr 527.0 kJ/mol 
Terbium  100.0% 
159
Tb 565.8 kJ/mol 
Holmium  100.0% 
165
Ho 581.0 kJ/mol 
Thulium  100.0% 
169
Tm 596.7 kJ/mol 
Lutetium  97.4% 
175
Lu 
 2.6% 
176
Lu 
523.5 kJ/mol 
Secondly it was presumed that it is sufficient to quantify only a few representative peaks 
of a digest chromatogram to determine its absolute amount, given that the peaks are 
well separated.  
Based on these presumptions, an absolute quantification experiment employing 
standard peptides of known quantities was conducted.  
In connection with the experiments in 4.1.1 on the reduced recoveries after SPE, a 
special interest lay in the determination of the absolute losses with a quantitative 
approach. This is why the peptide recoveries after SPE treatment with ZipTips, as well as 
the quantification of the total peptide quantity in a treated and labelled cytochrome C 
digest, were the focus in this approach. 
The semi-quantitative approach utilised in this section was based on the approximate 
quantification of the most prominent peaks in the Cyt C chromatogram by calibration 
with the standard peptide signals, which were acquired in a multiplex analysis. 
Experimental: 
Alongside the quantified standard peptides from the section before, a Dionex 
cytochrome C model digest was labelled with NHS-DOTA. The labelled digest sample was 
split in half and complexation was performed with the lanthanides 175Lu or 165Ho 
respectively.  
In order to quantify the recovery for the digest peptides after ZipTip treatment, the 
digest was treated with ZipTip C18. During SPE all leftover solutions (remnant), such as 
the solution from which the peptides were extracted, as well as all wash solutions, were 
collected and pooled. Bound peptides were eluted from the C18-material applying two 
IV RESULTS 
-91- 
 
times 4 µL elution solution. After elution from the ZipTip, the eluate as well as the 
remnant solution were dried separately and reconstituted in each the same amount of 
100 mM TEAA (pH 5).  
The ZipTip eluate contained all the labelled peptides that were bound to the C18-
material during the purification procedure, whereas the remnant contained all the 
unbound components, such as excess reagent and the unbound labelled peptide fraction 
(see also: section 4.1.1, p. 70). 
Two sample series were analysed, one based on a Lu-NHS-DOTA labelled eluate and one 
on a Ho-DOTA-labelled eluate (exact series compositions in Table 14). The employed 
amount of the digest in the samples was based on the following calculation: The 
recovery of peptides in the remnant (X) plus the recovery of the peptides in the eluate 
(Y) equals 100%. Since the actual recovery was unknown in the beginning, employed 
amounts were based on an implied recovery of 100 % in the eluate.  
Example: 1 pmol digest should be employed, at 100 % recovery this equalled 1 µL, thus 
employing 1 µL of the eluate and 1 µL of the remnant solution. The actual employed 
amounts were therefore X % of 1 pmol in the eluate and Y % of 1 pmol in the remnant 
sample. This nomenclature will be used in Table 14, together with the determined 
recoveries. 
The labelled digest variants were, together with a set of the labelled standard peptides 
of known quantity, analysed using nanoHPLC ICP-MS. Analysis was done in a multiplex, 
monitoring six elements at the same time, including the internal standard erbium (an 
exemplary chromatogram is shown in Figure 40). Each digest was accompanied by up to 
four labelled standard peptides. In one measurement a comparison of the eluate with 
the respective ZipTip remnant was conducted (sample 1). For series one, all sample 
components were employed in equimolar amounts. Series two employed the standard 
peptides and the digest eluate in a ratio of 1:2. 
The results of the measurements in greater detail are shown in appendix 9.3, Table 27 
and Table 28. The peak areas were integrated directly from the raw data in a 
reproducible manner, employing the in-house developed software T.S.T (Logiciel de 
traitement de signaux transitoires, v1.1) from the LCABIE in Pau. 
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Figure 40: nanoHPLC ICP-MS chromatograms of a set of standard peptides (1 pmol each) and the ZipTip eluate of a 
Ho-NHS-DOTA labelled cytochrome C digest (2 pmol –X pmol) 
Results 
Figure 40 illustrates one of the sample sets of the Ho-labelled Cyt C eluate together with 
the four standard peptides. The peak areas of the respective standard peptides are 
greater than the peak areas in the digest sample. Peak areas for all four equimolar 
standard peptides were in the same order of magnitude throughout the whole 
experiment series, with an average of 21 x 106 counts and a RSD of 0.674. As a basis for 
the semi-quantitative approach, the peak area average (in counts) of the employed 
standard peptides was set as a representative peak area in total counts, equalling 
1 pmol absolute injected amount of whichever of the employed lanthanide. 
For determination of the overall peptide recoveries of both the eluate and the remnant, 
the entire area underneath the two corresponding Cyt C chromatograms was integrated 
(chromatograms in Figure 28 b, page 71). For the Lu-labelled eluate this resulted in a 
value of 29 x 106 total counts, for the Ho-labelled remnant solution this gave a number 
of total counts of 232 x 106. Taking these two amounts together shows that 88.7 % of 
the digest peptides were left behind in the remnant solution during ZipTip treatment 
and only 11.3 % were recovered in the eluate.  
For sample series 1 and 2 this consecutively lead to an expected value for the eluate 
quantity of 11.3 % of 1 pmol injected amount, so that the determined values should be 
close to 0.113 pmol (‘expected’ value in Table 14). 
In order to determine the recovered amounts for the Cyt C digest eluates, the four 
highest representative peaks were chosen from the chromatogram of the Cyt C eluate 
and integrated. An average was calculated from the peak areas and compared to the 
peak area average of the standard peptides.  
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This resulted in the determined values ranging from 0.144 to 0.196 pmol in the samples 
1 and 2, which is very close to the expected value mentioned above. Analysis of a 
10-times less concentrated sample (sample 3) affirms this result and shows at the same 
time, that the findings are seemingly concentration independent in the observed range. 
The second series is also in good accordance with the results of series 1. Employing two-
times more of the eluate, the expected value should be around 0.226 pmol. Applying the 
calculation method to the representative digest peaks from sample 4 and 5, both show 
calculated average quantities between 0.293 and 0.299 pmol. 
The results and sample compositions are summarised in Table 14. Employed amounts 
for the digest samples are based on the determined recoveries as explained in the 
‘experimental’ section. 
Table 14: ZipTip eluate sample series of the NHS-DOTA labelled Cytochrome C digest. Sample compositions and 
component amounts (injected total amounts in nanoHPLC ICP-MS). Expected and acquired values were calculated 
based on ICP-MS total counts after peak integration, with the standard peptides as 1 pmol and 0.1 pmol 
respectively. 
Sample series 1 Sample component 
Component quantities 
Employed Expected Determined 
Sample 1 Eluate Lu-NHS-DOTA Cyt C 
Remnant Ho-NHS-DOTA Cyt C 
3 Standard peptides (Tb, Tm, Pr) 
11.3 % of 1 pmol  
88.7% of 1 pmol 
1 pmol each 
0.113 pmol 
 
 
0.144 pmol 
 
 
Sample 2 Eluate Lu-NHS-DOTA Cyt C 
4 Standard peptides (Ho, Tm, Tb, Pr) 
11.3 % of 1 pmol  
1 pmol each 
0.113 pmol 
 
0.196 pmol 
 
Sample 3 Eluate Lu-NHS-DOTA Cyt C 
4 Standard peptides (Ho, Tm, Tb, Pr) 
11.3 % of 0.1 pmol  
0.1 pmol each 
0.013 pmol 0.020 pmol  
Sample Series 2 Sample component Employed Expected Determined 
Sample 4 Eluate Ho-NHS-DOTA Cyt C 
4 Standard peptides (Lu, Tm, Tb, Pr) 
11.3 % of 2 pmol 
1 pmol each 
0.226 pmol 
 
0.299 pmol 
 
Sample 5 Eluate Ho-NHS-DOTA Cyt C 
4 Standard peptides (Lu, Tm, Tb, Pr) 
11. 3 % of 2 pmol 
1 pmol each 
0.226 pmol 
 
0.293 pmol 
 
 
Conclusion and outlook 
The results from this experiment provided a quantitative approximation of the 
recoveries for labelled Cyt C digest samples after ZipTip treatment. The acquired data of 
this experiment was in the expected range, taking into account the lowered recoveries. 
Calculated average peak quantities were in the expected order of magnitude and 
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showed a reproducible deviation from the expected value (35 % for series 1 and 32 % for 
series 2). Variability of the results between the different corresponding samples was 
low. Taking a look at the standard error in % for the standard peptide peaks, it shows 
that it is more than ten times higher than the standard error of the 1st ionisation 
energies mentioned in the beginning (30 % for the peptides, 2.6 % for the ionisation 
energies). This leads to the conclusion that the deviation due to the different ionisation 
efficiencies would not have a great impact on the determined values. 
At this time point it is not yet finally elucidated, whether the method is suitable for 
absolute quantification purposes. For validation, the method should be further tested 
with characterised standard material, e.g. on a Ln-NHS-DOTA labelled standard digest 
that was quantified with a validated method (MeCAT for example). After this, its 
application on other protein samples needs to be verified. Additional validation is also 
needed for the utilisation of the representative digest peaks on which the quantification 
is supposed to be performed. 
It should also be noted that in this case, no identifications were taken into account, so 
that possible multiple labels on the same peptides and coelutions were not considered 
for calculations, for reasons of simplification. This might also explain why the calculated 
values are generally higher than the expected values.  
Keeping Figure 28 b (page 71) in mind, showed that the peptide recoveries cannot be 
generalised throughout the whole chromatogram. This is why the average values were 
given. It should be noted that the peptides in the eluate should show increasing 
recoveries/quantities with rising hydrophobicity/retention time.  
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4.5 Offline Coupling of nanoHPLC with MALDI-MS and fsLA-ICP-MS 
Experiments for a novel approach, combining analysis via fsLA-ICP-MS and MALDI-MS on 
MALDI-targets were conducted. The approach is based on the idea of measuring the 
exactly same spotted sample twice, firstly with MALDI-MS for identification and a 
second time via LA-ICP-MS for quantification. The main principle is shown in Figure 41. 
First the labelled peptide sample is separated via IP-RP-nanoHPLC and then spotted on a 
special MALDI-target. Secondly, peptide identification of the fractions is conducted via 
MALDI-MS and MS2. In the last step, the remains of the MALDI-spots are ablated using 
LA-ICP-MS, to obtain quantitative data for the fractions. 
 
Figure 41: Generic scheme for the hyphenation of MALDI-MS with fsLA-ICP-MS: consecutive measurement of a Ln-
labelled sample, including nanoHPLC separation and spotting on a MALDI-target (left), analysis via MALDI-TOF-MS 
and MS
2
 for peptide identification (middle) and lanthanide detection via fsLA-ICP-MS for quantification (right). 
Ablation cell design by C. Pécheyran 
Figure 42 shows a comparison of different hyphenations, which can be employed 
together in order to obtain complementary data sets. In (a) the coupling used in the 
earlier sections is shown (online nanoHPLC ICP-MS and offline nanoHPLC MALDI-MS), 
plus the third commonly used option, the online hyphenation of nanoHPLC with ESI-MS. 
Approaches based on (a) require an individual separation for each of the different 
hyphenations and detections. In contrast to this, the hyphenations in (b) require only 
one separation. The sample is separated and spotted on a MALDI-target, which is then 
measured firstly via MALDI-MS (1). The same target is measured a second time using LA-
ICP-MS (2), resulting in two detections for only one separation.  
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Figure 42: Schematic comparison of hyphenations of chromatographic separation with (a) online coupling with 
ICP-MS or ESI-MS, offline coupling with MALDI-MS using a spotter, and (b) offline coupling using a spotter for the 
consecutive measurement of the same sample via (1) MALDI-MS and (2) LA-ICP-MS. Based on Tholey and 
Schaumlöffel.
[3]
 
In the earlier sections, issues regarding the comparability of independently acquired 
data sets were addressed. Especially the comparability regarding retention times and 
thus the attribution of identities to the respective peaks in ICP-MS chromatograms were 
challenging. The possibility of a consecutive measurement of the same sample with both 
elemental and molecular MS would rule out such an issue.  
LA-ICP-MS, being mostly employed on solid samples, therefore would be the perfect 
option for a second measurement of the already solid sample on the MALDI-target. The 
laser of the MALDI-instrument does not ablate everything, thus leaving entire parts of 
the sample spots untouched. This can already be seen with the bare eye when looking at 
the measured sample spots after MALDI-MS. The remaining sample spot therefore 
would be available for analysis with LA-ICP-MS. Given the high sensitivity of the ICP-MS 
detection regarding the lanthanides, it is very likely, that there will be enough material 
left for the LA-approach. 
The following sections describe a proof of concept study. The experiments showed very 
promising results demonstrating the general potential of this novel approach.  
The model sample consisted of a labelled peptide mixture, comprising Ln-NHS-DOTA 
labelled peptides from a cytochrome c digest and a set of differentially labelled standard 
peptides with known quantities.  
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4.5.1 MALDI-Target Preparation and Plate Design for fsLA-ICP-MS 
Dimensions of the LA-chamber were the limiting factor for the size of the MALDI-plate 
pieces. Therefore the MALDI-targets were cut using a guillotine. Because of the equal 
force distribution of this type of cutting, surface distortions were avoided, which is an 
imperative prerequisite for MALDI-TOF-MS. Grave differences in the height of the target 
surface could result in variations of the ion flight times. Slight differences can be cleared 
out by MALDI-MS calibration. Details on the plate design and occurring difficulties can 
be found in methods section 3.11. MALDI-MS calibration parameters can be found in 
section 3.12. 
4.5.2 Preliminary Tests using MALDI-MS 
The first question to be answered was how much sample material will be removed from 
the MALDI-plate by MALDI-MS and MS2 and if there would still be enough material left 
for fsLA-ICP-MS. A quantitative determination would be possible by comparison of the 
same sample, once measured with MALDI-MS prior to fsLA-ICP-MS and once measured 
directly using fsLA-ICP-MS. 
To ensure proper detection of the labelled peptides and high peptide signal intensities 
even without such a quantitative determination, a sample with higher concentrations 
was spotted and analysed via MALDI-MS on a normal plate: the injected amounts of 
each sample component were 10 pmol. The sample was separated using nanoHPLC and 
the fractions were spotted using a Probot and a normal CHCA matrix, containing the 
internal standard GluFib (5nM end concentration). 
Internal calibration in MALDI-MS failed for most spots and it was found that there was 
no GluFib signal for internal calibration to be detected. For some of the spots, internal 
calibration was only successful because of calibration on the masses of the matrix 
clusters. 
In a following experiment, 2x, 4x and 8x GluFib was added to the matrix and spotted 
alongside a normal sample. GluFib signals in the 2x matrix had still low intensities, 
whereas in the 8x matrix, signal intensities of 2000 counts were detected. The same 
matrix without sample was remeasured and the signal was in the same range.  
The massive excess metal evidently lead to a quenching of low abundance peptide 
signals which needs to be taken into account for the future analysis of peptide species 
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with a low abundance. For the preliminary tests this effect did not pose a problem, since 
the model digests and peptides were present in sufficient concentrations for proper 
identification. 
After optimisation of the MALDI-MS calibration parameters (listed in section 3.12), it 
was possible to identify as many peptides using the cut-target as on a normal target 
plate. 
4.5.3 Compilation of MALDI-MS Chromatograms 
Sample composition: Cyt C digest labelled with 175Lu-NHS-DOTA; 159Tb-NHS-DOTA GluFib; 
141Pr-NHS-DOTA LeuEnk; 169Tm-NHS-DOTA S17 (standard peptides of known quantities, 
from section 4.4.1, for sequences see Table 24) 
After nanoHPLC separation and spotting of the sample on a cut target it was 
consecutively analysed via MALDI-MS and MS2 using the optimised parameters: the 
chromatographic run – distributed on three different target pieces, was measured using 
three independent spot sets. As already mentioned, this was necessary because of 
MALDI-MS alignment and calibration problems when using a vendor defined plate spot 
set. Between measurements, the plate had to be ejected and re-loaded again, in order 
to apply the matching spot set template for each part. The plate was then aligned and 
calibration was performed (parameters in section 3.12). The MALDI-MS and MS2 
measurements were fully automated. 
A Mascot search was performed (parameters, see section 3.8.1), identifying all of the 
labelled standard peptides, except S27, which could not be found by manual inspection 
of the spectra either. For the labelled Cyt C digest, 35 labelled peptide species could be 
identified, including some with missed cleavages; only 4 unlabelled species were found, 
of which only one showed a considerable signal intensity (a list of the identified peptides 
can be found in Table 29). 
For visualisation, the peak explorer software from ABSCIEX was employed. Extracted ion 
chromatograms (XICs) for each precursor m/z ratio were generated, plotting the 
respective signal intensities of the precursor against the different fractions. Precursor 
masses were verified by Mascot search, manual inspection and/or generation of ion 
current chromatograms for characteristic fragment ions (XFC). Matching fragments and 
precursors from the XIC and XFC would show peaks in the same Probot fraction. 
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An example for the XICs of three labelled standard peptides is shown in Figure 44, 
including the manually inspected MS2 spectra and the identified fragment ions. The ‘cut’ 
between the target pieces is marked with an arrow. The cuts are also visible in the XICs 
from the labelled Cyt C digest in Figure 43 after the fractions 86 and 170. In this figure 
only the most intense peaks are shown, which had matching MS2 data. Due to the fact 
that this data was acquired completely independent from the fsLA-ICP-MS data, it was 
not possible to align both chromatograms perfectly. Being only a preliminary test, the 
fsLA-ICP-MS measurements in the following sections did not cover the whole length of 
the chromatography (80 spots instead of 245), thus making it difficult to conduct a 
proper alignment. Nevertheless, an alignment of the data will be shown in section 4.6. 
 
 
Figure 43: MALDI-MS extracted ion currents for peptides from a 
175
Lu-NHS-DOTA labelled cytochrome C digest 
(most intense signals), analysed on a cut target plate. 
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4.5.4 fsLA-ICP-MS on MALDI-Targets 
The measurements using fsLA-ICP-MS were conducted according to the parameters 
shown in section 3.10. 
  
Figure 45: fsLA-ICP-MS signals for the internal standard erbium in the matrix and nickel as a representative for the 
ablated material of the steel target itself. 
Figure 45 shows typical raw signals from the ablation of eight MALDI-spots, with the 
internal standard 166Er on the left and 60Ni as the representative for the ablated target 
material on the right. ICP-MS data acquisition was running constantly, the peaks being 
the signals acquired during the ablations of the matrix spots. The time in between the 
peaks was used to move to the next spot on the target and refocus the laser for the next 
ablation. Since the signal always goes back down to the baseline level after each peak, 
there is evidently no contamination of the tubing system. The ablated sample is carried 
to the ICP-MS in a quantitative manner. To further exclude spot-to-spot sample 
carryover (e.g. no sample deposit on the neighbouring spot) samples were placed in the 
ablation cell with the first sample spot to measure closest to the exit of the ablation cell 
and the last sample spot closest to the cell entrance.  
4.5.5 Detection Limit and Calibration Curves 
A determined limit of detection (LOD) for the method was calculated based on the blank 
measurement. The blank sample consisted of the MALDI-matrix CHCA containing the 
internal standard erbium in a fixed concentration without addition of any other 
lanthanide salts, which was spotted on a ground steel MALDI-target. Lanthanide signals 
were normalised on the respective 166Er signal.  
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The ablation of the steel target without matrix already hinted that some lanthanide 
metals were present in the target material: while 166Er showed virtually no signal, 175Lu 
and 159Tb showed low signal intensities. Important quantities were detected for 169Tm, 
165Ho and 141Pr. This observation is also reflected in the determined LODs for the 
respective elements (Table 15). 
The instrument noise level was calculated based on the counts acquired between the 
ablations of the blank where no material was ablated. The method noise was based on 
the acquired blank signal in form of its standard deviation when ablating the erbium 
matrix. Detection limits were calculated using the equation taken from the IUPAC 
compendium of chemical terminology[181]:  
                      
with    being the smallest measure,      being the average of the blank measures,   
representing the confidence level (  = 3) and     being the standard deviation of the 
blank measures.  
Table 15: Noise levels and limits of detection for the utilised lanthanide metals. 
Element Instrument 
noise  in cps 
Method 
noise in cps 
Limit of detection[181] 
in counts in µg/kg  in amol/µg Matrix 
175Lu  30.7  30.4 103.3 5.38  30.72 
169Tm  38.0  264.6 1228.7 27.04  160.00 
159Tb  33.4  54.5 189.4 4.58  28.80 
165Ho  31.2  150.8 601.5 10.55  63.92 
141Pr  58.6  307.0 1423.3 20.99  148.90 
The LODs for the respective elements is in the expected range for a fsLA-ICP-MS 
approach (see also Figure 5 on page 26, LOD < 100 µg/kg)[41]. LODs for the elements 
present in the steel target material were elevated. 
For acquisition of the calibration curves, the respective lanthanide salts were diluted in 
erbium matrix and spotted on the steel target with a pipette. The first trial with a 
dilution series was too low in concentration with several dilutions being below the later 
determined LOD. In addition the LA-parameters were chosen poorly, since it was still 
during the optimisation process. Therefore a second, more concentrated series was 
prepared ranging from 1 pg/µL to 1000 pg/µL Ln3+ in liquid matrix, equalling a range 
from 333 µg/kg to 333 mg/kg Ln3+ in the dried matrix spots. The measurements from the 
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first (low concentration) dilution series cannot be compared directly with the ones 
acquired for the LOD, due to the great difference in the acquisition parameters. 
Taking a look at the calibration curves in Figure 46, most of the observed lanthanides 
have a similar behaviour. Only Lu-175 varies significantly from the other four metals. 
This is also represented by the slopes listed in Table 16. Tm-169, Tb-159, Ho-165 and Pr-
141 seem to be comparable, having a very similar steepness of the slope. As for 175-Lu, 
the difference in the slope might be influenced by the fact that it is not monoisotopic 
(2.6 % Lu-176). It cannot be ruled out that also statistical reasons are involved. With a 
higher number of measurements, the slopes might show a lower deviation. 
4.5.6 Quantification of the Labelled Standard Peptides 
The labelled standard peptides were analysed together with a labelled Cyt C digest using 
nanoHPLC. Fractions were collected and mixed with Er matrix using a Probot. The 
resulting spots were ablated completely using the same parameters as for the 
calibration curves in Figure 46.  
The standard peptides were used in different quantities, in order to elucidate whether 
the peptide ratios can be recovered as expected. The measurements were normalised 
using the respective erbium signal. Integration of the peaks and calculation of the 
quantities for the peptides lead to the following results: 
 
Figure 46 (left): fsLA-ICP-MS calibration curves 
 
 
Element slope y-intercept R2 
169Tm 36889  28733 0.9995 
165Ho 36114  47891 0.9998 
141Pr 35502 115435 0.9985 
159Tb 32743  84992 0.9988 
175Lu 25212  -1102 0.9993 
 Table 16 (below): fsLA-ICP-MS calibration curves and 
equation data from trend lines 
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Table 17: Results for the quantification of the Ln-NHS-DOTA labelled standard peptides via fsLA-ICP-MS 
Peptide  Employed quantity 
in pmol 
Normalised signal 
in total counts 
Recovered quantities  
pg Ln / μg matrix    in pg Ln  in pmol 
165Ho GluFib  1.0  841 684 22.0 148.2 0.90 
169Tm S17  2.0  not available - - - 
159Tb LeuEnk  4.0  3 141 459 93.3 629.4 3.96 
141Pr  S27  5.0  3 300 638 89.7 604.9 4.29 
Unfortunately no integration data is available for peptide S17, which did not show a 
proper peak after fsLA-ICP-MS. Only the respective 169Tm background was elevated (see 
Figure 47). In contrast to this, the same peptide gave a proper peak in both MALDI-MS 
(Figure 44, page 100) and nanoHPLC ICP-MS analysis (see Figure 28 d, page 71). Up to 
now it was not clear why this was not the case for fsLA-ICP-MS.  
The determined quantities for the three other peptides are all in the expected order of 
magnitude: deviation from the expected value was 10.18 % for 165Ho GluFib, 1.04 % for 
159Tb LeuEnk and 14.19 % for 141Pr S27. In general, values for recovered quantities were 
smaller than the expected values. The deviations are consistent with the measurements 
from the experiment in section 4.4.2: Calculation of an average from all standard 
peptide measurements gave a value of roughly 27 x 106 total counts. The average counts 
for 165Ho GluFib with 24 x 106 counts (-13 %) were lower than this reference value. 
159Tb LeuEnk with 28 x 106 counts (+2.8 %) was very close to the reference value, 
whereas 141Pr S27 showed the biggest deviation with only 17 x 106 total counts (-39 %).  
 
Figure 47: Normalised fsLA-ICP-MS chromatogram for the four Ln-NHS-DOTA labelled standard peptides GluFib, 
S27, LeuEnk and S17, applied in different quantities. 
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4.5.7 Quantification of a Labelled Cytochrome C Digest 
The same 175Lu NHS-DOTA labelled Cyt C digest as previously analysed in section 4.4.2, 
was also analysed in this experiment, employing it with doubled concentration for 
nanoHPLC fsLA-ICP-MS. In section 4.4.2 supposedly 1 pmol of 175Lu Cyt C was injected, 
which due to the application of ZipTips lead to a lowered average recovery and an 
expected value of 0.113 pmol. For 2 pmol this leads to an expected average quantity of 
0.226 pmol.  
After nanoHPLC analysis and fraction collection of the new sample, the spots were 
ablated completely and the counts were normalised on the erbium signal; the resulting 
chromatogram is shown in Figure 48. The peaks are not baseline resolved very well. This 
is due to the limited number of spotted fractions, resulting in a low number of data 
points for the measurements. Each fraction represents 15 s of the chromatographic 
separation, thus one fraction contains everything eluting from the chromatographic 
column during this time period. Therefore peaks that were resolved on the nanoHPLC, 
might not be resolved properly anymore after laser ablation. Less abundant peptides 
might disappear as a fronting or tailing of a more dominant peak. The loss in resolution 
can also be seen in MALDI-MS analysis of the 15 s fractions. Still, in this case it did not 
pose a problem, since peptides with overlapping elution can still be identified 
independently. However this problem needs to be resolved for future applications 
encompassing more complex sample mixtures. 
Being aware of this resolution problem, a quantification approach was still conducted on 
the more dominant peaks of the chromatogram. Through identification via MALDI-MS, it 
was known that the peaks 1 a and b contain the same peptide with one (b) or two labels 
(a). Peak 2 also contained a singly and doubly labelled peptide, whereas peak 3 could not 
be identified unambiguously. Peak 4 contained a mixture of 4 mainly singly labelled 
peptides. Peaks 5 and 6 were mainly consisting of variations of similar peptides with and 
without missed cleavages, which most likely coelute with some other peptides, of which 
the ratios are unknown.   
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Figure 48: Normalised fsLA-ICP-MS chromatogram for the 
175
Lu NHS-DOTA-labelled cytochrome C digest. Numbers 
and letters indicate peaks used for the quantification approach in Table 18. (The same chromatogram is shown in 
an overlay with MALDI-MS in Figure 50) 
In a simplified quantification approach, the normalised data was integrated and the 
acquired signal was then multiplied with a correction factor, taking into account the 
multiple labels and the expected number of peptides comprised in the peak. Applying 
the 175Lu calibration curve from Table 16 to the counts, an approximation of the peptide 
quantities was given. Values for the quantities were expected to rise from earlier to later 
fractions, due to the ZipTip treatment. 
 
Table 18: Set of integrated peaks from the chromatogram in Figure 48 and calculated quantities. 
 
 
 
Peak Start spot End spot Counts Factor Sum 
 counts x factor 
pg 
absolute 
pmol 
absolute 
1 a 
 b 
1 
6 
5 
12 
31 368 
92 755 
0.5 
1.0 
108 439 29.3 0.167 
2 19 25 106 544 0.75 79908 21.6 0.123 
3 28 33 248 140 ?  66.7 0.381 
4 42 47 303 317 0.25 75 829 20.6 0.118 
5 a 
 b 
 c 
48 
51 
54 
50 
53 
60 
142 313 
195 482 
56 540 
0.5 
0.33 
0.5 
163 935 44.1 0.252 
6 a 
 b 
57 
61 
60 
66 
70 380 
223 896 
1.0 
0.75 
238 302 64.0 0.366 
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The employed factors are based on the number of labels and the number of peptides 
identified in the respective peak: 
 For Peak 1 a, the factor was 0.5 since the corresponding peptide had two labels and 
did not show coelution. The peptide in peak 1 b carried one label and showed no 
coelution (factor 1).  
 For Peak 2, a peptide with both one and two labels was identified. Since the ratio 
between the doubly and singly labelled peptide was unknown, they were estimated 
to be found in the same proportion, thus a factor of 0.75 was employed 
(0.5 x 1.0 + 0.5 x 0.5).  
 Peptide composition of peak 3 was unknown, this is why there was no correction 
factor employed, resulting in a calculated quantity for peak 3 which is most likely too 
high (possible coelution with other peptides and/or double derivatisations).  
 Peak 4 showed coelution of 4 mainly singly labelled peptides. Those peptides were 
estimated to contribute to the peak in equal proportion (factor 0.25). 
 For peak sets 5 and 6, the factors depended on the number of labels in the respective 
peak (a, b or c), mainly including double derivatisations (factor 0.5) but also showing 
single (factor 1.0) and triple (0.33) labelled peptides. Most likely there are more 
peptides coeluting in the fractions whose contribution to the peak areas cannot be 
predicted with certainty. This is why the quantities for the peptides in these peaks 
were probably also overestimated. 
These factors can only be applied, because the sample composition is known. For a 
completely unknown sample or a protein mixture this approach would not be applicable 
this way. 
The lower peptide complexity in the fractions at lower retention times identified by 
MALDI-MS, is in good accordance with the lowered recovery for the earlier fractions due 
to the ZipTip treatment as seen in section 4.1.1. This is why the calculated quantities in 
the earlier fractions (peaks 1, 2 and 4) are around 0.136 pmol, whereas the quantities 
for the later fractions (3, 5 and 6) are more than doubled. Averaging all calculated 
amounts enables a comparison to the results from section 4.4.2. Having applied twice 
the amount, the expected value should be around 0.226 pmol. The average acquired in 
this experiment is 0.234 pmol and thereby deviates from the expectation by only 3.5 %. 
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This shows that both methods give comparable results, even if one uses the averaged 
quantities of the standard peptides as reference system and the other one separately 
acquired calibration curves. 
4.5.8 Manual Construction of a fsLA-ICP-MS Chromatogram 
During one acquisition period of 10 min on the Perkin Elmer ICP-MS, approximately 
11 spots were ablated without automation. For the ablation of 80 spots – equalling a 
chromatogram of 20 min length, this meant an analysis time of 73 min, not counting the 
time needed for changing the target pieces and restarting the ICP-MS for the next series. 
With automation, this time can most likely be reduced significantly.  
As shown in Figure 45 on page 101, the acquired signals for the fsLA-ICP-MS 
measurements did not result in a chromatogram directly, so that the chromatograms 
had to be generated manually after data acquisition: the peaks for each ablated spot 
were integrated separately using the software T.S.T. and the signals were then 
attributed to the respective spot numbers in an excel sheet. 
Examples for chromatograms acquired in this way were shown in Figure 47 and Figure 
48 on the pages before. The ablated spots correspond to a retention time window from 
35 min to 55 min. 
4.5.9 Microscopic Examinations of Ablation Craters 
Several examples for images of laser ablations on the MALDI target are shown in Figure 
49. (A) shows a 5x magnification of four ablated nanoHPLC spots, with an ablated 
diameter of 1350 μm (77 concentric circles), (B) is the lower left spot with 10x 
magnification. (C) to (F) show an ablated standard spot from the preliminary test in 
magnifications from 5x to 50x. Matrix crystals can still be seen around the ablated areas. 
The smaller circles represent diameters of 900 μm which were shot with 20 % laser 
intensity, the bigger circle (1350 μm) was ablated with 7 % laser intensity. This 
difference in laser intensity is represented by the difference in depth of the single 
craters in (E) and (F). In Figure 49 (F) marked by a blue arrow, the lower crater depth for 
7 % laser intensity can be observed, the craters left behind by 20 % laser intensity are 
hinted by an orange arrow.  
Figures (G) and (H) show matrix spots after MALDI-MS analysis: Spot parts where the 
MALDI-laser had hit during MS and MS2 were already visible by naked eye. MS2 is not 
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conducted on the entire spot, but only on a randomised area. Under the microscope it 
became visible, that even in areas where MS2 seemingly left a hole in the spot, matrix 
crystals were still as abundant as in untouched areas. The surface which was hit by the 
laser showed iridescent discolouration on a microscopic scale, which was the only visible 
trace of the MALDI-laser. A rough estimation of the covered surface showed that not 
even one third of the matrix spot was used for the MALDI-MS measurements. This leads 
to the conclusion that there should be enough material left for LA after MALDI-MS and 
MS2. The visible scratches on the target surface were a result of the target cutting 
process in the workshop. 
The dilution series for the calibration curves obtained in fsLA-ICP-MS were also 
examined under a microscope in order to find out whether the rising concentration of 
the lanthanide salts had an influence on the crystallisation behaviour of the matrix. As 
can be seen in the series of pictures in appendix 9.6, there was no great influence 
observable between the lowest lanthanide concentration and the dilution with the 
highest concentration of the series (33 µg/kg to 500 mg/kg in dry matrix). The size of the 
matrix crystals varied with the amounts of salts: only few, but big crystals were present 
on the spot area starting with the lowest concentration of 30 µg/kg. With rising amount 
of salt a slight tendency for formation of bigger crystals was observable. When 
comparing the dilution series spots to the erbium blank and a lanthanide free matrix, it 
can be seen that there is a huge difference between the crystal sizes and their 
distribution.  
In the Er blank, as well as in the metal ion free matrix the crystals were much smaller 
and distributed more evenly on the whole spot area. This might also explain why at high 
salt contents, the peptide signals were seemingly quenched: less unevenly distributed 
crystals obviously lower the ionisation efficiency of the MALDI process. This was also 
observed earlier for ionic liquid matrices based on 2,5-DHB.[182] 
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Figure 49: Laser Ablation craters under the microscope with different magnifications (5x to 50x). A and B: ablated 
nanoHPLC fractions (A: 5x, B: 10x), C to F: ablated standard spots, preliminary test with 900 an 1350 μm ablation 
diameter (C: 5x, D: 10x, E: 20x, F: 50x), G and H: discolourations after MALDI-MS and MS
2
 (G: 10x, H: 50x) 
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4.5.10 Conclusion and Outlook  
The results shown here demonstrate the high potential of this novel approach. The 
consecutive measurement with MALDI-MS and fsLA-ICP-MS enables the acquisition of 
complementary data sets for the same chromatographic separation. The first 
approaches showed very promising results. Parameters could be optimised for both 
fsLA-ICP-MS and MALDI-MS, including an ameliorated cut target design. Optimised 
calibration and the use of target piece specific spot sets resulted in very good 
identification results using Mascot search after MALDI-MS2.  
Data normalisation taking the erbium signals as reference in fsLA-ICP-MS reduces spot to 
spot variations and makes the acquired data more reliable concerning the quantities of 
ablated sample. Monitoring of 80Ni signal intensities during laser ablation allows for 
evaluation of the ablation crater depth and thus the amount of ablated target material 
from the steel target. Therefore the 80Ni signal might be used for correction of signals 
from samples with low lanthanide content. The 80Ni signal should be in direct relation to 
the signals from lanthanides which were present in the target material in traces.  
Lanthanide traces in the target material also caused a slight elevation of the LODs for 
several elements. Still the LODs stayed in the expected range for LA-ICP-MS approaches 
(< 100 µg/kg, see Figure 5 on page 26). The exact lanthanide content of the target 
material needs to be verified in additional measurements.  
It is also necessary to acquire more statistical data, in order to elucidate questions about 
sensitivity and accuracy of the method. The LOD needs to be verified and it would also 
be interesting to determine the limit of quantification. 
The determined quantities for the model peptides in the sample were generally close to 
the expected values. Especially the quantity for the 159Tb-labelled standard peptide 
showed a low deviance with a determined value of 3.96 pmol (expected 4.0 pmol) and 
also the quantities for the 175Lu-labelled digest peptides were in the range of the 
expectation, taking their hydrophobicities into account.  
Surprisingly two of the standard peptides were not detectable with either one of the 
analytical methods: S27 was not identifiable using MALDI-MS, whereas S17 did not show 
a peak in fsLA-ICP-MS (sequences in Table 24). In contrast to this, both peptides showed 
IV RESULTS 
 
-112- 
 
signals in UV detection and normal ICP-MS analysis. It needs to be determined whether 
this finding is reproducible.  
Furthermore it needs to be elucidated whether ionisation in MALDI-MS is the same for 
free lanthanide ions and peptide bound lanthanides: when conducting MALDI-MS and 
MS2 on the matrix spot, Ln-labelled peptides and the internal standard erbium need to 
be removed from the spot to the same degree. This is necessary for the normalisation of 
the peptide signals with the internal standard erbium in LA-ICP-MS. The erbium signal 
stands in direct relation to the amount of ablated matrix/overall sample material and 
can be employed to rule out spot to spot variation. It should therefore be made sure 
that the sample composition is not altered after MALDI-MS and that erbium can be 
employed for normalisation. If the comparability would not be given an alternative 
peptide-bound internal standard could be developed. 
It was found that the chromatographic resolution of the method with both MALDI-MS 
and LA-ICP-MS detection was low compared to the chromatographic resolution of the 
nanoHPLC. This is due to the fractionation and the relatively big fraction volumes. At the 
same time the analysis time is very long because of the number of spots to be analysed 
by hand. This shows the need for automation of the method, should it be implemented 
in a laboratory workflow. A reduction in analysis time could already be achieved by the 
use of standardised material, such as specially developed target plates or adapted LA-
equipment. Already an automated measurement of the spots, including auto focussing 
of the laser would reduce the measurement time tremendously. 
Microscopic observations indicate that spots after measurement with MALDI-MS2 do not 
suffer a visible reduction of the matrix amount. The surface covered by the MALDI laser 
is roughly one third of the matrix spot, leading to the conclusion that there will still be a 
sufficient amount of sample left for the following fsLA-ICP-MS measurement. It was also 
found that the size and distribution of the matrix crystals are influenced by the 
lanthanide content of the sample. Already the lowest dilution of the series with 33 µg/kg 
of lanthanide, together with the erbium standard resulted in a deviant crystallisation 
behaviour. With rising metal content, the crystal size rose, while at the same time less 
crystals were observable on the spot surface. A high metal content therefore attributed 
to less efficient ionisation in MALDI-MS. This effect was also observable in the quenching 
of GluFib peptide signals during analysis of a sample with higher salt content.  
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4.6 Superposition of Chromatograms using Retention Time Markers  
Not only were the labelled standard peptides thought to serve as a standard for 
quantification purposes, they were also thought to aid the alignment of data acquired 
with different methods, serving as retention time markers (RTM).  
The problem of shifted retention times was already addressed in section 4.3. Probot 
fraction collection caused an active backpressure to the nanoHPLC outlet due to the 
addition of the matrix by a syringe. This backpressure differed from the conditions in the 
online coupling of the nanoHPLC with ICP-MS, thus resulting in a retention time shift for 
chromatograms of the same sample measured with the different techniques. For low 
complexity samples, alignment could be achieved by comparison of the UV-
chromatograms. For samples of higher complexity, this alignment technique will not be 
applicable. 
The addition of a set labelled standard peptides to the sample of interest prior to 
analysis can add reference points to the chromatograms, which thereafter can be 
employed for alignment purposes. As shown in the sections before, the peptide 
standards are detectable independently from the sample itself: through their specific 
m/z in molecular MS and through their differential labels in ICP-MS. Therefore, by 
aligning these retention time marker signals in the respective chromatograms, an 
alignment of the sample chromatograms should be achieved, thus ensuring sample 
comparability for data sets acquired with different methods.  
An example for such an alignment is shown in Figure 50 on the following page. The 
analysed samples were each composed of a 175Lu-NHS-DOTA labelled Cyt C digest (grey 
scale) and different sets of Ln-NHS-DOTA labelled standard peptides (colour coded).  
Standard peptides for fsLA-ICP-MS and ICP-MS: 169Tm S17, 141Pr S27, 165Ho GluFib and 
159Tb LeuEnk.  
Standard peptides for MALDI-MS: PPA PPL and PPQ with 165Ho, 169Tm S17, 159Tb GluFib 
and 141Pr LeuEnk.  
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Figure 50: Superposition of five independent chromatogram sets using retention time markers. (Explanation in text) 
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The data sets in Figure 50 are acquired by application of four different experimental 
setups:  
 For fsLA-ICP-MS, the sample was separated on a nanoHPLC with a 15 cm C18-column, 
coupled to a Probot for fraction collection on a cut target. The dry matrix/sample 
spots were then ablated using fsLA-ICP-MS (details in section 4.5). 
 For ICP-MS, the same nanoHPLC as above was coupled directly to an Agilent 7500 
ICP-MS for online data acquisition. 
 For MALDI-MS (normal target), a nanoHPLC with a 25 cm C18-column was coupled to 
a Probot fraction collector. Fractions were spotted on a normal target and measured 
using MALDI-TOF-MS and MS2. 
 For MALDI-MS (cut targets I and II), the same nanoHPLC and spotter as above for 
MALDI-MS was employed, only difference was the faction collection on a cut target. 
To resume, the data sets encompass techniques employing two different ionisation 
types (MALDI and ICP) and two sample introduction techniques for ICP-MS (LA and 
nanonebuliser). The data was acquired on three different instruments (Agilent 7500, 
Perkin Elmer Elan II and ABSCIEX TOF/TOF 5800). One method was based on an online 
coupling (nanoHPLC-ICP-MS), while the others were offline setups and two different 
nanoHPLC systems with varying column lengths and varying gradients were employed.  
All of these different parameters lead to a very limited comparability of fraction 
numbers and retention times. 
By alignment of the RTM peptides in each data set, the chromatograms for the Cyt C 
digest should be aligned automatically. Even after alignment, a difference can be seen in 
the peak patterns of the two Cyt C ICP-MS chromatograms. This is mainly due to the low 
chromatographic resolution of the LA-approach. Unfortunately S17 (orange) did not give 
a signal in the fsLA-ICP-MS, so that one of the RTMs is missing for this data set, leaving 
the fsLA-ICP-MS alignment unconfirmed.  
Cyt C peptides identified via MALDI-MS and Mascot search were assigned to the peaks in 
the ICP-MS chromatograms. The labels (a) to (k) in Figure 50 are explained in Table 19, 
with an asterisk marking the labelling site. 
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Table 19: Assigned peptide identities for the most prominent peaks in Figure 50, with labelling sites (*) and m/z 
 Labelled Cyt C peptide  m/z  Labelled Cyt C peptide m/z 
a *KYIPGTK*    2580.71 g   *KGEREDLIAYLK* 2550.91 
b   KYIPGTK* 1922.64 h **KGEREDLIAYLK* 3109.12 
c *KIFVQK* 2436.70 i   *GEREDLIAYLK* 2422.92 
d   YIPGTK* 
*YIPGTK*  
1236.42 
1794.52 
j      EDLIAYLK* 1522.61 
e *KTGQAPGFSYTDANK* 
*KTGQAPGFSYTDANK 
2700.90 
2142.85 
k     EDLIAYLK* 
  *EDLIAYLK* 
1522.61 
2080.73 
f *TGPNLHGLFGR 
*MIFAGIK 
1337.52 
1726.72 
   *MIFAGIK* 
  *KGEREDLIAYLK 
1895.63 
1992.64 
Table 19 shows that there are several groups of similar peptides assigned to the peaks in 
Figure 50. The groups consist of peptides with and without missed cleavages, which can 
carry up to 3 labels (see peak h) and have a similar retention behaviour. Unfortunately 
the peaks are overlapping, as seen for the peaks g to k, making a quantitative analysis 
difficult. The ratios between the singly and multiply labelled peptides are unknown and 
cannot be easily determined using ICP- or MALDI-MS.  
It can also be observed that not all peptides are identified likewise in the three MALDI-
MS data sets, or that at least the signal intensities are not alike. The overlapping and 
multiple labels emphasise yet again the difficulties when working with DOTA-labellings. 
Still data interpretation was facilitated by the application of the RTM peptides. It was 
shown that even chromatograms acquired with different instrument setups and varying 
chromatographic parameters, which would not be comparable otherwise, could be 
aligned. The superposition using RTM peptides enabled proper peptide identification 
and unambiguous assignment to previously unidentified peaks in ICP-MS.  
It was also observed that the different lanthanides used in the two sets of RTM peptides 
do not have an influence on the retention behaviour. The Ln-labels can be chosen freely 
according to their application in the multiplex analysis. For future applications the 
number of different metals employed in the RTM peptides can be further reduced. The 
standard peptides are well characterised, they show low overlapping and their retention 
behaviour is known. In theory the number of Ln could be reduced to only one or 
maximum two. This would leave the other multiplex channels open for the labelling of 
other sample components. 
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The peptide mixture was still in the course of development at the stage where the fsLA-
ICP-MS experiment was performed. The peptides PPA, PPL and PPQ (see Table 24 in 
Appendix III) were purchased only after this and will be implemented in the future fsLA-
ICP-MS experiments. As can be seen in Figure 50, the whole RTM set covers most of the 
chromatographic separation. S27 and S17, not detectable in either one of the 
techniques, were deemed unreliable for analysis. Still, a proper alignment of the five 
chromatogram sets was achieved. At least 4 RTMs seem to be necessary for a definite 
adjustment. The RTMs should also have an adequate retention time distance to each 
other.  
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V Discussion and Outlook 
5.1 DOTA Derivatisation Efficiencies and Reagent Excess 
Both DOTA-reagents used in this work have their advantages and disadvantages. 
Kinetically, the lanthanide DOTA-label on the peptide is very stable, making it a 
potentially very interesting and useful tag. The biggest issue is with the derivatisation 
procedure itself: as with every chemical label, the reaction is not quantitative in the 
majority of cases, and a huge excess of reagent is required in order to get close to 100 % 
labelling efficiency. This is due to many factors, such as steric effects, e.g. due to the AA 
side chains and experimental conditions. Another issue is that under basic conditions 
both reagents hydrolyse very quickly, which is most unfortunate as a slightly basic pH is 
needed for the derivatisation. Keeping the pH in the necessary range was found to be 
the biggest challenge during the entire labelling procedure. With the adequate pH 
though, efficient derivatisation can be ensured.   
The labelling procedure using NHS-DOTA was further simplified in the course of the 
research and now provides a nearly 100 % derivatisation efficiency for protein digest 
samples. The underivatised peptides were mainly present in traces and showed 
negligible peak intensities in MALDI-MS. 
NHS-DOTA is very universal in its application, and can be used on virtually any peptide 
sample which contains free amino-groups. Unfortunately, this typically results in a high 
complexity of the respective sample as almost every peptide can be labelled, and when 
peptides contain one or more lysine residues, multiple labelling occurs frequently – even 
more so when missed cleavages following enzymatic digestion are involved. This 
complexity, and the requirement of digestion of the samples for quantification using 
ICP-MS, makes the baseline separation of even low complexity samples very difficult.  
Mal-DOTA on the other hand, seems to be an elegant alternative to NHS-DOTA, since in 
theory it should only target the much rarer sulfhydryl groups in Cys residues. Therefore, 
it should have less target peptides in digested samples and analysis should show a far 
lower complexity. Unfortunately, due to its rarity, it can occur that there are no proper 
target peptides in the protein of interest. It must also be taken care, that the sample is 
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not treated with alkylation reagents prior to derivatisation with Mal-DOTA, which can 
cause unwanted scrambling of disulfides or lead to inefficient digestion. 
The protocol for the derivatisation of model peptides by Mal-DOTA was optimised and 
employed a 20-fold molar excess regarding free sulfhydryl groups. In the course of this 
study it was found that by employing a 20-fold molar excess of reagent on protein digest 
samples, the resulting labelling efficiency was far below the efficiency of respective NHS-
DOTA labellings. This is most likely due to the fact that the Mal-DOTA can also react with 
primary and secondary amines if present in high amounts, groups which are more 
frequently present in protein digests compared to the sulfhydryl-groups. The 
consequence of this is the need for an elevated molar excess of the reagent (more than 
20-fold) for application on protein digests. The problems encountered with this lead to 
the decision that the later experiments with protein digests were only performed using 
NHS-DOTA. If the application of Mal-DOTA to a digest sample is deemed essential, 
possibilities for targeted blocking of amino-groups could be taken into consideration, in 
order to reduce the above mentioned side reactions. However, this comes with the cost 
of additional –error prone – derivatisation steps. 
Even when using the optimised derivatisation protocol together with nanoHPLC online 
precleaning, the lanthanide background can still be far too high for real world 
applications. In general, the lanthanide background increases with increasing complexity 
of the sample, caused by the need of higher excess of DOTA-reagent.  
For further reduction of the lanthanide salt excess, a pre-complexation of the reagent 
with clean-up could be considered. The DOTA reagent could be incubated with the 
respective lanthanide salt and cleaned up afterwards in preparative HPLC. The 
derivatisation would then be conducted with the Ln-DOTA reagents, without further 
addition of lanthanide salts. A similar preparation procedure is employed for the 
commercially available MeCAT reagents.[179] 
However, the preparative pre-complexation approach was ruled out because of 
economical and practical reasons in this study. The approach requires larger amounts of 
highly expensive NHS-DOTA reagent as starting material. However, the practical reasons 
held more importance for the decision: being prone to hydrolysis, the reagents hold the 
prospect of degradation during the pre-complexation and clean-up procedure. It is also 
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highly doubted that the degraded (hydrolysed) DOTA can be separated from its active 
form with ease. This probably leads to the necessity to employ an even larger excess of 
complexed DOTA reagent, thus negating the benefits from the prior removed excess 
metal to a degree.  
Another point against the pre-complexation is due to the possibility of splitting the 
derivatisation preparations prior to complexation with different metals in the normal 
approach, thus ensuring that resulting samples are labelled with DOTA to the same 
degree, before adding the lanthanides. With pre-complexed DOTA-reagents, two 
samples would need to be derivatised, not ensuring their direct comparability. It may 
also be viable to guard the uncomplexed DOTA-peptides in buffered solution at -20 °C 
(pH 5) for later complexation with lanthanides, according to the needs of the 
experimental setup.  
An alternative labelling protocol using NHS-DOTA, which might be interesting regarding 
higher derivatisation efficiencies, was presented in a preliminary study by Christopher 
et al. [165] The approach employed microwave assisted derivatisation and chelation using 
NHS-DOTA on peptides for the use with ICP-MS. Microwave heating was theorised to 
increase reaction kinetics, thus enabling reduction of the incubation time under basic 
conditions. Derivatisation with the microwave system was conducted for up to 10 min 
and for another 5 min to aid complexation. The authors showed that the labelling was 
up to 40% more efficient compared with a 2 h derivatisation / 2 h complexation at RT. 
Comparing these results to the optimised protocol B presented in section 3.5.1, it might 
be considered in future applications to employ microwave assisted derivatisation. As the 
method seems capable of increasing labelling efficiency, and may help to reduce the 
currently employed 100-fold molar excess of NHS-DOTA in the optimised protocol. 
It was also found that the quality of the DOTA reagents can vary largely between the 
fabrication batches. Generally, it is advisable to test the labelling efficiency for each new 
batch using standard peptides. 
5.2 NHS-DOTA Peptide Retention Behaviour 
By monitoring the retention times of labelled peptides and their unlabelled 
counterparts, it was found that both could be separated at lower solvent polarities, thus 
V   DISCUSSION AND OUTLOOK 
-121- 
 
earlier fractions, in reversed-phase LC (Figure 38, page 85). The labelled peptides in most 
cases eluted later than their unlabelled counterparts. This peptide elution time 
difference grew smaller with rising retention time and the labelled and unlabelled 
peptides showed complete coelution in the very late fractions. This lead to the 
conclusion that the DOTA-label adds to the interaction of the peptides with the 
stationary phase. The influence on the retention time of hydrophobic peptide species is 
less pronounced, resulting in the coelution of unlabelled, singly and multiply labelled 
peptides. The increasing coelution in the later fractions though, posed a serious problem 
for quantification approaches. This can already be seen for samples with low complexity, 
such as digests of single model proteins. Data interpretation gets more complicated with 
rising sample complexity making it necessary to use bioinformatics tools for calculation 
of peptide ratios in overlapping/coeluting peaks and assignment of the signals to the 
respective peptides.  
5.3 Separation Efficiency versus Quantitative Analysis 
Separation efficiency still remains one of the biggest challenges in protein and peptide 
analysis. This is in accordance with the findings of recent publications on similar LC-
based approaches: they mostly concern themselves with the separation of peptide 
mixtures or digests of purified proteins (see Table 23). For molecular MS, the coelution 
of peptides can, in many cases, be balanced by the additional separation in the m/z 
domain, unless the analytes are (close to) isobaric. 
Baseline separation is an important prerequisite for a reliable quantification in 
nanoHPLC ICP-MS. Since structural information is lost in the ICP process, the signals for 
coeluting analytes form a single peak and are therefore indistinguishable. In this case 
the acquired quantitative data cannot be confidently attributed to the complementary 
identification data e.g. from MALDI-MS. A complete baseline separation of peptides 
could only be achieved for the synthetic peptide mixtures used in this study, whereas for 
protein digests baseline separation could only be partially achieved. In the latter case, 
groups of coeluting peptides usually consisted of variations of the same peptide with 
and without missed cleavages and different numbers of attached tags. It can be 
considered to quantify them as groups. 
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In this prospect, and regarding applicability of the DOTA label, a whole proteome 
analysis by these means does not seem possible under quantitative conditions. As 
shown with the application of ZipTips, quantitative recovery is not always ensured for 
routine standard protocols in proteomics. Each additional purification and separation 
step holds the potential risk of analyte losses. In quantitative analysis, protein and 
peptide recovery must not be sacrificed for efficient separation or purification. 
Therefore it would be very interesting to analyse the sample losses in routine 
proteomics approaches, e.g. a bottom-up approach, starting with a cell culture or lysate 
sample and monitoring each step until it is broken down to its peptides. The results 
could thereafter be compared to the results from the recovery (sample loss) monitoring 
in a top-down approach. The presented approach holds the potential to perform such a 
study. For the monitoring of the recoveries of the different procedures used in a 
proteomics workflow, a set of labelled model proteins with different sizes and 
properties could be spiked into a lysate sample. During each step of the proteomics 
workflow, including SDS-PAGE (1D or 2D) and chromatographic separations, a sample 
could be drawn and analysed in regard to the present lanthanide signals. On the peptide 
level, labelled model peptides could be employed and monitored.  
5.4 fsLA-ICP-MS on MALDI-Targets 
A novel approach employing the combination of MALDI-MS together with fsLA-ICP-MS 
was presented. The consecutive application of both techniques together has been 
shown to provide a great potential in this first proof-of-concept study. The combination 
of a molecular and an ablation based elemental mass spectrometric method allows 
complementary information from a single LC-run to be gathered by permitting 
unambiguous attribution of peptide identifications from MALDI-MS to the 
corresponding quantitative information from LA-ICP-MS. Beside applications in 
bioanalytics, e.g. proteomics, this basic principle will certainly also find widespread 
applications in other fields such as environmental analysis etc.. However, some virtues 
may still need to be uncovered prior to this approach becoming a standard method.  
The chromatographic resolutions of both MALDI- and fsLA-ICP-MS chromatograms were 
very low, which is due to the limitations of the spot sizes during Probot fractionation. 
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Smaller spotter fractionation time is plausible but most likely very impractical in its 
application. Reducing the fractionation time equals a reduction in the spot size which 
may pose problems for automated MALDI-MS measurements, especially in regard to the 
alignment. Spots may also be missed more easily by the randomised laser shots.  
For better chromatographic resolution, it might also be considered to modify the 
spotting in a way that decreases only the nanoHPLC fraction size, but still guards the size 
of the matrix spots. This would simply result in a higher number of measurement spots 
for the same chromatogram. For this purpose, spot intervals could be shortened while 
the dosage flow of the matrix would need to be increased accordingly. A potential 
solution is the choice of alternative matrices which allow proper measurement at 
altered matrix-to-analyte ratios. However this still needs to be evaluated, especially in 
regard to the sensitivity of the MALDI-MS measurements. Lower fraction volumes equal 
less analyte in each spot, which may result in analyte levels encroaching on the limits of 
detection of the MALDI-MS.  
Another option might lie in longer gradients for a greater separation of the peaks and 
thus a decrease in coelution. This would also allow for the proper matching of LA-ICP-MS 
signals to their identified peaks in MALDI-MS. Unfortunately, both of these mentioned 
possibilities would result in a further elongation of the analysis time in LA-ICP-MS, which 
on the current stage is already a very long and tedious process. The manual LA-ICP-MS 
analysis is quite time consuming: the measurement of 80 spots, equalling barely 20 min 
of chromatography, took longer than an hour. So far no automation is possible but 
would be highly beneficial both in terms of reproducibility and overall measurement 
times.  
A compromise for lowering of the required measurement times could be a pre-
evaluation of the MALDI-MS and UV data: interesting parts of the chromatography could 
be identified prior to LA-measurements. By only measuring the spots of interest using 
LA-ICP-MS, the measurement time could be reduced significantly.  
The manual measurement of LA-ICP-MS spectra bears the danger of performing errors. 
During the preliminary test, two persons were involved in the experiment: one 
conducting the measurements and a second to keep track of the data. A high level of 
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attention needed to be maintained and already small diversions could have accounted 
for errors. 
For further reduction of analysis time, an automation of LA-ICP-MS would be an option. 
To achieve this, either the cut target pieces would need to be standardised, including a 
specific holder, or an adapted ablation cell would need to be designed. In both cases, a 
spot set pattern could be applied in a reproducible manner, so that the spots can be 
located automatically in LA-ICP-MS. This could be achieved in a similar way to MALDI-
MS, in which manual alignment of MALDI target plates is performed. Like this the laser 
could also autofocus itself properly, avoiding too deep ablation craters.  
One possibility for an adapted ablation cell that can be applied on an uncut target would 
be a small cell which can be put on the target and be moved around as needed. A cell 
which can contain a whole MALDI-plate is not a feasible option. The cell size must not be 
too big because of a higher risk of turbulences in the cell volume and thus ineffective 
transfer of the analytes to the ICP-MS.  
For the adapted cell design a matching spotting pattern would be easy to be 
programmed on the robotic plate spotter, avoiding areas were the ablation cell comes 
into contact with the target. In order to get the ablation cell air-tight, a rubber seal could 
be employed, together with a set of clips. Like this, the cell could be positioned on 
different areas of the target.  
It is also imaginable to employ standardised targets of small size that fit in normal-sized 
ablation cells. Special targets could be developed in collaboration with a manufacturer 
of MALDI-MS instruments. In this context the reusability of already ablated targets for 
further use in MALDI-MS could be inquired. However, the re-use of targets is not a very 
practical option due to the destructive nature of the LA. This is why it would be more 
practical to consider disposable target slips/plate covers which could be composed of 
different materials or combinations, such as metal covered glass slides; however this 
would require extensive validation and testing. 
The current workload during application of the method, especially regarding the 
measurement time during LA-ICP-MS, underlines the need for automation of the 
method. Still, it already shows some important virtues: most of all the possibility to 
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reanalyse exactly the same sample twice with two complementary techniques. As with 
every new method, all of its merits will only become apparent once it is refined further.  
Recent developments in the application of LA related to MALDI-MS typically concern 
themselves with a sample transfer from one medium to another. Park et al. used an 
infrared LA-system to resolve a solid sample which was deposited on a steel target 
surface into small solvent droplets. The solved samples were then either measured via 
ESI-MS or redeposited on a MALDI-target together with matrix and the sample 
measured in MALDI-MS.[183] LA-sample transfer was also used in combination with 
MALDI-imaging for the analysis of tissue samples.[184]  
The approaches shown in this thesis did not employ a reaction cell for ICP-MS 
measurements. The lanthanides show only a few polyatomic interferences among each 
other (see Table 1 on page 25) and it is questionable that a reaction cell will be able to 
rule out those interferences. Currently, there are only a handful of reports on the 
application of collision/reaction cell technology for analysis of lanthanides, all of which 
show only limited improvements.[185, 186] 
Given that the interfering element is not present in the sample, these interferences will 
not pose a problem. This was mainly the case for the samples employed in nanoHPLC 
ICP-MS. For fsLA-ICP-MS though, the sample matrix in form of the MALDI-plate might 
contain significant amounts of interfering lanthanides, as was hinted during the 
determination of the LODs (section 4.5.5). Lanthanides tend to form oxides, which is the 
main reason for the interferences. The impact of those interferences can be measured 
by application of single element solutions and monitoring of the signal at the element’s 
mass + 16 mass units. The determined impact can then be applied in form of a 
correction factor.[187] Alternatively, the targeted oxidation of lanthanides using a 
dynamic reaction cell with oxygen as reactive gas has been reported.[185] 
In both mentioned cases, correction factors would need to be employed. It can be 
questioned whether the effort of employing such a correction will have a great impact 
on the outcome of the presented quantitative approaches. The correction is mainly 
meant for trace element analysis, where the impact of these interferences can result in 
significant errors. The systematic error from the interferences is conceivably much 
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smaller than the sample to sample variation from the peptide samples, thus must not be 
overlooked but can be considered as of negligible effect.   
5.5 Superposition of Chromatograms 
Problems with data alignment are commonly encountered in many analytical 
applications, in form of stretching or shrinking of signals along a horizontal scale. This is 
especially problematic for data destined for automated computation at a later stage. 
There are a multitude of approaches that address these alignment problems, e.g. 
dynamic and parametric time warping. They are based on warping algorithms, which can 
compare and align large data sets ,[188] and have also been reported for the use with LC-
MS based proteomics.[189] The alignment is commonly based on searching for matching 
peaks in two chromatograms.[190] However, the basic aim of all warping algorithms is a 
reliable automatic alignment of data.  
The retention time marker (RTM) peptides developed in this thesis might contribute to 
the reliable superposition of differentially acquired chromatograms, also in automatic 
warping methods. The recognition of the RTM peptides would need to be implemented 
into the algorithms, leading to a facilitation of the computational approach. This way, 
the RTMs could improve the accuracy of the alignments and make them more 
comprehensible.  
The RTMs are expected to be applicable in a broad range of experiments and with a 
multitude of application possibilities, which are not reduced to the marking of retention 
times. A set of labelled peptides e.g. with different pI values could be employed as pI-
markers for isoelectric focussing strips used in LA-ICP-MS. 
5.6 Final Conclusions 
It could be shown that even with the geographical distance between two laboratory 
facilities, complementary experiments could still provide conclusive data. By following 
some strict rules regarding sample transportation in between the experiments, it was 
made sure that no sample alterations occurred. On the whole, the complementarity of 
both laboratories was combined to the benefit of both parties. Collaborations of this 
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kind can contribute largely to the forthcoming of projects and to intensive scientific 
interchange between laboratories in general. 
Several novel approaches were developed in the course of this PhD thesis, which can 
contribute to the analysis of metal labelled peptide samples. The presented online 
precleaning step enables a reliable metal background reduction for labelling approaches, 
while guarding peptide recoveries. Samples can be analysed directly after labelling 
without prior desalting and the precleaning can be implemented into normal nanoHPLC 
workflows very easily. The optimal precleaning step only took 6 min, resulting in an 
extension of the analysis time of usually less than 10 %.  
The development of a set of retention time marker peptides largely facilitated the 
alignment of complementary data which was acquired independently. By application of 
these peptides there was no need to strictly apply exactly the same analysis parameters, 
such as gradient or column length in nanoHPLC, to all samples while not compromising 
their comparability. This is especially interesting for data acquired on different 
instruments or by different operators, e.g. in the different laboratories of two 
cooperation partners. It was also shown that this set of labelled peptides might be 
employed as a standard for a quick and approximate absolute quantification when 
conducting online nanoHPLC ICP-MS analysis. There was no need for an additional setup 
with an additional pump for the generation of an isotope spike flow, like in isotope 
dilution analysis. [133, 151]  
The different independent quantification approaches showed conclusive and 
comparable results in the range of the expected values. The developed quantification 
techniques are promising, however further refinement is required, and it the results 
need to be confirmed with an independent technique, e.g. using MeCAT or an isobaric 
tagging approach. 
The novel approach employing MALDI-MS and fsLA-ICP-MS for acquisition of 
complementary data by re-measurement of the same separation, showed great 
potential and after refinement will certainly also be applicable for approaches outside 
the field of proteomics. 
It could also be shown that there is still some potential left for the refinement of the 
DOTA-labelling protocols. The versatility of the label is unrivalled regarding the number 
V   DISCUSSION AND OUTLOOK 
 
-128- 
 
of possible labels for multiplex analysis. Still some limitations of the label have surfaced, 
especially in regard to quantitative analysis after chromatographic separation. The 
baseline separation remains the limiting factor when employing ICP-MS for 
quantification of complex samples. This is why it will be very hard to apply the DOTA 
labelling to proteome analysis. 
New tags could be developed in the future, such as lanthanide DOTA based isobaric tags, 
which could be quantified via both MALDI-MS and ICP-MS, in order to elucidate the 
ratios of overlapping peaks and the behaviour of similar peptides. This could also allow 
for the development of a computational model which would consecutively enable ICP-
MS based quantification of peaks that are not baseline separated. 
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VII    Appendix I: Indices 
7.1 Abbreviations 
µ  micro (10-6) 
2D  Two-dimensional 
Å  Angström (10-10m) 
a  atto (10-18) 
AA  Amino acid 
AB  Antibody 
ABC  Ammoniumbicarbonate 
ACN  Acetonitrile 
AcOH  Acetic acid 
APEX  Absolute protein expression profiling 
APS  Ammonium Persulfate 
AQUA  Absolute quantification 
AUC  Area Under Curve 
BSA  Bovine serum albumin 
C  Cysteine 
ca.  Circa, approximately 
CAE  capillary array electrophoresis 
Cal  Calibration spot 
CE   Capillary electrophoresis 
CEC  capillary electro chromatography 
CGE  capillary gel electrophoresis 
CHAPS  3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate 
CHCA  α-cyano-4-hydroxycinnamic acid 
CID  Collision induced dissociation/decomposition 
cps  Counts per Second 
Cys  Cysteine 
CZE  Capillary zone electrophoresis 
Da  Dalton 
DIGE  Differential gel electrophoresis 
DNA  Deoxyribonucleic acid 
DOTA  1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid 
DRC   Dynamic reaction cell 
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DTPA  Diethylenetriamine pentaacetic acid 
DTPAA  Diethylenetriamine pentaacetic acid anhydride 
EC  Electro chemical 
ECD  Electron capture dissociation 
EDTA  Ethylenediaminetetraacetic acid 
emPAI  Exponentially modified protein abundance index 
ESI  Electrospray ionisation 
ETD  Electron transfer dissociation 
EtOH  Ethanol 
eV  electron volt 
f  femto (10-15) 
FFF  Field flow fractionation  
FIA  Flow-injection analysis 
FT  Fourier transform 
FWHM  Full width at Half Maximum 
g  gram 
GC  Gas Chromatography 
GluFib  Glu1-fibrinopeptide B (EGVNDNEEGFFSAR) 
GRAVY  Grand average of hydropathicity 
HCD  High energy CID 
HCl  hydrochloric acid or hydrochloride 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HFBA  Heptafluorobutyric acid (2,2,3,3,4,4,4-heptafluorobutanoic acid) 
HIC  Hydrophobic interaction chromatography 
HILIC  Hydrophilic interaction liquid chromatography 
HPLC  High performance liquid chromatography 
HSA  Human serum albumin 
Hz  Hertz (s-1) 
I.D.  Inner diameter 
IA  Iodoacetamide 
ICAT  Isotope-coded affinity tag 
ICP  Inductively coupled plasma 
ICPL  Isotope-coded protein label 
ICR  ion cyclotron resonance 
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ID  intentity/identification 
IDA  Isotope dilution analysis 
IEF  Isoelectric focussing 
IEX  Ion exchange chromatography 
IgG  Immunoglobulin G 
IP  Ion-pairing 
IR  Infrared 
IRMPD  Infrared multiphoton dissociation 
iTRAQ  Isobaric tag for relative and absolute quantification 
IUPAC  International Union of Pure and Applied Chemistry 
K  Kelvin 
k  kilo (103) 
K  Lysine 
L  Liter 
LA  Laser ablation 
LC  Liquid chromatography 
LeuEnk  Leu-enkephalin (YGGFL) 
LIF  Laser induced fluorescence 
Ln  Lanthanide 
LOD  Limit of detection 
Lys  Lysine 
m  metre 
M  molar (mol/L) 
m  prefix: milli (10-3) 
m/z  Mass to charge ratio 
Mal  maleinimido-(monoamide) 
MALDI  Matrix assisted laser desorption/ionisation 
max.   maximum 
MC  Missed Cleavage(s) 
MeCAT  Metal-coded affintity tag 
MEKC  micellar electrokinetic chromatography 
MeOH  Methanol 
MeThio  methylthio- 
min.  minimum 
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MMTS  Methyl methanethiosulfonate 
Mr(calc) Relative molecular mass calculated from matched peptide sequence 
Mr(expt) Experimental m/z transformed to a relative molecular mass 
MRM  Multiple reaction monitoring 
MS  Mass spectrometry 
MS2  Tandem mass spectrometry 
MΩ  Electrical resistance (megaohm) 
n  nano (10-9) 
Nd:YAG  Neodymium-doped yttrium aluminium garnet (Nd:Y3Al5O12) 
NHS  N-Hydroxysuccinimide 
N-term  N-Terminus 
O.D.  outer diameter 
p  pico (10-12) 
PAGE  Polyacrylamide gel electrophoresis 
PDMS  Polysimethylsiloxane 
Ppm  parts-per-million 
PTM  Post translational modification 
Q  Quadrupole 
QIT  Quadrupole ion trap 
RP  Reverse phase 
RT  room temperature (20°C) 
RTM  Retention time marker 
s  second 
S/N  Signal to noise ratio 
SCN  Isothiocyanate 
SCX  Strong cation exchange 
SDS  Sodium docecyl sulfate 
SEC  Size-exclusion chromatography 
SI units  Units of the International System of Units 
SI  Signal Intensity 
SILAC  Stable isotope labelling with amino acids in cell culture 
SPE  Solid phase extraction 
TEMED  Tetramethylethylenediamine 
TFA  Trifluoroacetic acid 
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TMT  Tandem mass tag 
TOF  time of flight 
TRIS   tris(hydroxymethyl)aminomethane 
ULB  Urea lysis buffer 
uPLC  ultra performance liquid chromatography 
UV  ultraviolet 
v/v  volume concentration 
W  Watt 
w/v  mass concentration 
z  zepto (10-21) 
7.2 Tables 
Table 1: Polyatomic interferences for selected lanthanides [38, 39] .................................... 25 
Table 2: Typical figures of merit for different mass analysers. Adapted from Hart-Smith 
and Blanksby[32] .................................................................................................................. 31 
Table 3: Overview of main approaches in quantitative proteomics. Adapted from 
Wasinger et al. and Bantscheff et al.[1, 2] ........................................................................... 40 
Table 4: Comparison of characteristics of molecular (MALDI/ESI) and ICP-MS. 
Reproduced from Tholey and Schaumlöffel.[3] .................................................................. 41 
Table 5: Stabilities of lanthanide complexes formed by DOTA, DTPA and EDTA, ............. 46 
Table 6: Overview –selected publications on labelling approaches in combination with 
detection via ICP-MS since 2010. ....................................................................................... 52 
Table 7: Employed nanoHPLC systems and parameters ................................................... 60 
Table 8: Variable modifications for mascot search. .......................................................... 62 
Table 9: ICP-MS system operating conditions when coupled to nanoHPLC ..................... 63 
Table 10: fs-LA-ICP-MS system and parameters ................................................................ 64 
Table 11: Recoveries for the respective peptide samples in Figure 28 (c) to (f) ............... 72 
Table 12: Sequence coverage in percent for differentially labelled model protein digests 
and detected peptides using Mascot search ..................................................................... 86 
Table 13: Isotopes and first ionisation energies for the employed lanthanides.[180] ........ 90 
Table 14: ZipTip eluate sample series of the NHS-DOTA labelled Cytochrome C digest. 
Sample compositions and component amounts (injected total amounts in nanoHPLC ICP-
VII  APPENDIX I 
 
-145- 
 
MS). Expected and acquired values were calculated based on ICP-MS total counts after 
peak integration, with the standard peptides as 1 pmol and 0.1 pmol respectively. ....... 93 
Table 15: Noise levels and limits of detection for the utilised lanthanide metals. ......... 102 
Table 16 (below): fsLA-ICP-MS calibration curves and equation data from trend lines . 103 
Table 17: Results for the quantification of the Ln-NHS-DOTA labelled standard peptides 
via fsLA-ICP-MS ................................................................................................................ 104 
Table 18: Set of integrated peaks from the chromatogram in Figure 48 and calculated 
quantities. ........................................................................................................................ 106 
Table 19: Assigned peptide identities for the most prominent peaks in Figure 50, with 
labelling sites (*) and m/z ................................................................................................ 116 
Table 20: List of apparatus and instruments ................................................................... 151 
Table 21: List of Chemicals ............................................................................................... 151 
Table 22: List of consumables .......................................................................................... 153 
Table 23: List of standard proteins and enzymes ............................................................ 154 
Table 24: Synthetic peptides (including GRAVY index[191] as classification of their 
hydrophobicity) ................................................................................................................ 154 
Table 25: Tryptic digest of chicken lysozyme (LYSC_CHICK) labeled with 141Pr Mal-DOTA. 
Labeled peptides found by Mascot Search after LC-MALDI MS/MS. (only ion scores 
above the identity threshold of p<0.05 are listed), original data from Holste et al. 2013[4]
.......................................................................................................................................... 155 
Table 26: Tryptic digest of chicken lysozyme (LYSC_CHICK) labeled with 169Tm NHS-DOTA. 
Labeled peptides found by Mascot Search after LC-MALDI MS/MS. (only ion scores 
above the identity threshold of p<0.05 are listed), original data from Holste et al. 2013[4]
.......................................................................................................................................... 156 
Table 27: Quantification of a labelled Cytochrome C (Cyt C) digest after treatment with 
ZipTip C18, samples 1 and 2. Peak areas of the respective peaks were acquired by 
integration with the software TST (LCABIE, Pau). Eluate Peptide A to D correspond to 
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VIII Appendix II: Material 
8.1.1 Apparatus 
Table 20: List of apparatus and instruments 
Apparatus / Instrument Company Type 
Absorbance microplate reader Biotek ELx800NB 
Bench centrifuge  vwr Galaxy ministar 
Centrifuge (0.5 - 2 mL) Heraeus  Biofuge Fresco 21 
Centrifuge (Falcon size) Heraeus  Biofuge stratos 
Fraction collector LC Packings  Probot 
fs Laser Ablation System Novalase Alfamet 
ICP-MS 1 Agilent 7500ce 
ICP-MS 2 Perkin Elmer Elan II 
Lyophiliser  Scanvac  Coolsafe 110-4 
Magnetic stirrer Heidolph MR Hei-Standard 
MALDI-MS ABSCIEX TOF/TOF 5800 
Microscope Leica Leica dfc 280 
nanoHPLC 1 Dionex Ultimate 3000 
nanoHPLC 2 LC Packings Famos Switchos Ultimate 
pH-Meter Metler-Toledo SevenEasy, Benchtop, S20 
Pipettes (2.5 µL to 1 mL) Eppendorf Research 
Pipettes (2.5 µL to 1 mL) Eppendorf Reference 
Special accuracy weighing machine Sartorius Mechatronics Sartorius ME  
Speedvac Eppendorf Concentrator plus 
Thermomixer Eppendorf comfort 
Ultra sonic bath Elma Elmasonic S40H 
Ultrapure Water filter Sartorius stedim Arium 611VF 
Vortex mixer Neolab VM-300 Vortex Mixer 
 
8.1.2 Chemicals 
Table 21: List of Chemicals 
Compound Company Ordering Info 
2-(4-(2-Hydroxyethyl)-1-piperazinyl) ethansulfonic acid (HEPES) Sigma-Aldrich H3375-100G 
2-Mercaptoethanol Sigma-Aldrich 63689-25ML-F 
4700 Mass Standards Kit ABSCIEX 4333604 
Acetic acid Sigma-Aldrich 45726-1L-F 
Aceton  Fluka 00585-2.5L 
Acetonitrile - CHROMASOLV
®
 gradient grade, for HPLC, ≥99.9% Sigma-Aldrich 34851-2,5L 
Ammoniumhydrogencarbonat Fluka 09830-1KG 
Ammoniumpersulfate Sigma-Aldrich A9164-25G 
Bromophenol blue Sigma-Aldrich 80126 
Cerium(III) chloride heptahydrate Sigma-Aldrich 202983 
CHAPS Sigma-Aldrich C3023-1G 
CHCA Sigma-Aldrich C2020-10G 
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Table 21, continued: list of chemicals 
Compound Company Ordering Info 
CHCA Laserbio Labs * M001 - aCHCA  
Coomassie G250 Sigma-Aldrich 27815-25G-F 
Coomassie R250  Sigma-Aldrich 27816-25G 
Dimethyl sulfoxide, >=99,7%, Hybri-Max/ DMSO Sigma-Aldrich D2650-5X5ML 
Dithiothreitol Sigma-Aldrich 43815-1G 
EDTA Di-Na-Salz Sigma-Aldrich E5134-50G 
Erbium(III) chloride hexahydrate Sigma-Aldrich 289256 
EthOH Sigma-Aldrich 34963-1L 
Europium(III) chloride hexahydrate 1g Sigma-Aldrich 203254 
Helium Linde   
Heptafluoro butyric acid Fluka 52411-25ML-F 
Holmium(III) chloride hexahydrate Sigma-Aldrich 289213 
Iodoacetamide Sigma-Aldrich I1149-5G 
Isopropanole Sigma-Aldrich 24137 
Lutetium(III) chloride hexahydrate Sigma-Aldrich 542075 
Maleimido-mono-amide-DOTA macrocyclics B-272-100 
MeOH Sigma-Aldrich 34966-2.5L 
NaOH Sigma-Aldrich 30620-1KG-R 
Neodymium(III) nitrate hexahydrate 25g Sigma-Aldrich 289175 
NHS DOTA Chematech DOTA-NHS ester 
Praseodymium(III) nitrate hexahydrate Sigma-Aldrich 205133 
Proteaseinhibitor complete mini Roche  11836170001 
Rare Earth element mix for ICP  Sigma Aldrich 67349  
SDS ultra pure C.Roth 2326.2 
S-Methyl-methanthiosulfonat Fluka 64306-1ML 
TCEP (tris(2-carboxyethyl)phosphine) Merck 580560-1GM 
Terbium(III) chloride hexahydrate Sigma-Aldrich 212903 
Thulium(III) chloride hexahydrate Sigma-Aldrich 204668 
Triethylamine - ≥99% Sigma-Aldrich T0886-500ML 
Triethylammonium acetate buffer Sigma-Aldrich 90358-100ML 
Triethylammonium bicarbonate buffer - puriss. p.a., for HPLC, 
volatile buffer, 1 M 
Sigma-Aldrich 17902-100ml 
Trifluoroacetic acid - ReagentPlus
®
, 99% Sigma-Aldrich T62200-100ML 
Tris base C.Roth 4855.2 
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8.1.3 Consumables 
Table 22: List of consumables 
consumable Company Ordering Info 
Acclaim PepMap100, C18, 3 µm, 100 Å, 75 µm 
i.d. x 15 cm 
Dionex/Thermo fisher scientific 160321 
Acclaim PepMap100, C18, 3 µm, 100 Å, 75 µm 
i.d. x 25 cm 
Dionex/Thermo fisher scientific 164569 
ZipTip w/ 0.6µL C18 resin 96/Pk millipore ZTC18S096 
Universal indicator paper 1-14 vwr 1109620003 
Micro-Precolumn 300µmi.d.x5mm, packed with 
Acclaim PepMap100 C18 
Dionex 160454 
Cutter for fused silica tubing Dionex P/N 160483 
LLG glass sample vials N9-1  Macherey-Nagel 702282 
Sample vial Inserts 15mm tip Macherey-Nagel 702813 
Caps for sample vial N9  Macherey-Nagel 702285.1 
Pipette tips 100-1000µl vwr/ axygen 613-0669 
Pipette tips 1-200µl vwr/ axygen 613-0652 
Pipette tips 0.5-10µl vwr/ axygen 613-0643 
Eppendorf Tubes 0.5mL, lobind Eppendorf 0030 108.094 
Eppendorf Tubes 1.5mL, lobind Eppendorf 0030 108.116 
Eppendorf Tubes 2mL, lobind Eppendorf 0030 108.132 
PCR Tubes, 200 µL lobind Eppendorf 0030 124.359 
Falcons 50mL Greiner bioOne 7.380 421 
Falcons 15mL Greiner bioOne 7.380 423 
Amicon Ultra-0.5 3kDa Ultracel-PL memb 24/Pk millipore UFC500324 
Glas beads 0.10 – 0.25 mm Ø Retsch 22.222.0001 
Glas beads 0.25 – 0.50 mm Ø Retsch 22.222.0002 
MALDI Targets LC  ABSCIEX 1018469 
MALDI Targets spot based  ABSCIEX 1016629 
MALDI Target plate holder ABSCIEX 1016492 
Scalpel pfm medical 200130010 
Parafilm Neolab 3-1011 
Nickel Skimmer cone Agilent G3270-65024 
Nickel sampling cone Agilent G1820-65238 
Standard-Mikrotiterplatten F- Boden  vwr 735-2002 
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8.1.4 Peptides, Proteins, Enzymes 
Table 23: List of standard proteins and enzymes 
 Protein / Enzyme Company Ordering Info 
Cytochrome c Digest Dionex P/N 161089 
α-Lactalbumin  Sigma-Aldrich L5385-100MG 
β-Lactoglobulin B Sigma-Aldrich L8005-100MG 
Lysozyme Sigma-Aldrich L6876-1G 
Trypsin promega V511A 
BSA Sigma-Aldrich A7511-1G 
Chymotrypsin promega V1061 
 
Table 24: Synthetic peptides (including GRAVY index
[191]
 as classification of their hydrophobicity) 
Peptide Sequence Manufacturer GRAVY Index 
S36  (peptide C) GACLLPK  R. Pipkorn (DKFZ, Germany)  +0.857 
S22  (peptide B) LRRACLG R. Pipkorn (DKFZ, Germany) +0.357 
T3    (peptide A) EGHIARNCRA R. Pipkorn (DKFZ, Germany) -0.900 
S17 RPQYAEASWNAR R. Pipkorn (DKFZ, Germany) -1.558 
S19 RPQYACASWNAR R. Pipkorn (DKFZ, Germany) -1.058 
S27 LRRASpLGERRASLGE R. Pipkorn (DKFZ, Germany) (-0.827) 
Leu-Enkephalin (LeuEnk) YGGFL Waters (70000 3276) +0.900 
[Glu1]-Fibrinopeptid B human 
(GluFib) 
EGVNDNEEGFFSAR Sigma-Aldrich (F3261-1MG) -1.107 
Hy ESLSSSEE A. Tholey -1.238 
PP A ASQDGTPALR Biosyntan, Germany -0.760 
PP L LSVYDPYR Biosyntan, Germany -0.625 
PP Q QDYLQYR Biosyntan, Germany -1.971 
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IX Appendix III: Additional Data 
9.1 Identified Labelled Peptides for MALDI-MS Analysis of a Labelled 
Lysozyme Digest 
Corresponding to section 4.3, starting on page 81. 
 Table 25: Tryptic digest of chicken lysozyme (LYSC_CHICK) labeled with 
141
Pr Mal-DOTA. Labeled peptides found by 
Mascot Search after LC-MALDI MS/MS. (only ion scores above the identity threshold of p<0.05 are listed), original 
data from Holste et al. 2013
[4]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Observed mass Mr (expt) Mr (calc) MC Score Peptide labels 
1500.5123 1499.5051 1499.5161 0 32.45 CELAAAMK Mal-DOTA Pr (C) 
1500.5148 1499.5075 1499.5161 0 27.33 CELAAAMK Mal-DOTA Pr (C) 
1516.4982 1515.4909 1515.5110 0 19.16 CELAAAMK Mal-DOTA Pr (C) 
1600.4925 1599.4853 1599.4937 0 7.95 WWCNDGR Mal-DOTA Pr (C) 
1656.6218 1655.6146 1655.6172 1 11.60 CELAAAMKR Mal-DOTA Pr (C) 
1656.6239 1655.6166 1655.6172 1 42.83 CELAAAMKR Mal-DOTA Pr (C) 
1932.7096 1931.7023 1931.7248 0 26.78 GYSLGNWVCAAK Mal-DOTA Pr (C) 
1932.7100 1931.7027 1931.7248 0 30.43 GYSLGNWVCAAK Mal-DOTA Pr (C) 
1932.7240 1931.7167 1931.7248 0 27.24 GYSLGNWVCAAK Mal-DOTA Pr (C) 
1932.7352 1931.7280 1931.7248 0 17.86 GYSLGNWVCAAK Mal-DOTA Pr (C) 
1940.7644 1939.7571 1939.7623 1 25.38 CKGTDVQAWIR Mal-DOTA Pr (C) 
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9.2 Analysis of Labelled Digests 
Corresponding to section 4.3.1. 
For the following sequences: Green: Labelled. Red: not detected.  
Black: no target for the reagent. Labelling site underlined. 
9.2.1 Sequence Coverage for Chicken Lysozyme (LYSC_CHICK) 
 
9.2.2 Sequence Coverage for α-Lactalbumin (LALBA_BOVIN) 
 
169Tm NHS DOTA labelled tryptic digest of α-lactalbumin: 
        10         20         30         40         50         60  
MMSFVSLLLV GILFHATQAE QLTKCEVFRE LKDLKGYGGV SLPEWVCTTF HTSGYDTQAI  
 
        70         80         90        100        110        120  
VQNNDSTEYG LFQINNKIWC KDDQNPHSSN ICNISCDKFL DDDLTDDIMC VKKILDKVGI  
 
       130        140  
NYWLAHKALC SEKLDQWLCE KL  
 
165Ho Mal-DOTA labelled tryptic digest of α-lactalbumin: 
        10         20         30         40         50         60  
MMSFVSLLLV GILFHATQAE QLTKCEVFRE LKDLKGYGGV SLPEWVCTTF HTSGYDTQAI  
 
        70         80         90        100        110        120  
VQNNDSTEYG LFQINNKIWC KDDQNPHSSN ICNISCDKFL DDDLTDDIMC VKKILDKVGI  
 
       130        140  
NYWLAHKALC SEKLDQWLCE KL  
 
169Tm NHS-DOTA labelled tryptic digest of lysozyme: 
        10         20         30         40         50         60  
MRSLLILVLC FLPLAALGKV FGRCELAAAM KRHGLDNYRG YSLGNWVCAA KFESNFNTQA  
 
        70         80         90        100        110        120  
TNRNTDGSTD YGILQINSRW WCNDGRTPGS RNLCNIPCSA LLSSDITASV NCAKKIVSDG  
 
       130        140  
NGMNAWVAWR NRCKGTDVQA WIRGCRL 
 
141Pr Mal-DOTA labelled tryptic digest of lysozyme: 
        10         20         30         40         50         60  
MRSLLILVLC FLPLAALGKV FGRCELAAAM KRHGLDNYRG YSLGNWVCAA KFESNFNTQA  
 
        70         80         90        100        110        120  
TNRNTDGSTD YGILQINSRW WCNDGRTPGS RNLCNIPCSA LLSSDITASV NCAKKIVSDG  
 
       130        140  
NGMNAWVAWR NRCKGTDVQA WIRGCRL 
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9.2.3 Sequence Coverage for β-Lactoglobulin (LACB_BOVIN) 
 
 
9.2.4 Sequence coverage for cytochrome C (CYC_BOVIN) 
 
  
165Ho NHS-DOTA labelled tryptic digest of cytochrome C (Dionex standard): 
        10         20         30         40         50         60  
MGDVEKGKKI FVQKCAQCHT VEKGGKHKTG PNLHGLFGRK TGQAPGFSYT DANKNKGITW  
 
        70         80         90        100  
GEETLMEYLE NPKKYIPGTK MIFAGIKKKG EREDLIAYLK KATNE  
 
169Tm Mal-DOTA labelled tryptic digest of β-lactoglobulin: 
        10         20         30         40         50         60  
MKCLLLALAL TCGAQALIVT QTMKGLDIQK VAGTWYSLAM AASDISLLDA QSAPLRVYVE  
 
        70         80         90        100        110        120  
ELKPTPEGDL EILLQKWENG ECAQKKIIAE KTKIPAVFKI DALNENKVLV LDTDYKKYLL  
 
       130        140        150        160        170  
FCMENSAEPE QSLACQCLVR TPEVDDEALE KFDKALKALP MHIRLSFNPT QLEEQCHI  
 
141Pr NHS-DOTA labelled tryptic digest of β-lactoglobulin: 
        10         20         30         40         50         60  
MKCLLLALAL TCGAQALIVT QTMKGLDIQK VAGTWYSLAM AASDISLLDA QSAPLRVYVE  
 
        70         80         90        100        110        120  
ELKPTPEGDL EILLQKWENG ECAQKKIIAE KTKIPAVFKI DALNENKVLV LDTDYKKYLL  
 
       130        140        150        160        170  
FCMENSAEPE QSLACQCLVR TPEVDDEALE KFDKALKALP MHIRLSFNPT QLEEQCHI  
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9.2.5 nanoHPLC-ICP-MS Chromatograms of the Digests above 
 
 
 
 
IX  APPENDIX III – Additional Data 
 
-160- 
 
9.3 Quantification of Labelled Cytochrome C via nanoHPLC ICP-MS 
using Standard Peptides 
Table 27 and Table 28 are complementary data to section 4.4.2 on the quantification of 
a labelled cytochrome C digest after treatment with C18 ZipTips. Labelled standard 
peptides were applied with an amount of 1 pmol each. The Cyt C eluate and remnant 
solution were both dried after ZipTip treatment and reconstituted in exactly the same 
way prior to analysis. Both solutions were employed as if they contained the same 
amount of digest peptides. Employed amounts equalled 1 pmol at 100 % recovery. 
Sample 1 in Table 27 shows quantification data matching the chromatogram shown in 
Figure 28 b in section 4.1.1. 
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Table 27: Quantification of a labelled Cytochrome C (Cyt C) digest after treatment with ZipTip C
18
, samples 1 and 2. Peak 
areas of the respective peaks were acquired by integration with the software TST (LCABIE, Pau). Eluate Peptide A to D 
correspond to four representative peptide peaks in the digest. 
Continued in Table 28. Complementary data to section 4.4.2 
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Table 28: continued from Table 27. Quantification of a labelled Cytochrome C (Cyt C) digest after treatment with ZipTip C
18
.  
Sample 3 is a 1:10 dilution of sample two. Sample 4 and 5 have the same composition as sample 1 to 3, with switched metal 
labels.  
Complementary data to section 4.4.2. 
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9.4 Identified Cytochrome C Peptides in MALDI-MS (Modified Target) 
Table 29: Identified peptides for a Lu-NHS-DOTA labelled cytochrome C digest, after MALDI-MS and MS
2
 on a cut 
target for consecutive measurement with fsLA-ICP-MS. Corresponding to section 4.5.3. For the Mascot search 
parameters see section 3.8.1 
Observed 
mass 
Mr (expt) Mr (calc) MC Score Peptide and labels/modifications 
964.5226 963.5153 963.5277 0 65 EDLIAYLK 
1168.5897 1167.5824 1167.6149 0 92.44 TGPNLHGLFGR 
1168.6108 1167.6036 1167.6149 0 37.19 TGPNLHGLFGR 
1168.6218 1167.6146 1167.6149 0 49.2 TGPNLHGLFGR 
1168.6278 1167.6205 1167.6149 0 101.5 TGPNLHGLFGR 
1192.4579 1191.4506 1191.5085 0 12 IFVQK + NHS-DOTA Lu (K) 
1192.4689 1191.4616 1191.5085 0 22.56 IFVQK + NHS-DOTA Lu (K) 
1236.4263 1235.419 1235.4983 0 22.65 YIPGTK + NHS-DOTA Lu (K) 
1236.4651 1235.4578 1235.4983 0 13.42 YIPGTK + NHS-DOTA Lu (N-term) 
1306.6885 1305.6812 1305.6928 1 1.61 GEREDLIAYLK 
1320.5663 1319.5590 1319.6034 1 24.46 KIFVQK + NHS-DOTA Lu (N-term) 
1320.5770 1319.5698 1319.6034 1 20.6 KIFVQK + NHS-DOTA Lu (N-term) 
1337.5222 1336.5149 1336.5646 0 0.82 MIFAGIK + NHS-DOTA Lu (N-term) 
1337.5264 1336.5191 1336.5646 0 37.1 MIFAGIK + NHS-DOTA Lu (N-term) 
1337.5394 1336.5322 1336.5646 0 7.58 MIFAGIK + NHS-DOTA Lu (N-term) 
1353.4764 1352.4692 1352.5595 0 22.25 MIFAGIK + NHS-DOTA Lu (K) + Ox(M) 
1353.5127 1352.5054 1352.5595 0 28.89 MIFAGIK + NHS-DOTA Lu (K) + Ox(M) 
1353.5198 1352.5125 1352.5595 0 23.24 MIFAGIK + NHS-DOTA Lu (N-term)  
+ Ox(M) 
1364.4362 1363.4289 1363.5932 1 16.52 KYIPGTK + NHS-DOTA Lu (N-term) 
1456.6360 1455.6287 1455.663 0 99.03 TGQAPGFSYTDANK 
1465.6250 1464.6177 1464.6595 1 14.49 MIFAGIKK + NHS-DOTA Lu (N-term) 
1465.6349 1464.6276 1464.6595 1 23.92 MIFAGIKK + NHS-DOTA Lu (K) 
1522.6111 1521.6038 1521.6511 0 37.51 EDLIAYLK + NHS-DOTA Lu (N-term) 
1633.6299 1632.6226 1632.8116 1 21.36 IFVQKCAQCHTVEK 
1650.7046 1649.6973 1649.7461 1 34.56 EDLIAYLKK + NHS-DOTA Lu (K) 
1726.7002 1725.6929 1725.7384 0 57.2 TGPNLHGLFGR + NHS-DOTA Lu (N-term) 
1726.7063 1725.6990 1725.7384 0 41.92 TGPNLHGLFGR + NHS-DOTA Lu (N-term) 
1726.7229 1725.7156 1725.7384 0 30.5 TGPNLHGLFGR + NHS-DOTA Lu (N-term) 
1794.4746 1793.4673 1793.6218 0 8.68 YIPGTK + 2 NHS-DOTA Lu (K + N-term) 
1794.4873 1793.4800 1793.6218 0 14.6 YIPGTK + 2 NHS-DOTA Lu (K + N-term) 
1864.7815 1863.7742 1863.8163 1 18.28 GEREDLIAYLK + NHS-DOTA Lu (N-term) 
1878.6011 1877.5938 1877.7269 1 22.49 KIFVQK + 2 NHS-DOTA Lu (K + N-term) 
1878.6751 1877.6678 1877.7269 1 17.89 KIFVQK + 2 NHS-DOTA Lu (K + N-term) 
1895.5641 1894.5568 1894.6881 0 20.23 MIFAGIK + 2 NHS-DOTA Lu (K + N-term) 
1911.5608 1910.5535 1910.6830 0 17.45 MIFAGIK + 2 NHS-DOTA Lu (K + N-term)  
+ Ox(M) 
1911.5749 1910.5677 1910.6830 0 5.75 MIFAGIK + 2 NHS-DOTA Lu (K + N-term) 
 + Ox(M) 
1922.6397 1921.6324 1921.7167 1 21.34 KYIPGTK + 2 NHS-DOTA Lu (K + N-term) 
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Table 29, continued 
Observed 
mass 
Mr (expt) Mr (calc) MC Score Peptide and labels/modifications 
1922.6440 1921.6368 1921.7167 1 17.2 KYIPGTK + 2 NHS-DOTA Lu (K + N-term) 
1992.8680 1991.8608 1991.9113 2 48.15 KGEREDLIAYLK  + NHS-DOTA Lu  
(N-term) 
2023.6942 2022.6869 2022.783 1 31.64 MIFAGIKK + 2 NHS-DOTA Lu (K + N-
term) 
2039.6796 2038.6723 2038.7779 1 19.97 MIFAGIKK + 2 NHS-DOTA Lu (K +N-term)  
+ Ox(M) 
2080.5879 2079.5806 2079.7746 0 28.54 EDLIAYLK + 2 NHS-DOTA Lu (K + N-term) 
2142.7869 2141.7796 2141.8815 1 55.57 KTGQAPGFSYTDANK + NHS-DOTA Lu  
(N-term) 
2142.7949 2141.7876 2141.8815 1 1.05 KTGQAPGFSYTDANK + NHS-DOTA Lu  
(N-term) 
2191.7659 2190.7586 2190.9351 1 30.58 IFVQKCAQCHTVEK + NHS-DOTA Lu (K) 
2208.7468 2207.7396 2207.8696 1 53.2 EDLIAYLKK + 2 NHS-DOTA Lu  
(K + N-term) 
2422.9031 2421.8958 2421.9398 1 40.54 GEREDLIAYLK + 2 NHS-DOTA Lu  
(K + N-term) 
2436.7031 2435.6959 2435.8504 1 14.53 KIFVQK  +3 NHS-DOTA Lu (2xK + N-term) 
2480.6589 2479.6517 2479.8402 1 13.18 KYIPGTK + 3 NHS-DOTA Lu  
(2xK + N-term) 
2550.9131 2549.9058 2550.0347 2 34.24 KGEREDLIAYLK + 2 NHS-DOTA Lu  
(K + N-term) 
2567.9688 2566.9615 2567.0686 0 51.25 GITWGEETLMEYLENPK + NHS-DOTA Lu 
(N-term) 
2572.7271 2571.7198 2571.9100 0 50.91 TGQAPGFSYTDANK 
 + 2 NHS-DOTA Lu (K+ N-term) 
2581.7607 2580.7535 2580.9065 1 24.82 MIFAGIKK + 2 NHS-DOTA Lu (K) 
2583.9690 2582.9617 2583.0636 0 11.61 GITWGEETLMEYLENPK  
+ NHS-DOTA Lu (N-term) 
2700.9038 2699.8965 2700.0049 1 25.08 KTGQAPGFSYTDANK  
+ 2 NHS-DOTA Lu (K + N-term) 
3109.0786 3108.0713 3108.1582 2 13.21 KGEREDLIAYLK  
+ 2 NHS-DOTA Lu (K + N-term) 
3254.1060 3253.0987 3253.2871 1 101.17 GITWGEETLMEYLENPKK 
+ 2 NHS-DOTA Lu (K + N-term) 
3270.2024 3269.1951 3269.2820 1 50.21 GITWGEETLMEYLENPKK 
+ 2 NHS-DOTA Lu (K + N-term) 
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9.5 Reactions 
9.5.1 Reaction of Maleimido-mono-amide DOTA with Cysteine Peptides 
O
N
N
N
N
NH
N
OH
O
OH
O
OH
O
O
O
R
1
NH
O
R
2
SH
+
R
1
NH
O
R
2
S
O
N
N
N
N
NH
N
OH
O
OH
O
OH
O
O
O
R
1
NH
O
R
2
SDOTA N
O
O  
After Complexation: 
R
1
NH
O
R
2
S
O
N
N
N
N
NH
N
O
-
O
O
-
O
O
-
O
O
O
Ln
3+
  
Mal-DOTA Cysteine peptide 
(R)-Mal-DOTA-peptide 
(S)-Mal-DOTA-peptide 
Lanthanide(III) Mal-DOTA-peptide 
IX  APPENDIX III – Additional Data 
 
-166- 
 
9.5.2 Reaction of NHS-DOTA with Amino Groups in Lysine 
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The reaction on lysine is an example. Reaction is also possible on all free amino-groups 
in a peptide, so all unmodified N-termini of other AA are targets as well. 
  
Lanthanide(III)-DOTA-labelled  
N-Terminus 
 
Lanthanide(III)-DOTA-labelled  
Lysine side chain 
 
Lysine 
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9.6 Microscopic Examinations of Matrix Crystal Sizes and Distributions 
 
Figure 51: Microscopic observations of matrix crystal sizes and distributions for different lanthanide salt contents. 
(Er stands for 40 μg/L erbium standard; Ln stands for the mixture of the five lanthanides 
141
Pr, 
159
Tb, 
169
Tm, 
165
Ho 
and 
175
Lu) 
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9.7 Sample Transportation 
For transportation in between the two laboratories, several possibilities were tested. It 
was made sure, that no sample degradation occurred in between transports.  
In general the tubes containing the samples were sealed additionally using Parafilm®. 
Tubes were placed in plastic bags, which were closed firmly. 
The samples themselves were usually transported in lyophilised form. If transportation 
took less than 24 hours, no additional cooling was necessary. For longer transports, by 
e.g. postal services or for samples in solution, a Styrofoam box was filled with dry ice, to 
ensure a temperature lower than -20 °C. 
Spotted MALDI-targets were put in their black transport box and fixated using foam 
material and sticky tape on the target corners. It was made sure that the surface was not 
touched during this process. Fixation was done in a way that ensured no movement of 
the target during transportation and that no friction of any kind was applied to the 
target surface. The transportation box was sealed with tape and put in an airtight 
transportation bag. No cooling was applied, to avoid attraction of moisture. Targets 
were generally measured within less than 48 hours of spotting. Good signal intensities 
and identification efficiencies were achieved using the transported targets. 
For targets that were cut by a guillotine, double-sided adhesive tape was used to fix 
them on a MALDI- target plate holder. The cut targets were transported on the plate 
holder, which was fixated in its transport box in a similar way to the normal targets. The 
transport box was sealed with parafilm and put into an airtight plastic bag, away from 
light, without cooling. 
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9.8 Publications and Conferences 
9.8.1 Publications 
Nano-High-Performance Liquid Chromatography with Online Precleaning Coupled to 
Inductively Coupled Plasma Mass Spectrometry for the Analysis of Lanthanide-Labeled 
Peptides in Tryptic Protein Digests 
Angela Holste †‡, Andreas Tholey ‡, Chien-Wen Hung ‡, and Dirk Schaumlöffel *† 
† Université de Pau et des Pays de l’Adour/CNRS UMR 5254, Laboratoire de Chimie 
Analytique Bio-Inorganique et Environnement/IPREM, 64053 Pau, France 
‡ Institute for Experimental Medicine−Div. Systematic Proteome Research, Christian-
Albrechts-Universität, 24105 Kiel, Germany 
Anal. Chem., 2013, 85 (6), pp 3064–3070 
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Publication Date (Web): February 1, 2013 
 
 
Laser Ablation ICPMS on MALDI-MS Target Plates for the Quantitative Analysis of 
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Angela Holste †‡, Julien Malherbe†, Christophe Pécheyran†, Andreas Tholey ‡, Chien-
Wen Hung ‡, Thomas Jakoby‡, and Dirk Schaumlöffel *† 
† Université de Pau et des Pays de l’Adour/CNRS UMR 5254, Laboratoire de Chimie 
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‡ Institute for Experimental Medicine−Div. Systematic Proteome Research, Christian-
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In preparation 
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9.8.2 Conferences 
Spectr’Atom 2012  
19-22 June, Pau France  
Poster Presentation:  
NanoLC-ICP-MS et MALDI-MS pour l'analyse de peptides marqués avec des lanthanides1 
 
 
 
European Winter Conference on Plasma Spectrochemistry (EWCPS) 2013  
10-15 February 2013, Krakow, Poland 
Poster Presentation:  
Analysis of lanthanide labelled protein digests via RP-IP-nanoHPLC coupled to ICP-MS 
and MALDI-MS  
                                                     
1 Awarded with the 1st prize for the best poster, provided by Bruker Daltonique, France 
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